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To the intoxicated patients
de lijn die voedt en stoffen zuivert
de hoop die aan het leven hecht
het zijn de handen van ons allen
die maken wat niet is
en breken soms wat blijven moest
maar allen zijn wij aangelijnd
ongemerkt in andere hand
zo koesteren wij ons in zekerheid
een zekerheid van korte duur
die - God zij dank! - voor eeuwig lijkt
Carel P. de Haseth
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In 1996, in a small dialysis center (Diatel Curaçao), ten hemodialysis
patients died of subacute aluminum encephalopathy, as a result of a unique set
of circumstances. This was caused by a hitherto unknown source of aluminum
exposure, namely aluminum that was released from the cement lining of a newly
installed drinking water distribution pipe.1-2 The clinical, forensic and legal
aspects of this tragic poisoning incident form the subject of this thesis. 
Aluminum
In 1857, Charles Dickens became very interested in the discovery of a
new metal that he believed would have an outstanding future, aluminum:
"Within the course of the last two years ... a treasure has been divined, unearthed
and brought to light ... what do you think of a metal as white as silver, as
unalterable as gold, as easily melted as copper, as tough as iron, which is malleable,
ductile, and with the singular quality of being lighter that glass? Such a metal does
exist and that in considerable quantities on the surface of the globe".3
Aluminum is a ubiquitous metal in the natural and industrial environment
and has been considered a harmless substance for a long time. After oxygen and
silicon, aluminum is the third most abundant element in the earth’s crust, of
which it comprises about 8.2%.4 Aluminum has a great affinity for oxygen and
therefore occurs only in the oxidized form, mainly as alumina (Al2O3). It is
found in almost 300 different minerals, especially in complex compounds such
as silicates like feldspars and micas, and is widely distributed in rocks, clay and
soils including gems such as ruby, sapphire and turquoise, and minerals of
industrial importance (alum, bauxite, cryolite, corundum and kaolin).5-6
Bauxite, the primary ore, is composed of impure oxides found in extensively
weathered rocks in the tropics. As a highly charged and reactive element,
aluminum is virtually always encountered in combined form.7-8 In fact, its
ability to form strong chemical bonds initially frustrated man’s attempts to
obtain even the most minuscule of purified samples of the metal. This made it
so rare that the Emperor Napoleon Bonaparte used aluminum plates and
cutlery in 1858 to serve the King of Siam at a state banquet. Aluminum was
then such a precious metal that "less important" guests had to eat from plates
of pure gold. However, although aluminum was not isolated until 1825 by
10
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Hans Christian Oersted from Denmark,3 alum (hydrated aluminum sulphate)
had already been used for several thousand years by the Egyptians, Greek and
Romans as a mordant in the dyeing process, in the preparation of hides, and
since Roman times for the purification of water.5,9 In 1886 the Hall-Heroult
process for the electrolyte separation of the metal finally yielded commercially
feasible quantities of aluminum and transformed what was an exceedingly rare
substance into a widely employed component of numerous industrial and
household products.10
Despite the ubiquity of aluminum in the environment it is present only
in trace amounts in living organisms and no biological function for the element
has been described. In a paper by Von Döllken in 1897, reference was made to
the earliest publication (by Orfila in 1814) discussing the potentially toxic
effects of aluminum salts on animals, where behavioral changes and irritability
were noted following parenteral administration. Von Döllken also commented
on work performed by Siem in 1887 in which detailed animal studies found
quite profound neurological changes following the parenteral administration of
aluminum.11,12 It was first recognized as a human neurotoxin in 1886, in a
Prussian army study of amputees whose wounds had been treated with alum to
staunch bleeding.13 Although toxicity was reported periodically, not much atten-
tion was given to Spofforth, who in 1921 published the first description of the
toxic effects of aluminum on man. He discussed the case of a 46-year-old metal
worker who had been dipping red-hot metal articles into concentrated nitric
acid using an aluminum holder and developed "loss of memory, tremor, jerking
movements and impaired coordination".12,14 A publication, in 1928, by Ernest
Ellsworth Smith referred to a study from 1880 in which feeding of alu-
minum containing baking powder to dogs led to an increase in organ alu-
minum, establishing the absorptive potential of the intestine for this ele-
ment. He also covered several aspects of current concern namely aluminum in
medicines, its absorption from the gastrointestinal tract, its presence in drink-
ing water and its potential effects as a health hazard.5,15-17 In 1940, Kehoe and
colleagues emphasized the need to establish normal aluminum values in man18
and in 1957, after reviewing 503 references, Campbell and coworkers concluded
that aluminum presents a hazard in only a few special circumstances.19 The
current interest in aluminum, however, began in the mid 1960s and early 1970s
11
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by developments in several areas of medical research and its applications.
Aluminum was not considered to be a toxic element until the 1960’s when
a few reports appeared on the toxic effect of aluminum in humans20 and
animals.21 In 1970, Berlyne and coworkers drew the attention to the occurrence
of hyperalumenemia in chronic renal failure due to the consumption of aluminum
resins. Increased levels were found in nondialyzed patients with chronic renal
failure either taking aluminum resins for hyperkalemia, or taking aluminum
hydroxide for hyperphosphatemia.22 Although the statement of Berlyne
appeared to be prophetic later, he was initially highly criticized when he
claimed that aluminum salts should not be prescribed for patients with renal
function impairment, and that these salts should be withdrawn from the
market. In 1972, in a paper by Alfrey and his colleagues, the first account was
given of an outbreak of encephalopathy in a dialysis center, which was called
"dialysis dementia".23 Unfortunately, numerous similar incidents followed,
especially due to the use of aluminum salts by water companies that contaminated
the water supply of dialysis centers,24-30 but also due to errors in design of
hemodialysis equipment.30-32 
In the face of abundant aluminum exposure and its demonstrated
toxicity, living organisms have both active and passive mechanisms to prevent
aluminum accumulation. In humans, this includes gut design that reduces
absorption; internal chelation and excretion primarily through the kidney;
sequestration in bone and binding by transferrin, the main blood metal shuttle
protein, which reduces blood levels.33,34 Being especially vulnerable to the
toxic effect of aluminum, the brain has lower aluminum levels than many
other tissues due to partial exclusion by the blood brain barrier.35 An active
efflux mechanism for aluminum from the brain, probably as aluminum citrate
is mediated by the monocarboxylate transporter,36,37 as well as removal by
other mechanisms such as by small peptides.38,39 Nevertheless, while some
aluminum that enters the brain is rapidly refluxed, another fraction is
eliminated very slowly,36,37 causing severe encephalopathy after repetitive or
continuous exposure.30
Presently, wide ranges of toxic effects of aluminum to hundreds of
cellular processes both in man, animals and plants have been demonstrated.
12
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From a medical point of view, it seems remarkable to associate a single agent,
especially one until recently considered to be completely harmless, with so many
disease conditions.40 Its wide range of toxic effects is largely attributed to its
small ionic radius (0.54 Å)41,42 and its high oxidation potential (+1.706 V)42,43
causing it to bind in a biological environment, to almost any oxygen or
nitrogen atom.44 In addition, because aluminum is amphoteric, it can combine
with both acids and bases to form respectively aluminum salts and aluminates.41-45
The ability to be bound nonspecifically to so many different structures implies,
for Al3+, a potential possibility to affect or interfere with almost any reaction in
organisms.44-46 The possible effects of aluminum also have escaped attention
because biological experiments tend to underestimate the effects as these may be
far too slow in relation to the study design and many effects appear only after
several decades of exposure. Numerous technical difficulties are also accountable
for the relative lack of knowledge of aluminum-related effects in biological
species.45-47 Using analytical methods that suffered from lack of sensitivity
and major interference problems -which resulted in erroneous and inconsistent
findings- hampered earlier studies predicated on the determination of
aluminum in biological samples. With the development of electrothermal atomic
absorption spectrometry (ETAAS) and other instrumental methods for the
measurement and speciation of trace metals, these problems have been largely
overcome.45,46 Nevertheless, due to the multifaceted interaction of aluminum
with molecules found in biological systems at trace levels,45 even today-after
more than thirty years of intensive research- several aspects of aluminum
metabolism and toxicity still remain to be elucidated.45,46 
Water production and distribution on Curaçao
Curaçao is a small island with a total area of 444 square kilometers (171
square miles), situated 40 nautical miles (74 km) off the north coast of
Venezuela. Being just 12 degrees from the equator, Curaçao has a warm, dry
(total annual rainfall averages only 570 mm or 22 inches) and sunny climate
year round with an average temperature about 27°C (81oF) and together with
the strong tradewinds (average velocity 7 meter/sec), a high degree of evaporation
is observed.47 Because Curaçao has no natural water resources its public drinking
water supply depends totally on seawater desalination which was performed,
13
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until recently, by multistage flash distillation.48,49 The distillation process mimics
the natural water cycle in that salt water is heated, producing water vapor that,
in turn, is condensed to form fresh water. However, for this to be done
economically in a desalination plant, the boiling point is altered by adjusting
the atmospheric pressure on the water being boiled to produce the maximum
amount of water vapor under controlled conditions. Of the more than 7,500
desalination plants in operation worldwide, 60% are located in the Middle East
and 12% in the Americas, most of them located in the Caribbean and Florida.50
Corrosiveness of the water on Curaçao
If iron water distribution mains are used, distilled water needs additional
modification because very pure water is highly corrosive, resulting in rusting,
leaks and reduced longevity of these mains. Among the water characteristics that
most significantly influence the corrosion rate is the alkalinity. Alkalinity is
composed mostly of carbonate and bicarbonate ions and is expressed as
CaCO3 mg/L. It provides water with buffering capacity to neutralize changes in
pH. It also helps lay down a protective coating of metallic carbonate on the pipe
wall and can help prevent the dissolution of calcium and metals from cement-
lined pipe. The lower the alkalinity, the more corrosive the water will be.51-53
Before 2001, until the fusion of the two companies, in Curaçao, the alkalinity
of the drinking water was established in the delivery contract between the water
company and the water distribution company. The alkalinity was low in the
past,53 but was increased substantially in June 2002 (Table 1).54
14
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a The extent to which water can corrode the material used for water distribution depends on the characteristics of both
the water and this material but there is no simple relationship of water characteristics defining the corrosiveness of water
for these materials. For cement protection, water with a high alkalinity provides water with buffering capacity to
neutralize changes in pH. It also helps to lay down a protective coating of metallic carbonate on the pipe wall and can
help to prevent the dissolution of calcium and metals from cement-lined pipe by sealing the cement pores.50-52
bThe alkalinity of the tap water was established in the water delivery contract between  the water company and the water
distribution company (or Aquaelectra after their fusion in 2001).
 cAquaelectra laboratory.
Table 1. Alkalinitya (mg CaCO3/L) of the drinking water in Curaçao, 1996-2002
Corrosive
Waterb,1,2,4,5
Before 19961 Water
delivery
contractc,
19791
Water
delivery
contractc,
200254
August 2002d
Alkalinity, as
CaCO3 (mg/L)
< 60-75 25-40 < 60 > 50 45-63
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Generally, the effectiveness of the corrosion-prevention system has a
direct bearing on the longevity of the pipeline and it significantly influences
operational costs such as general maintenance, pumping energy, and capacity
upgrades.55 Corrosion is therefore one of the most important problems in the
drinking water industry,56 and consumes about 3-4 percent of the gross
national product in developed countries.55,56 In Curaçao, the water utilities
have an operational water loss of about 30%, partly due to corrosion problems,
resulting in an energy loss of about 1403 TJ/year (thermal energy), which, in
1988, was almost the same amount as the total estimated energy consumption
(1447 TJ/year) of the population.57 This very high water loss is also reflected
in the cost of drinking water (flat rate domestic water: 9.42 NaFl/m3 or 5.3
US $/m3), which in Curaçao is by far the highest in the region.58,59
In Saudi Arabia, very large desalination plants experienced similar
corrosion problems in the past with soft water. By increasing the calcium
carbonate level to concentrations above 60 mg/L, the corrosion rate was
significantly reduced because a protective calcium layer was formed on the
inner pipe wall. Thereafter, the calcium carbonate concentration could be
reduced.51 In Curaçao, the adaptations made by the water company were
insufficient and some iron water mains had to be replaced within 10 to 15
years,60 in contrast with less corrosive drinking water conditions in other
countries where cemented pipes may have an asset life of 100 years or more.61
This prompted the water distribution company to install water pipes with a
cement layer to protect the iron pipe from corrosion and increase the
longevity of the water mains.52
Worldwide, cement coatings have been used for over 100 years by
the water industry and these generally provide considerable protection to
embedded ferrous materials against the corrosive effects of soil and water.61
Cement mortar pipes, however, cannot be used under all conditions, as its
appropriateness is not only related to the cement composition but also to
the characteristics of the water to be transported.1,51-53,61 In Curaçao the
cement lining dissolved partially due to the softness of the distributed
water. Consequently, components of cement leached into the water supply
of the dialysis center resulting in moderately higher calcium concentrations
and excessively high aluminum concentrations for a prolonged period of
time.1,2,30,52
15
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Renal disease and dialysis facilities on Curaçao
In 1981, Curaçao had 147.388 inhabitants, a number that
decreased to 130.067 in 2001. In the United States62 and in some European
Countries,62-65 men from African descent are among the fastest growing
racial minority groups with end stage renal disease (ESRD). Recently, as an
example, African-Americans comprised approximately 31% of the ESRD
population in the United States,62 resulting in a three to five times greater
incidence amongst subjects of African-Caribbean origin compared with
Caucasians in the United Kingdom.63 Likewise, as can be expected, the
high prevalence of end-stage renal disease in Curaçao is above 1 per 1000,
since 85% of the population is of (mixed) African origin.66 In 1992, with
the aid of the Dutch Kidney Foundation, a dialysis unit (Diatel Curaçao)
with eight units was opened as the eleven dialysis units in the local hospital, did
not suffice to take care of the increasing number of patients with ESRD.
Legislation 
Curaçao is the largest island of a federation called the Netherlands
Antilles. This federation, which is constituted by the islands of Curaçao,
Bonaire, St. Maarten, Saba and St. Eustatius, is an autonomous part of the
Kingdom of the Netherlands. With respect to the Netherlands Antilles,
the fundamental laws are enacted in the "Staatsregeling" and
"Eilandsregeling Nederlandse Antillen". Each of the islands of the
Netherlands Antilles is autonomous in a distinctive manner. Matters of
common interest to the islands, such as jurisdiction, police etc., are
administered by the Central Government of the Netherlands Antilles.
Deputies of the Executive Body of the Island Council (Bestuurscollege)
regulate matters of local concern.67 During the four years following the
aluminum intoxication, a criminal prosecution was conducted to evaluate
if the physicians in charge of the dialysis program had been criminally
negligent. Since the local law -which was to be amended the following
year-,68 did not permit the prosecution of board members of legal entities
like foundations,69 neither the water utilities, nor the board members of
Diatel were prosecuted. 
16
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Aim 
The general aim of this thesis is to address 1) the sequence of events
regarding the actual poisoning incident, including the new clinical and
pathogenetic insights of subacute aluminum-intoxication, 2) the causes of
the incident related to the water management, and 3) the forensic and legal
consequences. 
In chapter II, the impact is rendered of the use of water distribution pipes with
inner cement linings, on the quality of tap water. 
In chapter III, the outbreak of subacute aluminum encephalopathy in a
dialysis center is described.
In chapter IV, the post-mortem toxicological findings in subacute
aluminumencephalopathy are presented.
In chapter V, the literature on symptomatology, the sources of aluminum
exposure and pathogenic mechanisms of aluminum intoxications is
reviewed. Also a treatment schedule to treat hemodialysis patients with
aluminum intoxication is shown. 
In chapter VI, the judicial implications of the subacute aluminum
intoxication outbreak are discussed. 
17
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Abstract
I n 1996 in Curaçao, acute aluminum (Al) intoxication sickened patientsin a dialysis center that used tap water to prepare dialysate. The mortalityrate was 32 percent. A new factory-lined cement-mortar water distribution
pipe had recently been installed. It is known that substantial amounts of
barium, cadmium, and chromium can leach from cement-mortar linings. This
article shows that high concentrations of Al can leach from cement mortars for
at least two years in soft aggressive water. The newly installed pipe, cement
containing four times as much Al as usual, corrosive water, the high pH and
temperature of the water, long residence time and perhaps the use of the
corrosion inhibitor polyphosphate may have promoted this leaching.
Certification of cements used to line water pipes is warranted. Central water
treatment plants must distribute noncorrosive water, especially plants that use
membrane desalination or other reverse osmosis or nanofiltration processes.
Dialysis centers should be promptly informed of any impending change in
water treatment that might increase the Al content of tap water and also of any
accidental pollution of the water distributed. Dialysis centers should always
practice extended purification of tap water used for dialysate. Although Al as a
risk factor for Alzheimer’s disease in the general population is still debated,
there is no doubt that Al causes dialysis encephalopathy. 
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Introduction
Aluminum (Al), a ubiquitous metal in the natural and industrial
environment and has long been considered a harmless substance. It may be a
natural or an added ingredient in food and drinking water. In past decades, it
has been suggested that Al in drinking water plays a role in Alzheimer’s disease.
Al concentrations < 100-200 µg/L in drinking water do appear to be an
important risk for the normal population.1-3 A different situation exists with
regard to the role of Al in dialysis encephalopathy in hemodialysis patients. That
Al causes this neurological disorder is beyond dispute.4-6 Early epidemics of Al
intoxication in dialysis centers were largely due to contamination of
hemodialysis fluid made with tap water. The geographical distribution of these
incidents correlated with locally high concentrations of Al in rap water, mainly
from the use of Al salts as a flocculant during water treatment.5,7 To arrest these
epidemics, many dialysis centers began to purify their tap water with
combinations of  filtration, carbon adsorption, deionization, and reverse
osmosis (RO) tailored to the individual water supply.4-6,8,9
Even so, some dialysis centers still us drinking water for hemodialysis
without special treatment.8,9 In these cases the dialysis centers and home
dialysis patients rely on a constant, acceptable quality of drinking water from
the public supply. To protect such hemodialysis patients, some countries
require drinking water companies to inform the public health authorities if the
Al content in drinking water has exceeded 30 µg/L in the finished water
entering the distribution system.10 It has been generally assumed that the Al
concentration does not increase during distribution.11,12
This article describes for the first time an outbreak of acute Al intoxication in a
dialysis center because of Al contamination of drinking water during distribution. The
possible origin and consequences of this source of contamination are discussed.
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The intoxication episode was unexpected
The water supply had been reliable
With the support of the Dutch Kidney Foundation, a dialysis center
with eight stations (Diatel Curaçao) was opened in Willemstad, Curaçao, in
1992. The water used for dialysis was obtained from the local drinking water
company. The water company produced drinking water from desalinating
seawater, which has a very low metal content (Al concentration < 5 µg/L).
Because this water had been used for dialysis without purification for > 26 years
in the local hospital, further water treatment in the dialysis center was judged
to be unnecessary. 
On occasion, network flow conditions in the water mains caused low
water pressure that prevented normal dialysis at the center. The drinking water
company remedied the pressure problem by changing the distribution to the
dialysis unit, as part of a larger project for rebuilding the distribution network.
On Mar. 21, 1996, the drinking water company laid a cement-mortar
water distribution pipe; water began to flow to the dialysis center through this
new pipe on May 21, 1996. 
Dialysis patients became ill
The first signs of illness among the dialysis patients were noted on June
15, 1996; patients suffered nausea, vomiting and hypercalcemia. These illnesses
were attributed to a higher-than-usual calcium (Ca) content in the tap
water (on June 24, 1996, hardness as CaCO3 was 43 mg/L). On June 29,
1996, after the insufficient success of medical intervention, the dialysis center
was temporarily closed. Thereafter, patients were dialyzed in the hospital using
tap water further treated with RO and later, after installation of an RO unit,
in the reopened dialysis center. At first the patients seemed to do well, but after
a clinical silent period of days to weeks, nine of the twenty-eight intoxica-
ted patients (32 percent) died with symptoms of acute Al intoxication. 
The nature of the disease was difficult to trace in the beginning
because it was thought that only the calcium content of the water had changed.
Later, clinical symptoms such as seizures and coma pointed to acute Al
intoxication. The fist analysis of Al concentrations in the tap water was
obtained July 3, 1996, about six weeks after the pipe was put in use. The value,
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650 µg/L, was about 40 times as high as the usual value. Experts from the
Netherlands (International Water Consultancy, Keuringsinstituut voor
Waterleiding Artikelen, and Netherlands Organization for Applied Scientific
Research) concluded that both calcium and Al had leached from the cement
mortar of the newly installed water distribution pipe. 
Water is distributed through iron pipes
New cement-mortar pipe had been installed
The distribution mains consisted mainly of ductile-iron pipes.
Corrosion and red water problems led to the use of cement-coated pipes to
protect the iron in a region that supplied the dialysis center and a small
shopping area. The pipes connecting the water mains and the dialysis unit
were 2,200-m- (7,200-ft-) long ductile-iron pipes with a cement-mortar
lining. Two pipes from different companies were used. One pipe was 1,700
m. (5,580 ft) long and had a diameter of 200 mm (8 in.). The other pipe
was 500 m. (1,640 ft) and had a diameter of 150 mm (6 in.). The water
flow was 27.5 m3/d (7,266 gpd) providing a low velocity of about 0.01-
0.04 m/s (0.03 – 0.13 ft/s). Moreover, periods of suspended flow were
likely after office hours. On the basis of the flow rate, a residence time of
the water in each segment was calculated: it was two days in the  200 mm-
(8in.-) diameter pipe and 0.32 days in the 150-mm- (6-in.-) diameter pipe.
The total residence time of the drinking water in the cement-coated pipes
therefore is estimated as 2.3 days. Periods of suspended flow are likely after
office hours.
In July 1996, after the intoxication of the patients and installation
of a RO unit, the persistent extremely high Al concentration in the tap
water became apparent. In response, the original 2,200 m (7,200 ft) of
the cemented pipe was reduced to 1,000 m (3,280 ft) Aug. 1, 1996, by
changing the influent water point of the water mains. 
Both new pipes placed in the distribution network were lined
with cement mortar at the factory, by a rotary centrifugal process, and
neither had an asphaltic seal coat applied to the lining. The cement
type was very similar to blast furnace cement and had a high sulfate
resistance.* The cement used in the distribution network had a higher Al
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content than blast furnace cement, pozzolanic metallurgical cement, or
portland cement, but a lower content than high alumina cement (Tabel 1).
Drinking water is flash distilled seawater
The water used in the dialysis fluid was obtained from the local drinking
water supply, which was then filtered but not further purified. At the water plant,
seawater was treated with multistage flash distillation in a desalination plant. The
distilled water was filtered through coal and conditioned by marble filtration.
Fluoride was added and ultraviolet light disinfection was applied. Chlorine was not
routinely applied. Polyphosphate was added as a corrosion inhibitor at a dosage of
1 µg/l of the chemical product. The water entering the mains was aggressive, soft,
and of low alkalinity (maximum Langelier Index [LI]  between -0.5 and -1.5,
hardness as CaCO3 15-20 mg/L, and pH 8.5 to 9.5).
Al and Ca were high in tap water
Tap water was sampled many times for testing according to association for the
Advancement of Medical Instrumentation (AAMI)  standards.13 The samples were
placed in pyrrolytical tubes and shipped overnight for analysis.† Al analysis was performed
by inductively coupled plasma-atomic emission spectroscopy. Water quality
parameters were measured by the local water company and a laboratory in Holland.‡
* Netherlands Organization for Applied Scientific Research, The Netherlands
† Spectra Laboratories, Fremont Calif.
‡ International Water Consultancy
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Table 1.  Composition of cement types commonly used in cement-lined pipe and composition of
                cement described in this report
Parameter Blast
Furnace
cement
Pozzolanic
Metallurgical
cement
High-
Alumina
Cement
Portland
Cement
Cement
composition in
this case
SiO2, % 27 29 3.5 21 18
CaO, % 48 44 38 65 55
Free CaO, % 0.5 1.5 0.5 2.5 ND**
Al2O3, % 13 13 36 5 18.7
Fe2O3, % 1.5 3 18 2.5 3.5
SO3, % 3.8 2.2 0.1 1.9 ND
Na2O, % 0.4 0.3 0.1 0.1 ND
K2O, % 0.8 0.7-1.7 0.05 0.8 ND
MgO, % 2.8 3 0.4 0.5 4.3
Density, g/cm3 2.9 2.8 3.2 3.1 ND
Specific surface,
cm2/g
3,350-3,450 3.650 2,750 3,870 ND
**ND-not determined
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Water constituents and parameters important in dialysis were
measured in 1994, 1996, 1997 and 1998 (Table 2), and the Al concentration
in the tap water from July 1996 to March 1998 was plotted (Figures 1 and 2).
In 1994 the Al concentration in the tap water entering the dialysis unit was
16 µg/L. 
In 1996 AL was first measured after the new cement-mortar pipe had
been in use for six weeks. The Al concentrations ranged from 550 to 690 µg/L
for more than 2 months after the pipe was put in use. After the original
2,200-m (7,200-ft) was reduced to a length of 1,000-m (3,280-ft) Aug. 1,
1996, the Al concentrations dropped to a maximum of 443 µg/L. Flushing the
pipe several times temporarily lowered of the Al concentration. More than two
years after the pipe was put into use, Al still leached to concentrations above
100 µg/l (Figures 1-3). Initially, other water parameters changed as well: pH
increased from 8.5 to 9.1, total hardness as CaCO3 from 15 to 43 mg/L,
alkalinity from 18 to 32 mg/L (as CaCO3) and L1 from -0.5 to +0.4. Ca
concentrations as Ca2+ in the tap water ranged from 16.3 to 18.1 mg/L, only
slightly higher than the concentration of 15 mg/L at the water plant. Water
quality tests on July 30, 1996, found other components of cement as well,
especially silicon (22 µg/L), molybdenum (17 µg/L) and strontium
(2600 µg/L).
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Figure 1. Aluminum in tap water-July 1996-May 1997
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Figure 1. Aluminum in tap-water July 1996-May 1997
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Discussion
Cement is not inert
Several factors promote leaching of Al
Ferrous-metal water distribution pipe can corrode by electrochemical
action, which leads to scaling, leaks and tuberculation. Lining the pipe interior with
cement mortar protects the metal from corrosion by providing a coating of electro-
chemically inert material between the metal and water. Although cement-mortar
lining successfully protects against electrochemical corrosion, water can leach
cementitious materials from this lining for as long as four years. Extended contact
time under low-flow conditions can increase pH, alkalinity and concentrations of
leached components such as calcium.14 In addition, recent laboratory studies showed
that substantial amounts of barium, cadmium, and chromium can leach from
cement-mortar linings.15 Reports of these studies did not mention substantial
leaching of Al. Water that is low in pH and alkalinity and that contains little calcium
appears to be the most corrosive to cement-mortar linings.14-19
Cement composition influences leaching
Corrosion rates are influenced by cement mortar composition, the
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Table 2. Composition of tap water at Diatel Curaçao –January 1994-August 1998
Constituents and
parameters
January
1994
July
1996
August
1996
November
1996
February
1996
April
1997
May
1997
Sodium, mg/L 22.98 14.48 14.29 16.82 19.72 23.04 34.1
Potassium, mg/L 2.350 1.999 1.917 1.205 <1.000 1.726 2.445
Aluminum, µg/L 0.016 0.650 0.401 0.099 0.103 0.149 0.231
Calcium, mg/L 10.79 18.1 14.43 15.46 19.84 16.04 16.55
Copper, mg/L 0.003 <0.005 0.016 0.013 0.068 0.020 0.012
Magnesium, mg/L 4.618 1.665 2.082 2.541 4.545 3.377 4.601
Selenium, mg/L <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 <0.05
Zinc mg/L 0.184 0.062 0.093 0.081 0.207 0.063 0.054
Chromium, mg/L <0.005 0.007 0.006 <0.005 0.007 0.005 0.012
Lead, mg/L <0.001 <0.002 <0.002 <0.002 <0.002 <0.002 <0.002
Arsenic, mg/L <0.002 <0.002 <0.002 <0.002 <0.002 <0.002 <0.002
Mercury, mg/L <0.0002 <0.0002 <0.0002 <0.0002 <0.0002 <0.0002 <0.0002
Cadmium, mg/L <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Fluoride, mg/L 0.18 0.50 0.40 0.64 0.38 0.72 0.71
Nitrate(N), mg/L <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Sulfate, mg/L 5.1 4.1 3.9 3.70 4.8 5.5 8.5
PH 7.5 8 8.1 7.9 8.2 8.0 8.4
Resistivity, meg Ohms 0.005 0.006 0.006 0.005 0.004 0.004 0.003
Silver, mg/L <0.003 <0.003 <0.003 <0.003 <0.003 <0.003 0.003
Barium, mg/L 0.003 0.004 0.003 <0.001 0.002 0.001 0.002
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method of lining, and by protective coatings.14-19 Generally the concrete used for
water treatment plant pipes, water tanks, and filters is made of portland cement,
whereas cement mortar linings may be portland cement, high alumina cement,
blast furnace cement or super-sulfated cement. The use of high-alumina cement
and acrylic resins additives greatly increases corrosion resistance of the mortars, but
the setting behavior of high-alumina cement differs from that of any other type of
cement. The compounds formed are not the same, the nature of the process
depends on the temperature, and the reactions lead to an excess of Al hydroxide.16
More than 100 compounds and phases important to the chemistry of portland
related cements have been described,20 and because of the possibility of solid
solution, probably many more exist. 
Solution of Al compounds in cement poorly understood
Understanding of the thermodynamic solubility in water of  the major
compounds in cement lags far behind the understanding of minerals and
synthetic compounds important to drinking water chemistry. At present, only
some qualitative generalizations can be made. Three of the predominant
crystalline phases in cement are tricalcium silicate (nominally Ca3SiO5),
33
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Table 2. Composition of tap water at Diatel Curaçao –January 1994-August 1998,
Continued
Constituents and
parameters
August
1997
September
1997
November
1997
February
1998
April
1998
June
1998
August
1998
Sodium, mg/L 8.013 7.596 11.32 10.24 23.34 12.37 7..364
Potassium, mg/L <1.000 1.725 <1.000 <1.000 1.92 1.808 1.377
Aluminum, µg/L 0.090 0.090 0.064 0.088 0.090 0.103 0.070
Calcium, mg/L 25.42 23.16 29.10 18.95 22.88 17.87 16.56
Copper, mg/L 0.070 0.057 0.161 0.079 0.051 0.032 0.055
Magnesium, mg/L 1.246 1.872 1.759 2.382 4.213 2.562 1.895
Selenium, mg/L <0.05 <0.05 <0.05 <0.05 <0.002 <0.002 <0.005
Zinc mg/L 0.162 0.091 0.179 0.092 0.055 0.069 0.071
Chromium, mg/L <0.005 0.009 0.009 0.006 <0.005 <0.005 <0.005
Lead, mg/L <0.002 <0.002 <0.002 <0.002 <0.002 <0.002 <0.002
Arsenic, mg/L <0.002 <0.002 <0.002 <0.002 <0.002 <0.002 <0.002
Mercury, mg/L <0.0002 <0.0002 <0.0002 <0.0002 <0.0002 <0.0002 <0.0002
Cadmium, mg/L <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Fluoride, mg/L 0.47 0.42 <0.10 0.12 <0.10 <0.10 0.67
Nitrate(N), mg/L <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Sulfate, mg/L 1.7 1.9 2.5 2.4 5.4 2.9 1.8
PH 7.9 8.0 7.9 8.2 8.0 7.3 8.0
Resistivity, meg Ohms 0.005 0.005 0.005 0.006 0.003 0.006 0.007
Silver, mg/L <0.003 <0.003 <0.003 <0.003 <0.003 <0.003 <0.003
Barium, mg/L 0.002 0.002 0.002 0.001 0.001 <0.001 <0.001
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 9
dicalcium silicate (nominally Ca2SiO4), and tricalcium aluminate (Ca3Al2O6).
Possible dissolution reactions may be represented as follows:16
Ca3SiO5(s) + 5H2O  3Ca2+ + H4SiO4 + 6OH- (1)
Ca2SiO4(s) + 4H2O 2Ca2+ + H4SiO4 + 4OH- (2)
Ca3Al2O6(s) + 6H2O 3Ca2+ + 2Al3+ + 12OH- (3)
Cement-lined pipes in Holland studied
After the tragedy in Curaçao, studies in 1996 investigated the leaching of
Al from cement-mortar water pipes in Holland.21 Samples were taken from water
in cemented pipes and asbestose cement-pipes at 20 locations. Locations that favored
the leaching of Al were chosen: new, small-dimeter pipes, low flow and soft water.
Al concentrations in these samples never exceeded 11 µg/L at any location.
Investigators concluded that home hemodialysis might be safe with this water, but
because higher concentrations cannot be excluded in new pipes, they advised
testing for pH and Al shortly after new cemented pipes are installed.
In Holland the recommended cement types are portland cement and portland
cement with high resistance against sulphates.22 To use other types of cement, the
water supplier must prove the appropriateness of the pipe. In 1999, however, no laws
apply and no certification of the toxicological aspects of pipe has been implemented. 
Two types of cement investigated
A set of studies investigated ordinary portland cement (OPC) mortar
lining and a blast furnace slag (GGBFS) cement mortar containing 65 percent
GGBFS and 25 percent OPC applied in situ and in the factory.18, 19 The extent
and duration of pH increase appeared to depend primarily on the alkalinity of
34
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Figure 2. Aluminum in tap-water May-March 1998
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the water. The pH increased in water from all pipes (except one) containing in situ
linings;  water carried by the one exception was hard. Only in low-alkalinity water
did Al concentration increase after passing through cement-mortar pipes. Al
concentrations above the (EC) Directive23 maximum admissible concentration of
200 µg/L were found for a prolonged period, one to two months, low- alkalinity
water (about 10 mg/L CaCO3).18 After long contact times (up to 13.30 h) in cement-
mortar pipes that had been exposed for 40 days to a typical soft water, water was
sampled and analyzed for Al. Al concentrations were as much as 380 µg/L (GGBFS
in situ linings) and 450 µg/L (OPC in situ linings). Factory-applied linings leached
less Al into the water than did in situ linings. It was suggested that under conditions
of low flow and long retention times, should determine which cement type should
be used. In situ linings of OPC should not be used if the supply water has
an alkalinity  < 55 mg/L; in situ linings of GGBFS should not be used
if the supply water has an alkalinity < 35 mg/L.18 Factory-applied cement
linings could be used when the water supply alkalinity is > 25 mg/L CaCO3.19
Water quality influences leaching
High pH
Aside from high Al content of the cement linings,  mobilization of Al from
the cement may have been promoted by the high pH of the water, which increases
Al solubility. Al in water forms numerous complexes with inorganic and organic
ligands, as well as polynuclear intermediates and Al trihydroxide colloidal precipitates
under neutralizing conditions. The solubility and speciation of inorganic Al depend
strongly on pH, whereas the solubility of organically complexed Al correlates with
the concentration of dissolved organic matter. In distilled water with low concentrations
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of dissolved organic compounds such as humic and fulvic acids, the dependence of
dissolved Al on pH resembles on a logaritmic scale a parabola with a sharp solubility
minimum near pH 6.5 (figure 4). In water more acid than pH 5, Al3+ exists as an
octahedral hexahydrate, Al(H2O)63+, usually abbreviated as Al3+ and referred to as free
Al. As a solution becomes less acidic, Al(H2O)63+ undergoes successive deprotonations
to yield Al(OH)2+, Al(OH)2+, and soluble Al(OH)3, and the number of water molecules
with a decreases but is variable. At pH > 6.2 tetrahedral aluminate, Al(OH)4-, is the
primary soluble Al(III) species.24 Al concentrations in the water will be related to pH
and to Al hydroxide solubility equilibria. In addition to complexing with the hydroxide
ion, the Al ion will also form complexes with inorganic ligands such as fluoride (F-),
sulphate (SO42-) and silicate (HSiO43-).25,26
The pH has a pronounced effect on the corrosion of cement-mortar
linings. An EC directive for drinking water states that an appropriate pH range is
6.5-8.5, but for extremely soft water it should be 9.5 (EC 1980).23 In Germany,
Denmark, and some parts of France,
authorities require that drinking
water be calcifying to protect against
corrosion. The German national
regulation states that if the calcium
carbonate saturation index is < 0, the
pH must be adjusted to 7.8-8.0. This
regulation is intended to protect
cement materials and to avoid
releasing metals into drinking
water.23 The West German Standard
W342 (DVGW 1978) identifies the
type of water for which cement-
mortar lining is appropriate. Water
should have a total carbonic acid
concentration of < 0.25 mol/m3
(about 11 mg/L) as CO2 and a calcium
concentration of > 0.02 mol/m3
(about 1 mg/L) as Ca2+. Calcium
leaching increases as the concentration
of dissolved carbon dioxide increases.27
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Figure 4. Aluminum hydrolysis24
Al3+ hydrolysis. Upper half: mole fraction of soluble spe-
cies as a function of pH. Lower half: negative logarithm
of molar concentration in saturated solutions for the free
ion, [Al3+], straight dashed line; and the sum over all spe-
cies present, Tal, curved solid line. The straight dotted
line represents the concentration of the aluminate ion,
[Al(OH)4-]. 
Source: Elsevier Science Publishing Co. Inc.
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Polyphosphate
Polyphosphate may reduce tuberculation of iron and steel and provide
a smooth pipe interior.16,17 On the other hand,  at low dosages it may increase
iron and steel corrosion, and it may attack and soften cement linings.
Polyphosphates can form strong aqueous chelates or complexes with Ca2+ and
Al3+, which are major components of cement, as well as with other potentially
protective ions such as Zn2+, Fe3+, or Mn2+. These complexes may increase the
solubility of the cement-mortar pipe under many conditions. 
The chemical reactions that protect cement rely upon the sealing of the
porosity, most notably by calcium carbonate deposited between the cement
grains. If these voids are not sealed, then free lime will leach out, and pH
increase will rise. At the very least, CaCO3 deposits are not forming to protect
the cement. Continuing leaching will ultimately deteriorate the cement surface
in contact with water, and in time the lining will soften. Thus, chemicals that
inhibit the formation of these CaCO3, either by sequestering the Ca
(polyphosphates) or by retarding crystal growth (orthophosphates and
polyphosphates), will be detrimental to some degree.28
Al is widespread in drinking water
Al occurs naturally
Al is the most abundant metallic element in nature (8 percent
of the earth’s crust) and the third most abundant element of all elements.
Despite the ubiquity of Al in the environment and its present in living
organisms (in small amounts), no biological function for the element
has been found, and it is considered a non-essential element. 
Al in drinking water originates mainly from two sources. Al can
be found naturally in ground water or surface water sources, and Al
sulfate can be used in water treatment processes as a coagulant.3,7 In most
cases, Al concentrations in drinking water are monitored only at the
treatment plant and mainly when Al-based coagulants are used. It is
assumed that the Al concentrations will not increase during distribution.11,12
Few drinking water companies routinely monitor Al concentration
at the tap. Our findings however, prove that leaching from cement coatings
can substantially raise Al concentrations during distribution. 
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Al can pose a health hazard
Gastrointestinal absorption
The potential harm from exposure to Al depends not only on the
dosage but also the percentage of the dose that is absorbed and retained.
The gut is a very effective protective barrier: only 0.04 – 1 percent of oral
doses of Al appears to be retained.29 Even so, very high concentrations of Al
in drinking water may be harmful. On July 6,1988, 20 metric tons of Al
sulphate was deposited into a water tank that fed into the tap water supply
of the Lowermoor area of North Cornwall, England.  People (12,000 residents
and 8,000 tourists) were exposed for three days. The water tasted unpleasant
because of its acidity and Al content up to 620 mg/L; it also contained
abnormally high amounts of copper, lead and zinc that dissolved from the
water pipes. Consumers noted an unpleasant taste and reported acute
symptoms such as mouth ulceration, joint pain, gastrointestinal disturbance,
skin rashes, fatigue, nausea, vomiting, itching and sore eyes.30, 31
Nevertheless, the initial toxicological assessment concluded that the limited
exposure would not cause acute or chronic disease.30 Two years later, however,
400 of the 20.000 persons exposed to the contaminated water had illnesses
that they attributed to the incident.31 Bone Al concentrations remained
elevated at six to seven months, but not at 19 months after the accident
in at least two individuals.31,32 Thus, substantial Al can be deposited in
the bodies of normal individuals after a short exposure to highly
contaminated water. 
Alzheimer's disease
For many years a link between Al intake and Alzheimer’s disease has been
proposed. The evidence for this link is derived to a large extent from ecological
studies that compared rates of the disease in populations that were supplied with
water containing various amounts of Al. However, only a handful of major
epidemiological studies have addressed this possible association. Because of
methodological difficulties the results of these studies have been inconclusive.3 
Regulations mainly consider aesthetics
Because few countries set standards for Al in drinking water, Al is not
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routinely investigated.  The main objections to high concentration of Al in
drinking water are currently based on aesthetic aspects, and attention is focused
on the concentrations at the treatment plant. No attention is given to the
possibility that Al concentrations might rise during distribution.
World Health Organization
The World Health Organization (WHO) publishes no health-based
guideline value for Al, but it has stated that further studies were needed to
elucidate the role, if any, of Al in Alzheimer’s disease.33 A concentration of Al of
200 µg/L in drinking water provided a compromise between the practical use of
Al salts in water treatment and discoloration of distributed water. A recent
International Program on Chemical Safety Project document of WHO
guidelines for chemical substances in drinking water quoted the 1997
Environmental Health Criteria monograph: “The positive relationship between
Al in drinking water and Alzheimer’s Disease, demonstrated in several studies,
cannot be totally dismissed. However, strong reservations about inferring a
casual relationship are warranted in view of failure of these studies to account
for demonstrated confounding factors and for total Al intake from all sources.
Taken together, the relative risks for Alzheimer’s disease from exposure to Al in
drinking water above 100 µg/L as determined in these studies are low. Such
imprecise predictions may, however, be useful in making decisions about the
need to control exposures in the general population”.1
United States
The US Environmental Protection Agency (USEPA) has established a
secondary maximum contaminant level (SMCL) range of 50-200 mg for Al.34
Utilities are encouraged to meet an Al concentration of 50 µg/L when possible,
but differing water quality and treatment situations necessitate a flexible
approach. On this basis USEPA established an SMCL range rather than a
specific number. Each state primacy agency is responsible for setting the
precise concentration for each system, on a case-by-case basis.
Europe
The European Union defines a maximum Al concentration of 30 µg/L
in water used for hemodialysis and states that drinking water companies should
39
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warn health authorities if this concentration is exceeded.  In turn, authorities
responsible for water distribution shall inform all dialysis units, if possible in
advance, of any important change in the treatment of water that might
increase the Al concentration in the water distributed, and also of any accidental
pollution of the water distributed. The possibility of replacing of Al salts in the
treatment of water should be studied.10 The European Economic Community
Standard has a guide concentration of 50 µg/L and a maximum admissible
concentration of 200 µg/L Al in drinking water.23
Excess Al in dialysate is harmful
Standards exist for hemodialysis water
The maximum recommended concentrations for inorganic substances
include toxic substances described in the dialysis literature and non-toxic
substances normally included in the dialysate (Table 3). 
These concentrations are based on the lowest toxic concentrations reported in
the dialysis literature with an appropriate margin of safety. These recommendations34
have been adopted by AAMI.13
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Table 3. Maximum recommended concentrations of
inorganic substance in water* used to prepare the dialysate13
Contaminant Concentration-mg/L
Calcium 2 (0.1 mEq/l)
Magnesium 4 (0.3 mEq/l)
Sodium 70 (3.0 mEq/l)
Potassium 8 (0.2 mEq/l)
Fluoride 0.2
Chlorine (free) 0.5
Chloramine 0.1
Nitrate (N) 2
Sulfate 100.0
Copper, Barium, Zinc each 0.1
Aluminum 0.01
Arsenic, Lead, Silver each 0.005
Cadmium 0.001
Chromium 0.014
Selenium 0.09
Mercury 0.0002
*To prepare dialysis fluid (dialysate), (purified) tap water is mixed by the
  dialysis machine with a bicarbonate concentrate and an “acid” component
  containing calcium, magnesium and other compounds
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Dialysis encepahlopathy continues to be a threat
Two types of dialysis encephalopathy can be distinguished. The classical
type with encephalopathy and bone fractures is a slowly progressive disease that
takes months to many years to develop; the Al concentration in the dialysate is
typically < 600-1000 µg/L. Acute Al intoxication with seizures, myoclonic jerks,
and a high mortality rate within weeks develops when the Al concentration in the
water used for dialysis is much higher. In the past, most outbreaks of Al
intoxication were caused by residual Al in drinking water treated with Al salts
by water companies.4-6 Such incidents have been reported by centers with and
without on-site water purification.
Al encephalopathy in a dialysis center with on-site water purification
Probably because most water companies try to meet the WHO guideline
of 200 µg/L Al in finished water, outbreaks of acute encephalopathy because of
extremely high Al concentrations (> 600-1000 µg/L) in the dialysate are rare.
The only report (other than this one) of an outbreak of acute Al encephalopathy
occurred in a dialysis center in Portugal using RO.36-38 Scarce rainfall in the
south of Portugal in 1992 depleted water sources and markedly increased the
concentration of suspended particles. Huge amounts of alum were used to reduce
turbidity, an action not reported to municipal authorities. The severely
contaminated water obstructed the RO membranes of a water purification
installation in a dialysis center.36,37
The efficiency of the RO membranes relies on two rejection mechanisms: a
mechanical sieving filter with 200-D pores and an electrostatic repulsive mechanism.
Ionized Al is rejected very efficiently (by 99 percent) by the RO membranes.
However, most Al is present as a colloid, and colloids foul RO membranes. Fouling
causes Al to accumulate at the membrane, masks the electrostatic repulsion
mechanism, and leads to increased Al breakthrough. In these circumstances, the
RO membrane may reject as little as 30-50 percent.37 Consequently, RO membranes
and cartridge filters had to be replaced frequently. During these interventions,
which took place over a period of several days, insufficient treated water was sent
directly to the dialysis machines and to patients. Eighteen of 71 (25.3 percent)
patients died of severe encephalopathy. Patients’ mean serum concentrations of Al
were 505 + 255 µg/L (normal < 60 µg/L). Al concentrations up to 2,200 µg/L were
measured in water used to prepare the dialysate.37
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Al encepahlopathy in centers without on-site water purification
In countries where water companies use Al components to treat
water, many outbreaks of classical Al intoxication have been reported in
dialysis centers using tap water to prepare the dialysate.4-6 The cumulative
risk of death because of dialysis dementia in patients whose water supply
had a mean Al concentration > 200 µg/L was much greater (27.9 percent
deaths in the first 40 months) than the risk in patients whose mean water
Al content was < 200 µg/L (2.1 percent deaths in the fist 40 months). The
relation between the mean Al concentration in the dialysate and time to
death is given by this formula:4 the time in months from the first symptoms
of dialysis dementia to death equals 65 – 0.081 x (mean Al concentration
[µg/L] in dialysis water). According to this equation the patients in the case
reported here had been exposed to Al concentrations in the tap water of at
least 800 µg/L. 
Although most dialysis centers now have sophisticated water treatment
devices, there might still be dialysis centers or home dialysis treatments
without reverse osmosis, some do not (and home dialysis patients may
not). Of 173 dialysis units in Germany in 1989 and 1990, pure tap water
was still used without purification in 10 percent of university and 7 percent of
community hospitals.9 In addition, dialysis centers commonly bypass
membranes that do not function properly, and then they use only
deionization for water treatment. Because deionization removes Al less
efficiently, high Al concentrations in tap water may persist in the treated
water. It can be argued that dialysis centers should be fully responsible for
the water used for dialysis, but in practice they rely on a constantly
acceptable drinking water supply combined with extended water purification.
Conclusions
Water passing through cement-mortar pipes can leach substantial amounts
of barium, cadmium, chromium for the first 14-18 days of water stagnation
and increase pH, alkalinity and calcium for up to four years.14,15 Another
less well known effect, described in this article, can be the leaching Al into
tap water to unacceptably high concentrations for more than 2 years. In the
instance described, leaching may have been promoted by newly placed
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pipes, high alumina cement-mortar (an Al content four times as high as
usual), aggressive water, low-flow regimes, high water temperature, and
perhaps the use of polyphosphate corrosion inhibitors. 
To ensure public safety, a given cement type should be appropriate for a
given water source. In addition, certification of cemented pipes used for
drinking water distribution is warranted.  Bleaching of compounds from
the pipe not only poses possible health risks but may also reduce the
durability of the pipe. In the worst case, such water used for dialysis wit-
hout further purification can produce devastating outcomes. 
Dialysis centers should always be prepared for unsuspected variations in
tap water composition and always practice extended purification of tap
water used for dialysis. Cooperation between drinking water companies
and dialysis centers remains a prerequisite. Water utilities should notify
dialysis centers when changes in water quality are expected. In particular,
dialysis centers be warned if the Al concentration in drinking water may
exceed 30 µg/L, as when water utilities first begin to use Al flocculants. The
centers should also be informed if the concentration of Al exceeds the
relatively high concentration of 200 µg/L. When cemented drinking water
distribution pipes are put into service, tap water should be tested for Al,
and dialysis centers should be warned if Al concentrations are > 30 µg/L.
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Abstract
Background. In Curaçao, distilled seawater from the water plant was used
without further purification for hemodialysis for several decades. A new distribution
pipe supplying water to a dialysis center on the island was installed in May 1996. To
protect it from corrosion, this pipe was lined on the inside with a cement mortar.
Because of the aggressiveness of the distilled water, calcium and aluminum (Al) leached
from the cement mortar into the water used to prepare dialysate. This caused a possible hard
water syndrome and definite acute Al intoxication. 
Methods.We reviewed clinical details and outcome at follow-up, and
arranged laboratory and toxicological studies of serum and hemodialysis water. 
Results. Of the 27 patients who had a similar exposure (~60 hours) to the
contaminated dialysate, 10 died from acute Al encephalopathy, whereas 17 patients had
no or only minor symptoms and survived. The nonsurvivors were older (64 ± 3 years
vs. 52 ± 2 years, P < 0.01) and had a lower body weight (57.5 ± 5.9 kg vs. 86.5 ±
4.1 kg, P < 0.01) and lower serum albumin concentrations (33 ± 1 vs. 36 ± 1 g/L, P
< 0.01). Anuria tended to be more common in the nonsurvivors (8 out of 10 vs. 8 out
of 17, P> 0.05). Serum Al concentrations, available in seven nonsurvivors, were signi-
ficantly higher than in the survivors (808 ± 127 vs. 255 ± 25 µg/L, P < 0.01). 
Conclusions.The water distribution pipe was lined with a cement mortar
that was probably inappropriate for transporting drinking water. Water distribution
facilities as well as the dialysis community should be aware of the possibility of Al
leaching from cemented water distribution pipes. Similar Al loads appear to induce a
more severe intoxication in malnourished, older patients with smaller Al distribution
volumes and anuria. 
Key words: hemodialysis, calcium, aluminum intoxication, nephrotoxicity, hard water syndrome, 
dialysate preparation.
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Introduction
Hemodialysis patients are very susceptible to changes in the composition
of water used to produce dialysate. Their blood is brought in close contact with
hundreds of liters of dialysate every week, and contaminants present in the
water may diffuse across the dialysis membrane and cause intoxications.
Therefore, guidelines for the composition of water used to generate dialysate are
very strict.1,2 To reach this standard, most dialysis centers use more or less
elaborate water purification systems, consisting of combinations of water
softeners, activated carbon filters, deionizers, and reverse osmosis (RO).3–6
We report the combination of an acute aluminum (Al) intoxication and
a possible hard water syndrome in a small dialysis unit on the island of Curaçao
that traditionally used untreated tap water for dialysate production. The intoxication
was caused by a newly installed drinking water conduit pipe leading to the
dialysis center. This ductile iron pipe had an inner cement mortar lining from
which Al and calcium (Ca) leached into the water used to prepare the dialysate.
Although the patients had a similar exposure time to the contaminated dialysate,
10 patients became critically ill and died, whereas 17 had no or relatively mild
symptoms and survived. A subgroup analysis was performed in an attempt to
explain these interindividual differences.
Methods
Dialysis center and water supply
Curaçao is a small island with 160,000 inhabitants. Approximately 90%
of the population is of Afro-Caribbean origin. The prevalence of end-stage renal
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disease is 800 per million, which is among the highest in the world.
Because of the large number of patients, a separate dialysis unit (Diatel
Curaçao) with eight stations was opened in 1992 in addition to the
hospital dialysis facility. On Curaçao, drinking water is produced by
distillation of seawater. This expensive water treatment system produces
very pure water (low ionic content, Al < 5 mg/L, Ca < 5 µg/L), which is of
even better quality than produced by RO.6 Before distribution, however, Ca
and fluoride are added to the water supply in a low concentration. On
Curaçao, as well as on other small Antillean islands, the municipal water
supply has been used for more than two decades for dialysis without
further purification. Because the local hospital intended to begin a
high-flux dialysis program, for which ultrapure water is needed, an RO
unit was installed in this institution in 1993. Because Diatel did not have
a water storage tank and occasionally had insufficient water pressure for
dialysis, installation of a spare water tank together with a RO unit for
sterilization of the water was scheduled for August 1996. To solve the water
pressure problem, the Water Company replaced a distribution pipe to the
area of the center over a length of 2200 m. Water supply through this
pipe started on May 21, 1996, after flushing the entire pipe. This cast
iron pipe had an inner cement mortar lining to protect it from corrosion.
The hospital received water supply via a different conduit pipe than Diatel.
At the time of replacement of the new conduit pipe, 29 patients
were dialyzed in the dialysis unit. Patients were dialyzed three times per
week during 3.5 to 4.5 hours using hollow fiber kidneys (Fresenius®, F6
and F8) and Braun® or Fresenius® dialysis machines. Untreated tap
water was used to manufacture dialysate after passage through three
particulate filters (25, 10, and 5 mm, respectively). The intended Ca
content of the dialysate was 1.75 mmol/L. Because none of the patients
used Al-containing phosphate binders and the Al content of tap water
on Curaçao has traditionally been low, no regular serum Al determinations
were made.
Epidemiology
The epidemiology of the intoxication on Curaçao was retrospectively
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analyzed by systematically reviewing dialysis and hospital charts and
relevant laboratory sheets and correspondence. The day on which the new
water distribution pipe was put into use (May 21, 1996) was designated
"day 0" of the intoxication; all subsequent events, shown in Figure 1, were
related to this starting date.
Serum aluminum: Sampling and assay
In 6 of the 10 patients who died (Table 1, patients 3 through 5 and
7 through 9), serum samples taken during admission in the third week of
July 1996 (week 9 of the intoxication) were stored in the freezer in regular
glass tubes. Samples of three healthy control subjects were obtained in the
same tubes and processed in the same way as these patient samples. In three
patients, no serum samples had been stored (patients 1, 2, and 6). In one
patient (patient 10), who also eventually died, a serum sample for Al
determination was obtained while he was still alive. This was done using the
appropriate tubes mentioned later in this article. This was also the case for
all the samples of the survivors obtained in the fourth week of July 1996
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(week 10 of the intoxication). In these patients, serum samples were
collected using Al-free polypropylene and polystyrene tubes prerinsed with 1
N HNO3 to avoid Al contamination. All samples were sent by express mail
to the Toxicology Laboratory (Leiden University Medical Center, Leiden,
The Netherlands). The Al levels were analyzed with an atomic absorption
spectrometer (Perkin Elmer 3030; Perkin Elmer, Norwalk, CT, USA) with a
transversal Zeeman background correction system, using a graphite furnace
(HGA 600) and pyrolytically coated graphite tubes. A calibration range was
used between 0 and 200 µg/L (within-day precision was 13.8 and 6.1%,
between-day precision was 22 and 8% for standard solutions 20 and 100
µg/L, respectively). For levels>200 µg/L, the calibration range was adapted
between 200 and 1000 µg/L.7
Other analytical methods
Intact parathyroid hormone (PTH) concentrations were measured by
radio immunoassay (Elisa-PTH; CisBio Int., Gif-sur-Yvette, France). 
Concentrations of Ca, alkaline phosphatase, ferritin, albumin, and mean cellular
erythrocyte volume (MCV) were measured by standard laboratory methods.
Subgroup analysis
Two surviving patients with low serum Al levels (< 60 µg/L) caused by
a very short duration of exposure to the contaminated dialysate were excluded
from this analysis. The remaining 27 patients were divided in two groups:
survivors (N = 17) and nonsurvivors (N = 10). Both groups were compared with
respect to the following characteristics: age, sex, body weight, presence of
diabetes mellitus, diuresis, duration of exposure to contaminated dialysate,
PTH status, severity of hypercalcemia, and initial serum Al concentration.
Statistical analysis
Data are expressed as mean ± SEM. The statistical significance of
differences between mean values in the two groups was tested by Student's t-test
for unpaired samples or the Mann–Whitney ranks sum test when appropriate.
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Fisher's exact test was used to test the difference of two proportions. Differences
were considered to be of statistical significance at a P value of < 0.05.
Results
Epidemiology
The first day with regular dialysis sessions using water delivered
through the new distribution pipe (May 21, 1996, day 0) was uneventful,
but on the second and third days, several dialysis machines had transient
conductivity alarms, possibly because of small air bubbles in the water mains.
Extra flushing of the tap water solved this problem. The conductivity of the
dialysate, measured by an external conductivity meter, was normal. The first
patient (patient 6) was admitted to the hospital for a bleeding duodenal ulcer
on June 10, 1996 (day 20; Fig. 1). On admission, she was slightly disoriented
and developed seizures three weeks later (day 43) from which she died six
weeks after admission (day 60). She may have been the first patient to
become symptomatic because of Al intoxication, but it is also possible that
she died of uremic encephalopathy with convulsions because dialysis was
stopped two weeks prior to her death, and she had the shortest exposure time
to the contaminated dialysate of all patients dying during the intoxication.
The first patient (patient 1) without apparent underlying disease became
symptomatic (myoclonus of jaw musculature) on June 15, 1996 (day 25).
She was admitted to the hospital on June 22, 1996, because of hypercalcemia,
nausea, vomiting, and confusion. She developed unexplained seizures and
died on June 30, 1996 (day 40). On June 19, 1996 (day 29), seven patients
had minor complaints of nausea and vomiting. Postdialysis hypercalcemia
was observed in 25 of the 27 patients. The diagnosis "hard water syndrome"
was made, and the use of Ca carbonate and vitamin D preparations was
stopped. There was initial amelioration of the symptoms, but as the
improvement was incomplete, the dialysis unit was closed on June 30, 1996
(day 40). All patients were referred to the hospital for dialysis where the
symptoms of nausea, vomiting, as well as the hypercalcemia disappeared after
a single dialysis with low Ca dialysate (1.50 mmol/L). From week 7 onward,
transfusion-dependent microcytic anemia became evident (lowest MCV
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value: 70 ± 2 fL, N = 16). After installation of a RO system, including a
deionizer, dialysis was resumed at the Diatel unit on July 10, 1996.
Unexpectedly, another eight patients (patients 2 through 5 and 7
through 10) had to be admitted to the hospital because of severe neurological
symptoms (disorientation, myoclonus, convulsions and coma, N = 7) or
unexplained sepsis (N = 2) with a delay of days to three weeks after the last
dialysis with contaminated water (Fig. 1). Attempts to treat myoclonic jerks
or seizures with intravenous diphantoin or diazepam were unsuccessful. The
clinical diagnosis of acute Al intoxication was made on July 19, 1996 (day
59). Some days prior to this, the local toxicology laboratory reported a very
high serum Al level in one patient using a semiquantitative method. Because
the blood sample had not been processed correctly, the validity of this report
was doubted initially, and blood samples were sent to the toxicology laboratory.
When the diagnosis of "acute Al intoxication" was established by the results
from this laboratory, on July 25, 1996 (day 65), nine patients had died (Fig. 1).
A 10th patient, who was comatose, was transferred to a hospital in Florida
(Florida Hospital, Orlando, FL, USA). Daily high-flux dialysis treatment
combined with desferrioxamine administration was unsuccessful, and he
died on August 24, 1996 (day 95). Seventeen patients who had elevated
serum Al concentrations but were clinically asymptomatic were treated with
intravenous desferrioxamine and high-flux dialysis according to the protocol
suggested by Barata et al.8 For logistical reasons, especially the inability to
provide high-flux dialysis to all patients on short notice, these patients were
transferred to six different hospitals in the Netherlands. Two patients, who in
retrospect had been exposed to contaminated dialysate only briefly, did not
need further treatment.
Calcium and aluminum content of tap water
Water supplied through the new pipe was first used for dialysis on
May 21, 1996. On June 20, 1996 (day 30), the Ca-carbonate concentration
of tap water delivered to the dialysis unit was 43 mg/L (17.2 mg/L or 0.45
mmol/L as Ca2+), which is above the standard of 2 mg/L advised by the
Association for the Advancement of Medical Instrumentation.2 In the past,
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the Ca-carbonate concentration had been 15 to 20 mg/L (6.0 to 8.0 mg/L or
0.16 to 0.21 mmol/L Ca2+). A sample of tap water obtained on July 3, 1996
(day 43), after the closing of Diatel was sent for analysis to Spectra
Laboratories (Fremont, CA, USA). The results became available in August
1996. The Al content was excessively high (650 µg/L, normal below
10 µg/L), and the Ca2+ concentration was moderately elevated (18.1 mg/L,
0.47 mmol/L).
Serum calcium concentrations
In the two months prior to the intoxication, the mean predialysis
total Ca concentration was 2.59 ± 0.05 mmol/L (April 1996) and 2.68 ±
0.05 mmol/L (May 1996). On two occasions in June 1996, when a hard
water syndrome was suspected, Ca concentrations were determined before
and after dialysis. The mean predialysis and postdialysis Ca concentrations
were 2.75 ± 0.06 and 3.25 ± 0.06 mmol/L, respectively. The interdialytic
drop was to 2.84 ± 0.05 mmol/L, with an increase to 3.27 ± 0.06 mmol/L
after the next dialysis. The mean serum Ca concentrations in the survivors
and nonsurvivors did not differ (Fig. 2).
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Serum aluminum concentrations
The serum Al concentrations obtained in seven of the nonsurvivors were
invariably very high (mean 808 ± 127 µg/L, range 359 to 1189 µg/L; Table 1).
Seventeen of the surviving patients had clearly elevated serum Al concentrations
(mean 255 ± 25 µg/L, range 113 to 490 µg/L). The average value obtained
approximately one week later, when the surviving patients had been transferred to
the Netherlands, was virtually the same as before the initiation of desferrioxamine
treatment (248 ± 20 µg/L, P> 0.05). One patient, who had been exposed only brie-
fly (5 hours) to the contaminated dialysate, had a serum Al concentration of 50 µg/L
(normal < 60 µg/L). The serum Al concentration of another patient was 16 µg/L
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Table 1. Characteristics of non-survivors and survivors
Patient
number
Age
years
Serum
[Al]b
µg/L
sex Weight
kg
Exposure
hours
Diuresis
mL/day
PTH
pg/mL
Albumin
 g/L
Non-survivors
     (N = 10)
1 61 - f 66 52 0 28 35
2 79 - f 33 51 0 105 32
3 54 1189 m 85.5 68 150 52 34
4 64 725 f 52.5 52 0 22 35
5a 51 894 f 40 68 0 72 30
6 69 - f 39.5 39 2000 - 28
7a 62 1275 m 62 60 0 8 34
8a 63 359 f 47 68 0 325 36
9a 74 517 f 86 64 0 32 32
10 65 696 m 64 68 0 480 35
Mean 64 808 - 57.5 59 - 125 33
SEM 3 127 - 5.9 3 - 55 1
Survivors
 (N = 17)
11 64 490 m 57 68 0 710 40
12 57 395 m 65 59.5 0 80 39
13 50 321 f 87 68 0 21 34
14 44 319 m 97 62 0 630 39
15 49 318 m 57 66 200 50 36
16 23 315 f 104 68 0 97 39
17 66 303 f 78.5 64 60 280 34
18 57 301 f 90 68 350 170 37
19 50 248 f 57.5 64 1000 65 36
20 56 207 f 103 68 0 82 36
21 50 205 m 104 60 2 700 37
22 57 187 f 101 64 50 1200 32
23 57 182 f 95 62.5 1100 100 30
24 41 166 m 91.5 68 0 3 -
25 60 132 m 97.5 67 1200 270 39
26 41 116 m 93.2 60 200 680 38
27 56 113 f 91.5 67 1400 99 33
Mean 52c 255c - 86.5c 65 - 308 36d
SEM 2 25 - 4.1 1 - 84 1
  a patients in whom post mortem examination was performed
  b [Al]: serum aluminum concentration
  c P < 0.01
  d P< 0.05, survivors vs. non-survivors
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several weeks later. She also had a short exposure time to the contaminated dialy-
sate because she went to Holland on June 3, 1996, shortly after installation and
flushing of the new water pipe. The serum Al concentrations in three healthy con-
trols were all below 10 µg/L (Methods section).
Subgroup analysis
The patients who survived the dialysis with contaminated dialysate were
significantly younger than those who died (Table 1). The average body weight
in the nonsurvivors was almost 30 kg below that of the survivors. Serum albumin
was slightly but significantly lower in the nonsurvivors. The proportion of patients
suffering from diabetes mellitus tended to be greater in the nonsurvivors than in the
survivors (60 vs. 16%, P = 0.11), as was the proportion being anuric (80 vs. 47%, P
= 0.12). It is noteworthy that the duration of exposure to the contaminated
dialysate was even somewhat longer in the group of survivors. This was because two
of the nonsurvivors (patients 1 and 6) were admitted to the hospital relatively early and
consequently had a shorter exposure time. Survivors tended to have higher
serum PTH concentrations (survivors, 308 ± 84 pg/mL; nonsurvivors, 125 ± 55
pg/mL, normal, 11 to 62 pg/mL).
Discussion
We report a unique set of circumstances leading to a probable hard water
syndrome followed by an epidemic of acute Al encephalopathy in a dialysis unit
(Diatel) on the island of Curaçao. Traditionally, municipal water had been used
without extended purification for the production of dialysate because the
distributed distilled seawater was very pure and its ionic content low. Because of
complaints of low water pressure in the dialysis center, the water distribution
company replaced an old iron water distribution pipe by a new cement-coated
pipe. Three of the predominant crystalline phases of the cement matrix are
tricalcium silicate (nominally Ca3SiO5), dicalcium silicate (nominally Ca2SiO4),
and tricalcium aluminate (Ca3Al2O6). Possible dissolution reactions may be represented
by Ca3SiO5 + 5H2O      3Ca2+ + H4SiO4· + 6OH-, Ca2SiO4 + 4H2O     2Ca2+ +
H4SiO4· + 4OH-, and Ca3Al2O6 + 6H2O       3Ca2+ + 2Al3+ + 12OH-9. The
purity of the water with a relatively low Ca concentration enhanced the leaching
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of Ca and Al from the cement coating into the water used to prepare dialysate.
Approximately four weeks after the new water distribution pipe had
been put into use, a tentative diagnosis of a "hard water syndrome" was made.
This syndrome is characterized by dialysis-related nausea and vomiting, weakness,
and lethargy and is caused by hypercalcemia caused by elevated Ca concentrations
in the dialysate.10 Leaching of Ca from the new pipe was suspected, and the
patients were transferred to a hospital dialysis unit using water softening and
RO for water preparation and a low-Ca dialysate. This effectively ended exposure
to the contaminated dialysate; the symptomatic patients improved, and the
hypercalcemia disappeared. In retrospect, the Al intoxication may have contributed
to the development of hypercalcemia because Al can decrease the incorporation
of Ca into the bone by inhibiting bone formation.11 Additional Ca from the
dialysis fluid and therapy with vitamin D and Ca added to the severity of the
hypercalcemia.
Unexpectedly, with a delay of days to weeks after ending exposure to the
dialysate supposed to be contaminated only with Ca, 10 patients developed
severe and progressive neurological symptoms and all died. Because all serum
Ca levels already normalized, it became obvious that another contaminant had
to be responsible for the delayed neurotoxicity. A lag time causing "acute"
Al neurotoxicity has been observed in animal studies12 as it seems likely that
several steps are necessary in the process leading to Al encephalopathy and that
each step causes a delay in time before symptoms can occur.13 The actual
diagnosis of Al intoxication was later confirmed by very toxic serum Al
concentrations and elevated brain Al levels that were four to eight times higher
than normal. Acute Al intoxication is characterized by a neurological syndrome,
including seizures, myoclonus, obtundation, and coma. Bone disease and dialysis
dementia, features of classic chronic Al toxicity, are usually absent,14 but microcytic
anemia can occur.8 Sporadic cases have been reported after intake of Al-containing
phosphate binders alone15 and in combination with citrate-containing drugs,16
during treatment with desferrioxamine for chronic Al overload17 and following
intravesical Al infusion for hemorrhagic cystitis in renal patients.18 Epidemic
forms of acute Al intoxication have been described following the use of water
for dialysis, which was severely contaminated with Al.8, 19
In our center, the contamination of water used to prepare dialysate was
caused by installation of a new cast iron water distribution pipe supplying water
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to the dialysis facility. Water distribution pipes are commonly coated on the inside
with cement mortar to protect them from corrosion by the electrochemical
action of water. These coatings can adversely affect the water quality because its
constituents may leach from the cement matrix into the water increasing both
its Ca content and pH.20 Unfortunately, it was unknown to the local water
distribution company and to the water industry in general that not only Ca, but
also Al can leach from these cement mortars and cause excessively high water Al
concentrations. Conditions that enhance Al leaching include low water
alkalinity and hardness, relatively high water temperatures, and low or
intermittent water flow. Unfortunately, all of these factors coincided in the
situation, especially because Diatel was located at the dead end of a water main,
resulting in the highest Al concentrations on the island. The pipe was partially
bypassed by the water company (from 2200 to 1000 meters), but the Al
leaching continued for at least two years.21 Kidney patients with chronic renal
failure—not on dialysis—living in the small distribution area were told not to
consume the water because of the risk for developing Al intoxication. Elsewhere
on Curaçao, where the same pipe was used, higher water flow conditions
prevented Al concentrations to increase to very high levels.
In a number of European countries (for example, Germany, Denmark, and
some parts of France), the authorities require that drinking water should be
calcifying because of the pronounced effect on the corrosion of cement-mortar
linings. This regulation is intended to protect cement materials and to reduce
water quality deterioration, especially with regard to metal release.22 If the water
on Curaçao had been pretreated by the water company according to these
regulations, Al leaching from the cement coating would probably have been less.
Nevertheless, a crucial factor in the tragedy seems to be the deviant cement
composition of the water distribution pipe with an Al content that was four
times higher than usual,21 because Al leaching was not shown in similar
circumstances and the use of different cement pipes. After the tragedy in Diatel,
a study was performed in Holland to see whether the same problem existed
there as well. Samples were taken on 20 locations with (standard) cemented
pipes and asbestos cement pipes. Locations with "worst case scenarios" favoring
the leaching of Al were chosen, defined as low flow, soft water, new pipes, and
small diameter. The Al levels in the tap water in Holland never reached levels
above 11 µg/L at any location,23 while the Al level in our case was 690 µg/L two
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months after the installation of the pipe. Cement linings with a high Al content
are therefore probably inappropriate to distribute drinking water.
Although all patients were exposed to the contaminated dialysate for a
similar period of time, 17 patients survived the Al intoxication with only minor
symptoms, whereas 10 patients died from severe neurotoxicity. The nonsurvivors
were the older population with a low body weight and lower serum albumin
concentrations and a greater proportion of them had diabetes mellitus. This
suggests that the general state of health was an important determinant of the
chance of survival. In a review of 15 studies in animals and humans, an
extremely narrow margin of safety between normal and toxic levels of Al in
brain tissue seems to exists, with greater susceptibility in the older population.24
More importantly, however, the serum Al concentrations were considerably higher
in the nonsurvivors. This suggests that a similar Al load also caused higher Al
concentrations at the tissue level in the low body weight patients, possibly
because they had smaller distribution volumes. In addition, anuria was more
common in the nonsurvivors, which is relevant because the main natural route
of Al removal from the body is via the kidneys, and residual renal function
protects against Al toxicity.25.
Although this is the first report of intoxication in dialysis patients
caused by a water distribution pipe, it is not the first account of an intoxication
linked to the water industry. In a recent and equally treacherous acute Al
intoxication reported from Portugal, large amounts of Al sulfate had been
used as a flocculating agent in the process of manufacturing drinking water.
This was necessary because the concentration of suspended particles was
excessive due to a long period of drought in the area. This severely contaminated
water caused RO membrane fouling over several months of time, which might
have decreased the ability to reject Al to as low as 30 to 50%, but in addition,
the RO membranes were also temporarily bypassed several times for filter
exchange and RO maintenance.26 This resulted in an acute Al intoxication,
causing the death of 25 of 71 dialysis patients.8,26,27 Both the intoxications
on Curaçao and in Portugal underscore that dialysis centers should establish
a good working relationship with the local drinking water production and
distribution companies, as this may increase their awareness of the specific
needs and problems of the dialysis community.
The catastrophe on Curaçao clearly demonstrates that physicians in
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charge of a dialysis unit cannot rely on the quality of the water produced by the
water plant, no matter how excellent the specifications may be in terms of
appropriateness for hemodialysis when water leaves the plant. The hard lesson
was learned that the composition of the water could change unexpectedly and
erratically in the water distribution system, making it absolutely unsuitable for
preparation of dialysate upon its arrival in the dialysis unit without further
water treatment. Therefore, dialysis centers should use extended purification
procedures, including RO, at all times. In this respect, it is of note that dialysis
without water preparation by RO was common practice until recently.28
Nephrologists, who are responsible for the dialysate quality, often lack formal
training in water safety and purification procedures. They therefore tend to rely
unconditionally on the municipal water supply and the water purification
system in their unit. That this is not always justified has been shown by several
recent serious accidents with Al,8,19 chloramine,29 fluoride,30 copper,31 hydrogen
peroxide,32 sodium azide,33 and microcystins.34
In summary, our sad experience shows that the use of extended
water purification systems is imperative in hemodialysis. Furthermore, our
experience and that of others indicate that continuous monitoring of the water
before and after water treatment seems necessary as well and that dialysis
centers should establish a good working relationship with local water production
and distribution authorities. Finally, water purification procedures and water
quality control perhaps deserve more attention in the training of nephrologists.
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Abstract
The population of Curaçao, Netherlands Antilles (133,000) shows a veryhigh prevalence of end-stage renal disease (approx. 1 per 1000). Thesepatients are often treated chronically with haemodialysis. As the drinking
water on the island is prepared by distillation of sea water, the haemodialysis fluid
used to be prepared with tap water without further treatment.
In 1996, 7 of the 27 patients of one of the dialysis centers on the island presented with
nausea, vomiting, and hypercalcaemia in a short time span, which was initially
diagnosed as ‘hard water syndrome’. In spite of treatment with low-calcium dialysate,
microcytic anaemia and neurological symptoms developed. Ten patients died of
convulsions, sepsis, and coma. As aluminum (Al) intoxication was suspected, Al in
serum (AlS) was measured. Ante mortem AlS was 808 µg/L (n=7; range 359-1189);
in the survivors AlS was 255 µg/L (n=17; range 113-490). Normal AlS is < 10 µg/L,
and < 50 µg/L in asymptomatic dialysed patients.
The court requested post-mortem toxicological analysis of four patients. Al
concentrations in liver, bone, and cerebral cortex were significantly increased
as compared with background levels. Al intoxication was, therefore, considered to be
the most likely cause of death in these patients.
Investigations of the tap water supply revealed that a few weeks before the onset of the
symptoms, a water conduit pipe to the dialysis unit had been replaced, which was lined
with Al- rich cement mortar. These ions leached into the distilled water and caused both
Ca- and Al-intoxication through uptake from the dialysate into the patients’ circulation.
The symptoms of the latter were initially not recognized as they were masked by the
symptoms of hypercalcaemia.
Key words: Aluminum; Poisoning; Subacute; Haemodialysis; Post-mortem; Metals; Toxicity
© 2002 Elsevier Science Ireland Ltd. All rights reserved.
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Introduction
The prevalence of end-stage renal disease amongst the population of the
Caribbean island Curaçao is one of the highest in the world: approximately 1
per 1,000. This is due to the fact that 90% of the population totaling 133,000
is of Afro-Caribbean origin with a very high incidence of diabetes and
hypertension, both being a possible cause of renal insufficiency. About 140
patients with end-stage renal disease are chronically treated in the two haemodialysis
centers on the island. As other sources of drinking water are extremely scarce,
tap water is produced by distillation of sea water. For consumption, the distilled
water is supplemented with small amounts of calcium and fluoride. Water
quality used to be sufficient for the preparation of dialysate without further
treatment. No incidents due to water contamination have been reported in the
course of two decades. 
At the onset of the incident reported here, 27 patients were treated
with chronic intermittent haemodialysis in the Diatel Curaçao unit. From 10th
June 1996 onwards, some patients started to present with nausea, vomiting, and
hypercalcemia. These symptoms are consistent with the ‘hard water syndrome’
which may occur in patients treated with a high-calcium dialysate. This was
confirmed by the observation of postdialysis hypercalcaemia (up to 3.50 mmol/L),
and by a very high calcium concentration (17.2 mg/L) in tap water, considerably
exceeding the generally accepted maximum of 2 mg/L for dialysate. The source
of this high calcium concentration was a new cast-iron water distribution pipe,
which was internally protected against corrosion by application of a cement
mortar lining from which calcium leached into the tap water.1 As the laboratory
observations confirmed the clinical diagnosis of calcium intoxication, other
possible sources of poisoning were not considered. A more detailed description of the
clinical symptomatology has been published elsewhere.2
In spite of discontinuation of oral calcium carbonate and vitamin D
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preparations, the symptoms did not cease in some patients, which lead to the closing
of the unit and the referral of the patients to other centers. When aluminum
intoxication was suspected and confirmed in serum samples sent to the LUMC
Toxicology Laboratory in The Netherlands, 6 weeks after the first signs of
‘hard water disease’, 10 patients had died from seizures, sepsis, and coma. The
17 survivors, all showing increased serum aluminum levels, were transferred to
haemodialysis centers in The Netherlands, and treated with desferrioxamine
infusion and high-flux dialysis according to Barata et al.3 After installation of
reversed-osmosis equipment for water treatment, the dialysis unit in Curaçao
was re-opened, and the 17 survivors were repatriated.
The Court of the Netherlands Antilles then started a judicial investigation
into this case as to whether the medical staff of Diatel could be held responsible for
the death of these 10 patients, and requested the LUMC Toxicology
Laboratory to perform the post-mortem toxicological investigation. The
results of this forensic study are presented here.
Material and Methods
From 7 of the 10 patients who died, serum samples had been collected
during admission shortly (approx. 1 week) before death. Blood for AlS assay
was also sampled from the 17 survivors, and sent by express mail to the
LUMC Toxicology Laboratory in The Netherlands. All blood and serum
were collected and stored in Al-free polypropylene and polystyrene tubes
prerinsed with 1 M HNO3 to avoid contamination.
Tissue samples (liver, bone, and cerebral cortex) were obtained at
autopsy in Curaçao of four patients, under strict Al-free conditions. The
instruments were thoroughly washed and rinsed with Al-free distilled water,
and the (Al-containing) talcum was washed from the surgical gloves used
when taking the samples. The samples were kept frozen at -20ºC during sto-
rage and mailing to The Netherlands.
Al in serum was analyzed with electrothermal atomic absorption spectrometry
(EAAS; Perkin-Elmer 3030; Perkin-Elmer, Nordwalk, CT, USA) with a
transversal Zeeman background correction system, using a graphite furnace
(HGA 600) and pyrolytically coated graphite tubes. A calibration range was
72
C H A P T E R  I V
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 48
used between 0 and 200 µg/L; for standard solutions 20 and 100 µg/L the
within-day precision was 13.8 and 6.1 %, and the between-day precision 22
and 8%. For levels > 200 µg/L, the calibration range was adapted between
200 and 1000 µg/L.4
Al in tissues was analyzed likewise, with a procedure developed
earlier in this laboratory.5 Tissue samples were digested in 1 mL of a mixture of
65% HNO3 + 96% H2SO4 (4+1, v/v) and gradual heating to 105 ºC before EAAS
analysis.
Calcium and aluminum in tap water were determined by Spectra
Laboratories (Fremont, CA, USA).
Results
The serum of 7 deceased patients, collected before death, contained a
very high Al concentration: 808 ± 127 µg/L (mean ± S.E.M., n = 7, range 359
- 1275). In the survivors, this value was 255 ± 25 µg/L (mean ± S.E.M., n = 17,
range 113 - 490), significantly lower than that of the non-survivors (P < 0.01).
The results of the post-mortem analysis are presented in Table I, in
which the tissue levels of Al are compared with the concentrations in serum
obtained when the patients were still alive. In these serum samples, other ions
were measured with standard clinical chemical methods. These ions were: Fe,
Mg, Ca, V, Si, Pb, and Hg, none of them being outside the normal range. It
should be noted that at the time of blood collection for Al analysis the
hypercalcaemia had been normalized.
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Table 1. Post-mortem analysis of liver, bone and brain aluminum in four patients
Patient Serum
(µg/L)
Liver
(µg/g)
Bone
(µg/g)a
Cerebral cortex
(µg/g)b
A 517 43.0 21.9 1.09
B 696 32.7 88.7 1.40
C 1275 51.7 7.54 1.12
D 894 4.70 77.0 1.78
Reference values5,6,8 < 10 < 2 < 2 0.14 - 0.22
a Collected from a femoral shaft
b Collected from the gyrus temporalis inferior and superior
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From Table 1 it is clear that the Al concentrations in liver, bone and
cerebral cortex are extremely high in comparison to the reference values which
were taken from D’Haese et al.6 and Van Ginkel et al.5
Analysis of tap water -sampled at the time of closure of the unit-showed a
calcium concentration of 18.1 mg/L and an aluminum concentration of 650
µg/L. These concentrations, which are far too high for dialysate, were shown to
be caused by  release from the cement mortar with which a newly installed water
piping system was lined.1
Discussion
The case history presented here confirms that exposure of dialysed
patients to dialysate contaminated with Al may lead to systemic intoxication, as
was reported as early as 1976.7 The sources of Al were either extracorporeal
exposure to contaminated water, or high-dose oral aluminum hydroxide
prescribed to bind dietary phosphate. Most cases of Al intoxication in dialysed
patients that have been reported, however, are of the chronic type, showing a
gradually developing cerebral impairment, starting with speech disturbances,
motor apraxia, and twitching, slowly deteriorating into myoclonic jerks,
seizures, and global dementia.8 Together with normochromic mycrocytic
anaemia and Vitamin D-resistant osteomalacia, these symptoms of chronic Al
intoxication in long-term dialysed patients are generally well-known to
nephrologists involved in chronic intermittent haemodialysis. In this case,
sudden exposure to an extremely high Al concentration in the dialysate took
place, so that the normal onset of ‘dialysis encephalopathy’ was bypassed. In
addition, the symptoms that were observed approximately 3 weeks after
installation of the new water supply system were consistent with another
well-known side effect of haemodialysis, the ‘hard water syndrome’.
Hypercalcaemia was confirmed in all patients, and an extremely high calcium
concentration in the tap water (17.2 mg/L, preferred value < 2 mg/L) provided
an explanation for this diagnosis. These observations masked the underlying Al
intoxication, which was suspected only after the hypercalcaemia was normali-
zed without clinical improvement of the patients. Then, serum analysis
showed very high AlS values in all patients. Analysis of the tap water at that time
revealed an Al content of 650 µg/L, which should be below 10 µg/L.
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Comparison of the serum levels of aluminum (AlS) from seven of the 10
deceased patients, collected ante mortem, with the AlS in the group survivors (n=17)
indicates that the AlS level -which is generally accepted as an indicator for the total
body burden of Al8- may have a predictive value for the outcome of Al poisoning.
Conclusion
A sudden rise of aluminum (Al) concentrations in dialysis fluid may
lead to considerable systemic uptake of Al by patients dialyzed with this
fluid. The dramatic neurological symptoms that result from this heavy exposure
differ from the slowly developing, better known ‘dialysis encephalopathy’.
The subacute Al intoxication presented here initially resembled ‘hard water
syndrome’ in dialysis patients. This observation, supported by both hypercalcaemia
and a high calcium concentration in tap water, masked the underlying Al
intoxication. Only when serum Ca was normalized and neurological symptoms
(convulsions, myoclonias) were observed, Al intoxication was suspected.
In the report to the court it was explained that the death of the four
patients of whom autopsy was performed was most probably the result of
serious subacute aluminum poisoning, due to contamination of the water with
which the dialysate was produced.
75
Subacute fatal aluminum poisoning in dialyzed patients: post-mortem toxicological findings.
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 51
References
Berend K, Trouwborst T, Cement-mortar pipes as a source of aluminum. J AWWA 1999;
91: 91-100.
Berend K, van der Voet GB, Boer WH, Acute aluminum encephalopathy in a dialysis
center caused by a cement mortar water distribution pipe. Kidney Int 2001; 59: 746-753.
Barata JD, D'Haese PC, Pires C, Lamberts LV, Simoes J, De Broe ME. Low-dose
(5 mg/kg) desferrioxamine treatment in acutely aluminum- intoxicated hemodialysis
patients using two drug administration schedules. Nephrol Dial Transplant 1996; 11(1):
125-132.
Van der Voet GB, de Haas EJM, de Wolff FA, Monitoring of aluminum in whole blood,
plasma, serum and water by a single procedure using flameless atomic absorption
spectrometry. J Anal Tox 1985; 9: 97-100.
Van Ginkel MF, van der Voet GB, de Wolff FA, Improved method for analysis of
aluminum in brain tissue. Clin. Chem 1990; 36: 658-661.
D’Haese PC. Aluminum accumulation in patients with chronic renal failure: monitoring,
diagnosis and treatment. PhD dissertation. ISBN 90-72812-01-8. University of
Amsterdam 1988, pp. 113-134. 
Flendrig JA, Kruis H, Das HA. Aluminum and dialysis dementia. Lancet 1976; i: 1235.
Van der Voet GB, de Wolff FA. Neurotoxicity of aluminum. In: F.A. de Wolff (Ed.).
Intoxications of the Nervous System, part I. Vinken & Bruyn’s Handbook of Clinical
Neurology ISBN 0-444-81283-0. 1994; Vol. 64 (20), pp. 273-282. 
76
C H A P T E R  I V
1.
2.
3.
4.
5.
6.
7.
8.
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 52
77
Subacute fatal aluminum poisoning in dialyzed patients: post-mortem toxicological findings.
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 53
78
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 54
Acute Aluminum Intoxication
K. Berend1, G.B. van der Voet2, F.A. de Wolff2
1 Diatel Curaçao, Curaçao, Netherlands Antilles
2 Toxicology Laboratory, Leiden University Medical Center, Leiden, 
The  Netherlands 
In: Group 13 Chemistry II · Biological Aspects of Aluminum, Structure and Bonding. Roesky HW, Atwood
DA (Eds.). Springer-Verlag Berlin, Heildelberg, New York; 2002; 104: 1–58
C H A P T E R  V
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 55
80
C H A P T E R  V
Abstract
Despite the abundance of Aluminum (Al) in nature, it has no knownbiological function in humans. On the contrary, wide ranges of toxiceffects of Al to hundreds of cellular processes both in man and animals
have been demonstrated in plants and aquatic animals in nature, experimental
animals by several routes of exposure, and under different clinical conditions in
humans. Manifestations of Al toxicity that are encountered vary substantially,
with major differences arising due to different sources and varying intensity of the
Al burden in combination with differences in individual susceptibility. Al
neurotoxicity occurs only under extreme conditions and the conditions are the
worst in acute Al encephalopathy where myoclonic jerks, convulsions and a high
mortality rate are the major manifestations. Especially hemodialysis patients are
at risk when the dialysate is contaminated with high Al concentration, but also
the use of Al in bladder irrigation and the use of Al containing cement in
otosurgery have been related to acute Al encephalopathy. Therefore, every effort
should be undertaken to limit the use of compounds containing Al in medicine.
Key words: Aluminum, Intoxication Acute, Hemodialysis
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 56
1. Introduction
2.   Case Report
2.1   Course of Events and Clinical Symtomatology
2.2   EEG
2.3   Pathology (Table 3)
2.4   Predisponsing Factors
2.5   Detoxification Treatment and Follow –Up of the Survivors
2.6   Discussion
2.7   Legal Consequences
3       Symptoms and Diagnostics of Al Intoxication Syndromes
3.1 Definitions of Al Intoxications
3.2 Acute Al Gasteroenteropathy
3.2.1 Oral Exposure
3.2.2 Peritoneal Membrane
3.3     Hemodialysis. Clinical Symptoms of Acute Al Encephalopathy and Cronic
Al Encephalopathy (also Referred to as Classical " Dialysis Dementia ")
3.4      Diagnostic Parameters
3.4.1 S-Al Levels
3.4.2 Other Serum Determinants
3.4.3 Liquor
3.4.4 Microcytic Anemia
3.4.5 EEG
81
Acute  Aluminum Intoxicat ion
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 57
4 Sources of  Aluminum Exposure Leading to Acute and Chronic 
Aluminum Intoxication
4.1  Contamination of the Dialysate
4.1.1   Al Contamination at Drinking Water Plants
4.1.1.1 Al Use in the Drinking Water Industry
4.1.1.2 Relatively Low Al Levels (50 –75 µg/L) in Water Used for 
Preparation of Dialysate
4.1.1.3 High Levels of Al (> 75-200 µg/L) In Water Used for Preparation of Dialysate
4.1.1.4 Al Contamination During Drinking Water Distribution
4.1.1.5 Al Contamination by Hemodialysis Equipment
4.2 Desferrioxamine (DFO) Administration
4.3 Gastrointestinal Exposure
4.3.1 Oral Phosphate Binders
4.4 Bladder Irrigation with Al Sulfate
4.5 Al Containing Biomaterial (Cement) in Otosurgery
4.6 Peritoneal Dialysis and Acute Al Gastroenteropathy
4.7 Other Sources of Al Exposure not Related to Acute Al Intoxications
4.7.1 Parenteral Nutrition and Oral Milk Based Formula in Children
4.7.2 Drinking Water
4.7.3 Inhalatory Exposure
4.7.4 Dermal Exposure
4.7.5 Intranasal Absorption
4.7.6 Low, or Absent Toxicity of Sources of Al Exposure in Human in 
Normal Circumstances
5 Pathogenetic Mechanisms of Aluminum Intoxications
5.1 Speciation, Biokinetics and Metabolism
5.1.1 Al Speciation
5.1.2 Biokinetics
5.1.2.1 Absorption and Excretion
5.1.2.2 Distribution
5.1.2.2.1 Metabolism
5.1.2.3 Nucleotides and Organic Phosphates
82
C H A P T E R  V
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 58
5.2 Neuropathological Mechanisms
5.3 Theories of Pathophysiology of Aluminum Encephalopathy
5.3.1 Blood- Brain Barrier (BBB)
5.3.2 Brain Al Homeostasis and Cellular Mechanisms
5.3.3 Al and Neurotransmission
5.3.4 Delayed Neurotoxicity
5.4 Pathological Mechanisms of Bone Disease
5.5 Microcytic Anemia
6 Treatment of Aluminum Intoxications
6.1 Prevention and Management of Al Intoxication
6.2 Treatment
6.3 Desferioxamine (DFO)
6.4 Treatment with DFO in Hemodialysis Patients
7 Conclusions
8 Recommendations for Further Study
9 References
83
Acute  Aluminum Intoxicat ion
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 59
1. Introduction
Aluminum (Al) is present in small amounts in mammalian tissues
but it has no recognized physiological role. On the contrary, wide ranges of
toxic effects of Al have been demonstrated in plants and aquatic animals,
in experimental animals by several routes of exposure, and under different
clinical conditions in humans. Its neurotoxic effect on living organisms is
beyond any doubt and Al has been shown to interfere with a variety of
cellular metabolic processes in the nervous as well as several other systems.
About eight percent of the earth’s crust consists of Al (w/w) and despite its
abundance its toxicity remained disputed until the discovery of Al - related
diseases in renal patients. This is due to the fact that the bioavailibility of
Al is very low after oral ingestion and even lower after inhalation.1-4 These
protection barriers are bypassed during hemodialysis and during this
treatment, trace elements can cross the artificial kidney and enter the blood
of the patients. Due to the fact that patients are exposed to some 400
liters of water on a weekly basis, patients can be exposed parenterally to
huge amounts of the toxic element and evidence of Al as a neurotoxic
trace metal was established in the early 1970s after many years of uncer-
tainty. Al neurotoxicity was initially described in 18865 and rediscover-
ed in 19217 and 1937.6 Animal studies showed that local administration or
application of Al to the brain caused animals to develop a seizure disorder.6
In 1921 a possible single case of industrial poisoning with Al was reported7
but it lasted until 1962 before the second case with industrial-related Al
encephalopathy was described. In this case speech difficulties, seizures and
pulmonary fibrosis was associated with the inhalation of Al-containing
dust in an Al plant8 and in 1975 a similar case of neurotoxicity was
described in association with increased brain Al concentration.9 These
were the first reports to suggest that Al neurotoxicity could occur in
humans. In 1972 a new distinct neurological disease, dialysis encephalopathy,
dialysis dementia, or chronic Al encephalopathy with speech disturbances,
personality changes, seizures and myoclonus was described in dialysis
patients10 and numerous similar reports followed thereafter.11-46
Subsequently, it was found that certain species of animals, cats and rabbits
developed neurofibrillary tangles following exposure to Al,47-56 which
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prompted the suggestion that Al was a possible cause of Alzheimer’s disease.
However, this theory was disputed because not all patients with Alzheimer’s
have high brain levels of Al and the senile plaques that are common in
Alzheimer’s disease are not seen in experimental Al toxicity.57 Another reason for
disregarding a role for Al in Alzheimer’s disease has been the fact that the
incidences of cognitive impairment and Alzheimer’s disease are not increased in
renal patients with high s-Al levels. Nevertheless, these patients cannot be
compared with the general population, because dialysis patients have a
reduced longevity and may be protected by other compounds like silicon.58-61
It remains remarkable that, after the discovery of chronic Al encephalopathy
and numerous reports of patients suffering from this syndrome, fourteen years
passed before the first publication on acute Al neurotoxicity appeared.62 Acute
Al encephalopathy is a devastating, often fatal disease that is the result of
iatrogenic exposure to Al. Unfortunately, in spite of efforts to avoid Al exposure
as much as possible, recently new sources of serious exposure have been added
to the growing list of sources of Al exposure. In contrast to a fascinating history and
abundant literature, many uncertainties about Al toxicity still exist. Clinical
data in humans on acute Al neurotoxicity are very limited and we will, therefo-
re, compare our experience in one of the two documented outbreaks in dialysis
centers, with that of the literature. 
2. Case report
2.1. Course of events and clinical symptomatology
In Curacao, the major island of the Netherlands Antilles with a
population of 130.000 inhabitants, distilled seawater from the water plant
was used without further purification for hemodialysis for several decades.
Unfortunately, two months before the planned installation of a water
treatment system including a reverse osmosis (RO) in the dialysis center
Diatel, a new distribution pipe supplying water to a dialysis center on the
island was installed in 1996. To protect it from corrosion, this pipe was
lined on the inside with a cement mortar. Because of the aggressiveness of
the distilled water, calcium and Al leached from the cement mortar into the
water used to prepare dialysate. At the time of replacement of the new
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conduit pipe, 29 patients were dialyzed in the dialysis unit. Patients were
dialyzed three times per week during 3.5 to 4.5 hours using hollow fiber
kidneys (Fresenius®, F6 and F8). Untreated tap water was used to manufacture
dialysate after passage through three particulate filters (25, 10, and 5 mm,
respectively). The intended Ca content of the dialysate was 1.75 mmol/L.
None of the patients used Al containing phosphate binders. After the
installation of the new water distribution pipe, the patients were exposed
to the contaminated water from May 21, 1996, until June 29, 1996. This
caused a possible hard water syndrome and definite acute Al intoxication
in 27 patients and led to the death of 10 patients.
In the third week of June 1996, 7 of 27 patients had minor symptoms
of nausea, vomiting and post-dialysis hypercalcemia. On June 20, 1996, the
Ca-carbonate concentration of tap water delivered to the dialysis unit was 43
mg/L (17.2 mg/L or 0.45 mmol/L as Ca2+), which is above the standard of 2
mg/L advised by the Association for the Advancement of Medical
Instrumentation.63 In the past, the Ca-carbonate concentration had been 15
to 20 mg/L (6.0 to 8.0 mg/L or 0.16 to 0.21 mmol/L Ca2+). At that time the
diagnosis "hard water syndrome"64 was made, due to leaching of calcium
from the water distribution pipe. The use of Ca-carbonate and vitamin D
preparations was stopped and although there was initial amelioration of the
symptoms in almost all patients, the improvement was incomplete whereafter
the dialysis unit was closed on June 30, 1996. All patients were referred to
the hospital for dialysis where the symptoms of nausea, vomiting, as well as
the hypercalcemia disappeared after a single dialysis with low Ca dialysate
(1.50 mmol/L). After installation of a RO system, including a deionizer, dialysis
was resumed at the Diatel unit on July 10, 1996. Although the patients were
dialyzed on ultra pure water, either in Diatel after the installation of the RO
on July 10, 1996, or in the local hospital, before the manifestation of serious
symptoms, after a lag time of several days to weeks several patients had severe
neurotoxic symptoms. Eight patients (Table 1, patients 2 through 5 and 7
through 10) had to be admitted to the hospital because of severe neurological
symptoms (disorientation, myoclonus, convulsions and coma, n = 7) or
unexplained sepsis (n = 2) with a delay of days to three weeks after the last
dialysis with contaminated water (Fig. 1). Attempts to treat myoclonic jerks
or seizures with intravenous phenytoin or diazepam were unsuccessful.
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Table 1. Characteristics of non-survivors and survivors
Patient
No.
Age
(years)
[Al]s
(µg/ml)
sex Weight
(kg)
Exposure
(h)
Diuresis
(mL/day)
PTH
(pg/mL)
Albumin
(g/L)
ρte
Ef     Dg
Treatment
(weeks)
Non-survivors (n = 10)
1 61 - f 66 52 0 28 35 4     9 -
2 79 - f 33 51 0 105 32 7    12 -
3 54 1189 m 85.5 68 150 52 34 2    12 -
4 64 725 f 52.5 52 0 22 35 15   18 -
5a 51 894 f 40 68 0 72 30 7     20 -
6 69 - f 39.5 39 2000 - 28    7      22 -
7a 62 1275 m 62 60 0 8 34 5     23 -
8a 63 359 f 47 68 0 325 36 14    23 -
9a 74 517 f 86 64 0 32 32 21    24 -
10 65 696 m 64 68 0 480 35 21    30 -
Mean 64 808 - 57.5 59 - 125 33
SEM 3 127 - 5.9 3 - 55 1
Survivors (n = 17)
11 64 490 m 57 68 0 710 40 - 75
12 57 395 m 65 59.5 0 80 39 - 91
13 50 321 f 87 68 0 21 34 - 16
14 44 319 m 97 62 0 630 39 - 13
15 49 318 m 57 66 200 50 36 - 24
16 23 315 f 104 68 0 97 39 - 8
17 66 303 f 78.5 64 60 280 34 - 18
18 57 301 f 90 68 350 170 37 - 5
19 50 248 f 57.5 64 1000 65 36 - 13
20 56 207 f 103 68 0 82 36 - 16
21 50 205 m 104 60 2 700 37 - 82
22 57 187 f 101 64 50 1200 32 - 16
23 57 182 f 95 62.5 1100 100 30 - 9
24 41 166 m 91.5 68 0 3 - - 18
25 60 132 m 97.5 67 1200 270 39 - 4
26 41 116 m 93.2 60 200 680 38 - 11
27 56 113 f 91.5 67 1400 99 33 - 4
Mean 52c 255c - 86.5c 65 - 308 36d
SEM 2 25 - 4.1 1 - 84 1
a Patients in whom post mortem examination was performed.
b [Al]s: serum aluminum concentration.
c P < 0.01
d P < 0.05, survivors vs. non-survivors.
e ρt E/D Delay in time in days after end of exposure to Al, the onset of encephalopathy (Ef), and death (Dg).
With permission Blackwell Sciences. Adapted.
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When the diagnosis of "acute Al intoxication" was established on July 25,
1996, nine patients had died. The 10th patient, who was comatose, was
transferred to a hospital in Florida (Florida Hospital, Orlando, FL, USA).
Daily high-flux dialysis treatment combined with desferrioxamine admini-
stration was unsuccessful, and he died on August 24, 1996. Of the 27
patients who had a similar exposure (~60 hours) to the contaminated dialy-
sate, 10 died from acute Al encephalopathy, whereas 17 patients had no or
only minor symptoms and survived. The first Al tests in the water supply
were performed the first week of July 1996, and values of 550 to 690 µg/L
were observed. The water company flushed the pipe several times, but
because the values remained above 500 µg/L, 1000 m of the initial 2200
m pipe was bypassed.  Nevertheless, although the Al level at the water
plant was below 5 µg/L, the Al levels at the tap water in Diatel remai-
ned high (up to 443 mg/L several months after the bypass), and above
100 µg/L for more than two years.18
Of the 29 patients, two patients had been dialyzed for less than a
week (one at the end of May, and one at the end of June 1996) on the
contaminated water, had a s-Al levels of 16 µg/L and 50 µg/L (< 60 mg/L
normally seen in dialysis patients without symptoms) and were therefore
excluded from further evaluation. Table 1 shows the characteristics of
non-survivors and survivors. It is not certain if patient No. 6 did or did not
develop acute Al encephalopathy, because of the 27 patients she probably
had the lowest Al burden. The patient with a diabetic nephropathy had been
on hemodialysis for only two months and had a considerable residual kidney
88
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NR
1 M C D
2 S D
3 C D
4 C D
5 C D
6 C D
7 S M SO D
8 C M S D
9 C D
10 C D
Days 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 41
C = convulsions
D = death
M = myoclonic jerks
S = sepsis
SO = somnolence
Figure 1.Days between the onset of severe symptoms after the end of exposure to aluminum contaminated dialysate.
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function with normal diuresis. Compared with the other patients she was
exposed for the shortest period (39 h vs. 59-65 h) because she was admitted
twice to the hospital for a bleeding duodenal ulcer and hypercalcemia.
Hypercalcemia was due to a combination of factors consisting of the use
of a calcium phosphate binder, vitamin D, a higher than usual calcium
content of the water supply, the availability of calcium in the dialysate
and the Al contamination. The calcium level normalized after she had
been dialyzed in the hospital with a low-calcium dialysate. The patient
nevertheless developed convulsions and twitching of her hands that
might have been a sign of Al neurotoxicity, especially because the EEG,
performed two weeks before the start of convulsions showed, in retrospect,
signs of Al encephalopathy (Table 2). These symptoms however, could
also be due to a metabolic or uremic disorder because she had skipped
some dialysis sessions. These twitchings were also absent in the other
patients. After a one weeks of hospital admission dialysis treatment was
stopped because of worsening of the general condition with anorexia and
she died 22 days after the end of exposure to the contaminated dialysate
(Fig. 1). No blood samples had been available for Al testing. 
2.2. EEG
Table 2 shows the EEG recordings before treatment in 12 patients
(patient Nos. 1, 3, 4, 6, 7, 10-13, 20, 23, 25) and five patients after treatment
(patient Nos. 11, 12, 15, 20, 25). The abnormalities in the EEG recordings
of the patients who died were the most severe and consisted of an abnormal
ground pattern, some periods of slower high voltage activity, bilateral
synchronous with some frontal intermittent recurrent delta activity,
sometimes followed by short periods of suppression. After termination
of desferrioxamine therapy an EEG was performed in five patients
(patient Nos. 11, 12, 15, 20 and 25). Minor non-specific signs possibly
related to Al encephalopathy were found after therapy in two patients
(Nos. 11 and 25). Slightly abnormal EEG became normal in two
patients (patient Nos. 12 and 20). In patient No. 15 with a normal EEG
after therapy no EEG had been obtained before therapy.  
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2.3. Pathology (Table 3)
Post-mortem examination was done in four of the 10 patients (Patients Nos.
5, 7-9). Brain Al contents of cerebral cortex of these four patients were 0.93 to 1.81
µg/g dry weight (normal 0.14-0.22 µg/g; values in patients with chronic Al
encephalopathy 0.4-3 µg/g).65 On light-microscopic evaluation of gyrus frontalis
superior and inferior, hippocampus, nucleus lentiformis and insula, capsula interna
and caudatus, thalamus, nucleus dentatus cerebelli, brainstem, and pons,
non-specific changes of some fibrohyalin thickening of the wall of the blood
vessels and brain edema were noted. 
In patient No. 9, additional Al staining was performed and positive coloring
was found centrally in calcifying areas in the plexus chorioidea of the hippocampus
and in the wall of the vessels with mineralization in globus pallidus. No Al staining was
found in the epithelium of the plexus choreoidea, corpora amylacea, endothelium,
neurons or glia cells. In Bodian silver staining scattered neurofibrillary tangles with tau
protein were found in the hippocampus, similar to other studies.47-51,53,55-57,66 Iron (Perls)
and calcium (Alizarine) staining showed the same pattern of staining as in Al.
2.4. Predisposing factors
When the ten nonsurvivors are compared as a group, they were older (64 ±
3 years vs. 52 ± 2 years, P < 0.01), had a lower body weight (57.5 ± 5.9 kg vs. 86.5
± 4.1 kg, P < 0.01) and lower serum albumin concentrations (33 ± 1 vs. 36 ± 1 g/L,
P < 0.01) as a parameter for the feeding state of the patients. Anuria tended to be more
common in the non-survivors (8 out of 10 vs. 8 out of 17, P > 0.05). S-Al concentrations,
available in seven non - survivors, were significantly higher than in the survivors (808
± 127 vs. 255 ± 25 mg/L, P < 0.01).
The 17 patients who survived dialysis with contaminated dialysate were
significantly younger than those who died (Table 1) and the average body weight in
the non-survivors was almost 30 kg below that of the survivors.17 Diabetes mellitus
was more frequent in the non-survivors than in the survivors (60 vs. 16%, P = 0.11), as
was the proportion being anuric (80 vs. 47%, P = 0.12). Survivors tended to have higher
serum PTH concentrations (survivors, 308 ± 84 pg/mL; non - survivors, 125 ± 55
pg/mL, normal, 11 to 62 pg/mL). Shortly after the intoxication, the mean corpuscular
volume in the patients was low  (70.25 + 6.22, normal 81-99 fL) in seventeen patients.
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2.5. Detoxification Treatment and Follow-Up of the Survivors
The 17 surviving patients had elevated s-Al concentrations but were
fairly asymptomatic and had to be treated with intravenous desferrioxamine
(DFO) and high-flux dialysis according to the treatment schedule of Table 4. For
logistic reasons, especially the inability to provide high-flux dialysis to all patients
on short notice, these patients were transferred to six different hospitals in the
Netherlands. In the initial treatment week no serious side effects were observed. In
the second week one patient had a short period with myoclonic jerks during dialysis.
In the weeks following the treatment only minor neurological or ophthalmologic
symptoms were observed, expressed by slight headache (n = 3), and blurred vision
(n = 1). None of the patients had serious side effects of the treatment with
desferrioxamine. One patient had an allergic reaction expressed by generalized
itching during infusion of DFO, but when DFO was infused the next session after
92
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aAl levels in serum, liver and bone are much higher than in the brain, which shows the effectiveness of the blood
brain barrier and the storage capacity of liver and bones. Nevertheless, severe neurological symptoms are due to
an extremely narrow margin of safety between normal and toxic levels of Al in brain tissue and the lethal
concentrations exceed the normal level by only a factor 8-10 in literature studies31 and a factor 3-4 in this study.
Epilepsy and myoclonic jerks are prominent signs of neurological dysfunction due to Al encephalopathy. The
grey matter of the brain is vulnerable to Al-induced pathologic changes and dysfunction of the hippocampus
often manifests as epilepsy. Myoclonus is often associated with abnormally increased excitability of cortical
structures.274 The gyrus temporalis inferior and gyrus frontalis superior are related to speech disorders and
dyscalculia as can be seen in chronic Al encephalopathy and Alzheimer’s disease.275
Table 3. Postmortem Al in serum, brain, bone and liver in patients Nos. 5, 7-9a
Patient No 5 7 8 9
Normal values Chronic Al
encephalopathy in dialysis
patients
Serum Al µg/L < 10 µg/L23,129
(40-60 µg/l in dialysis
patients)23,129
> 100 µg/L20 894 1275 696 517
Brain
Hippocampus < 0.4 µg/g dry weight65 0.4-3.765 NAb 1.14 1.3 1.03
Gyrus temporalis
inferior
< 0.4 µg/g dry weight65 0.4-3.765 1.75 1.04 1.4 0.93
Gyrus Frontalis
Superior
< 0.4 µg/g dry weight65 0.4-3.765 1.81 1.19 1.51 1.3
Liver < 2 µg/g129 > 30 µg/g42 4.7 51.7 32.7 43
Bone < 2 µg/g23,129 50.8 + 29.5 µg/g197 77 7.54 88.7 21.9
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:01  Pagina 68
steroid infusion, no symptoms were recorded.  One patient had painful localized
swellings on both legs, diagnosed as erythema nodosum. This is not a known side
effect of desferrioxamine. The lesions disappeared rapidly with steroid treatment.
One patient had an infection of a dialysis shunt (Goretex graft).
A large variation of the duration of the detoxification was noted (Table 1).
Only five patients could be treated less than 10 weeks, while twelve other patients
had to be treated up to 91 weeks. The treatment was discontinued in patients in
whom both s-Al and the increment of s-Al after desferrioxamine treatment was
below 50 µg/L at two successive occasions). The treatment duration was
significantly related to the residual diuresis as all patients with a residual diuresis of
a liter/day or more could be treated for less than two months (Fig. 2). Other
studies have also established the protective capacity of an even minimal
functioning kidney.30,67 None of the patients died during treatment with
desferrioxamine, and six patients (patient Nos. 11-13, 22, 25, 26) died more than
one year after termination of the desferrioxamine treatment, due to causes
unrelated to the Al intoxication. As of November 2001, more than five years after
the intoxication episode, 12 of the 17 surviving patients (patient Nos. 11,12, 14,
16-24) are still alive and none of the patients developed any clinical signs
of Al toxicity, like speech disturbances, cognitive defects, bone fractures or
dementia-like symptoms. 
2.6. Discussion
An unique set of circumstances was responsible for symptoms resembling
hard water syndrome64 followed by an epidemic of acute Al encephalopathy in
a dialysis unit (Diatel) on the island of Curaçao. A tragic coincidence was that
the intoxication happened about two months before the planned installation of a
water treatment system with deionization and reverse osmosis (RO). Traditionally,
municipal water had been used for more than two decades without extended
purification for the production of dialysate. The pure (Al < 5 µg/L), destilled
drinking water, which is one of the purest drinking water sources worldwide,68 was in
fact indirectly responsible for the fatal outcome. The water entering the mains was
aggressive, soft and the alkalinity low (maximum Langelier Index [LI]
between -0.5 and -1.5, hardness as CaCO3 is 15-20 mg/L, pH 8.5 to 9.5).18 The
water utilities did not condition the water to make it less corrosive but installed
93
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other pipes with a "protective" cement coating.18 Water distribution pipes are
commonly coated on the inside with cement mortar to protect them from
corrosion by the electrochemical action of water. Although cement-mortar linings
have been successful in protecting iron pipes against electrochemical corrosive
effects, recent research indicates that water can leach cementitious materials from
this lining up to four years. Adverse effects of these coatings on the water quality
are generally an increase of calcium and pH,69 but recent reports did not
mention the possibility of Al contamination into drinking water from cement
linings.18 The water distribution company had replaced the water distribution
pipe to help the dialysis center with the low water pressure problem, but had
been unaware of the fact that these pipes are inappropriate for the local water
conditions. Conditions that enhance Al leaching include low water alkalinity and
hardness, relatively high water temperatures, and low or intermittent water flow.
Unfortunately, all of these factors coincided in this situation, especially because
Diatel was located at the dead end of a water main, resulting in the highest Al
concentrations on the island. The Al level rose form about 16 µg/L to at least
94
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Table 4.   Practical approach with desferrioxamine (DFO) treatment of severe aluminum
                 intoxication in hemodialysis patients, using Monday as the starting day.
Aluminum levels > 300 µg/l, or post DFO
administration > 300 µg/L.
Four times a week dialysis.
Aluminum levels < 300 µg/l, or post DFO
administration < 300 µg/l. Three times a
week dialysis.
Therapy DFO administration
5 mg/kg, 5 hours
before dialysis
(1 h infusion time)
High flux dialysis of
at least four hours,
F 80 or similar
DFO administration
5 mg/kg at the last
hour of dialysis
(1 h infusion time)
High flux dialysis
of at least four
hours,
F 80 or similar
Day 1
Monday
Yes Yes, four hours after
termination of infusion
Yes Yes
Tuesday No Yes, preferably 20 hours after
termination of last dialysis
session (within 72 hours)
No No
Wednesday No No Yes Yes
Thursday Yes Yes, four hours after
termination of infusion
No
Friday No Yes, preferably 20 hours after
termination of last dialysis
session
No Yes
Saturday No No No No
Sunday No No No No
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up to 690 µg/L. Clearly, no one, not even the water industry in particular
had ever been aware of the possibility of Al contamination during distribution,
as this had never happened before in dialysis history.18
2.7. Legal consequences 
The incident caused a flood of media coverage and a criminal investigation
followed with the help of the local and Dutch Health Inspectorate. Thereafter,
the prosecutor dismissed the case and held that the intoxication was caused by
a unique and complex set of circumstances that not only involved the physicians, but
also external consultants for the dialysis center, the local Water Authorities and the
government. After an appeal of family members of some of the patients that
died, the court reopened the case and after a preliminary judicial inquiry the
physicians were initially convicted, but acquitted at the Court of Appeal.
3. Symptoms and Diagnostics of Al Intoxication Syndromes
There are wide variations in the clinical manifestations and degrees of
expression of toxicity as patients are exposed to Al. In renal disease Al accumulation
in tissues and its resulting toxicity is mainly due to poor elimination, since
the kidney normally excretes the metal. There is no simple relationship between
the amount of Al to which the patient is exposed and the occurrence of the
clinical manifestations of the disease; apparently there is considerable interindividual
difference in sensibility since the symptoms developed in some patients but not in
other equally exposed patients. Some of the variations in the clinical features in Al
toxicity in the past most likely occured because of differences in both the rapidity
and magnitude of Al loading. Therefore the manifestations of Al toxicity that are
encountered vary substantially, with major differences arising due to different sources
and varying intensity of the Al burden. 
3.1. Definitions of Al Intoxications
In the past several clinical patterns have been described. The most
important recognized clinical patterns or types of Al toxicity include two
types of encephalopathy. Firstly, the "classical" dialysis dementia sometimes
95
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referred to as "dialysis encephalopathy syndrome (DES)" or dementia
dialytica24,28,37,42,70-74 and secondly, the "acute" or "subacute" Al encephalopathy.41
There are also two types of  bone disease –either osteomalacia with bone
fractures and proximal myopathy or aplastic bone disease.41,75,76 There is quite
some confusion in the definitions of Al toxicity in the literature. Because
there seems to be an obligatory lag phase of at least several days to weeks for
symptoms to occur, "acute" Al encephalopathy, defined as a direct result of
a single overdose, probably does not exist. Because of the long lag  phase of
several months to years necessary to develop the "chronic" dialysis encephalopathy
and also because "acute" Al encephalopathy has an abrupt, sudden onset of
symptoms one can understand why the term "acute" is used instead of the
more descriptive "subacute". The descriptions "dialysis dementia"37,42,46,73,74
and "dialysis encephalopathy"33-36,38,40,41,78 are also unfortunate because true
dementia is rare in Al encephalopathy73 and non-dialyzed patients can also
develop these symptoms.78 There are also many dialysis-related encephalopathy
syndromes unrelated to Al. As an example, the desequilibrium syndrome and
sodium disturbances can also produce seizures.79 In addition to this, some
publications on "acute Al intoxication"17,80 refer to the predominant
neurological symptoms, while other publications only described gastrointestinal
symptoms.20,81,82
To avoid this confusion it is necessary to separate acute Al intoxication into
"acute Al gastroenteropathy" and "acute Al encephalopathy". Chronic Al
gastroenteropathy as such probably does not exist, because patients will
terminate the oral exposure because of complaints.
3.2. Acute Al Gasteroenteropathy
Gastroenterological symptoms due to Al toxicity have been described as
massive gastrointestinal intoxication and as peritoneal dialysis fluid contamination
with Al.81-83
3.2.1. Oral exposure 
The potential negative effects of exposure to Al do not only reflect the dose,
but also the percentage of the dose that is absorbed and retained. The effectiveness
96
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of the gut as a protective barrier is illustrated by the observation that only 0.04 – 1
% of oral doses of Al appears to be retained.1-4,59,84-87 However, very high
concentrations of Al in drinking water may have health consequences. Drinking
water plants commonly use Al sulfate as a flocculent. Unfortunately, human errors
can increase human exposure to excessive amounts. On  July 6, 1988, twenty
metric tons of Al sulfate were accidentally emptied into the treated water reservoir
at Lowermoor Water Treatment Works that supplied the Camelford area of North
Cornwall, UK.  Twelve thousand residents and 8000 tourists were exposed for 3
days and when the error was detected corrective measures were started. The water
tasted unpleasant because of its acidity and Al content up to 620 mg/L; it also
contained abnormally high amounts of copper, lead and zinc dissolved from water
pipes. Consumers noted an unpleasant taste and reported a variety of acute symptoms
such as mouth ulceration, joint pain, gastrointestinal disturbance, skin rashes,
fatigue, nausea and vomiting, itching and sore eyes.82,88,89 Nevertheless, initial
toxicological assessment was that the limited exposure would not cause acute or
chronic disease.82 Two years later, however, of the 20,000 persons exposed to the
contaminated water 400 people had illnesses that were attributed to the incident.88
Bone Al concentrations remained elevated for 6 to 7 months, but were absent at
follow–up 19 months after the accident in at least two affected individuals.88,89 In
one study some patients demonstrated poor short-term memory and concentration
disturbances, which were regarded as a possible organic brain dysfunction due to
the accident in one study.20 Thus, Al absorption and deposition in the body can be
significant when normal individuals are exposed to highly contaminated water,
even when exposure is short. This may seem remarkable, considering the fact that
Al-related bone disease in dialysis patients disappears after kidney transplantation
and the rate of removal of Al from bone seems to be independent of graft function
and bone turnover.90,91 One would expect that healthy kidneys should be able to
eliminate Al in these circumstances. However, it has been demonstrated by special
Al staining that Al-induced argyrophilic degradation products remain in the
cellular cytoplasm in unchanged fashion up to 10 years after renal transplantation,
when the renal Al excretion was normalized.92
3.2.2. Peritoneal Membrane
Another route of exposure resulting in gastrointestinal symptoms
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have been in peritoneal dialysis. In three of the centers supplied with
contaminated peritoneal fluid in Paris, Glasgow and Edinburgh regular
monitoring of the s-Al disclosed unexpected high Al levels. In 14 of 19
patients plasma Al levels exceeded 470 µg/L; four patients had symptoms
of nausea, vomiting, cramp like abdominal pain and general malaise which
appeared within three days of first using the contaminated fluid. The cause
of the syndrome was recognized before irreparable harm was done, and all
patients eventually recovered. Al concentrations in the affected batches
ranged from 613-1440 µg/L. Within a month time, s-Al rose to peaks of
267-1440 µg/L.81,83 The mechanism of these symptoms is unknown; they
seem to be due to a direct irritation of the bowel wall. We are unaware of
any studies on neurotoxic damage to the autonomic nerves of the bowel
due to AL. 
3.3. Hemodialysis. Clinical Symptoms of Acute Al Encephalopathy and Chronic
Al Encephalopathy (also Referred to as Classical "Dialysis Dementia")
Hemodialysis patients are very susceptible to changes in the
composition of water used to produce dialysate, as the effective barrier of the
gut is bypassed during this treatment. Patients are exposed to about 120 L of
water during each dialysis treatment and contaminants present in the water
may diffuse across the dialysis membrane and cause intoxications.63
Slow, relatively "low exposure" accumulation of Al over a period of
years can lead to a number of clinical manifestations, some of which seem to
be "bypassed" in acute Al encephalopathy due to extremely high exposure to
Al. Al encephalopathy is a clinical syndrome and, as can be seen in Table 5,
there are similarities and differences in the neurological symptoms of acute
and chronic Al encephalopathy. In chronic Al encephalopathy, microcytic
anemia 41,93, 95-98 and EEG changes99-104 can precede clinical symptoms.105 It is
unknown if these symptoms can also precede the clinical symptoms of acute
encephalopathy. In contrast to acute Al encephalopathy, where speech
disturbances are absent, speech disorders are an important presenting clinical sign
of neurotoxicity in chronic Al encephalopathy. The neurological basis of the
speech apraxia is obscure but it appears to have elements of dysarthria and
dysphasia.33,73 The initial episodic nature of the condition suggests that it
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may be due to a transient toxic state as often occurs after dialysis with
contaminated dialysate, but it might as well be part of a complex seizure
state.33 The neuropil spongiosis of the upper layers of the temporal cortex was
thought to be relevant to the language disorder.103 In addition to
communication disturbances, cognition disturbances, fracturing
osteomalacia and/or myopathy can also be the presenting clinical symptoms
in chronic Al encephalopathy, while these symptoms are absent in the acute
form. Disturbed handwriting (dysgraphia) has been noted in some cases of
the chronic encephalopathy, but not the acute form of Al encephalopathy.
Changes in handwriting can be evaluated retrospectively in many cases,
because patients in dialysis centers tend to note some of their dialysis
parameters in the dialysis chart themselves. It should be stressed that many
of these symptoms like relapsing speech and language abnormalities,
clouding of consciousness, grimacing, tremor and asterixis, muscle jerks and
seizures are common to numerous metabolic encephalopathies unrelated to
Al.22,79,104
Patients with acute and chronic Al encephalopathy can demonstrate
unilateral or bilateral myclonic jerks of the extremities for several months in
the chronic form and days to weeks in the acute form, followed by
convulsions and coma even when the exposure is terminated. It seems as if
brain pathology reaches a point of no return, which results in frequent
epileptic insults and inevitably leads to coma and death, either due to
superimposed infections like aspiration pneumonia, or pulmonary edema
due to cardiac toxicity. Recovery is exceptional in severe cases. In the past,
reports showed that the early stages of chronic Al encephalopathy progressed
to death, mainly because the most important source of Al, namely the
dialysis fluid contamination was not recognized as such and the exposure
continued for months to years.10-17, 19-42
Fluctuation of neurological symptoms can be seen in relation to dialysis in
chronic Al encephalopathy, sometimes provoked by dialysis sessions due to
additional exposure with contaminated dialysate superimposed to chronic Al
intoxication.28,29
One of the most confusing features of Al encephalopathy is the lag
phase between exposure and clinical symptoms and the subsequent rapid
course of the disease. The delay can be months to years in the classical form
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and several weeks in the acute form. Because patients are generally
symptom-free or demonstrate minor symptoms like microcytic anemia,
physicians are unaware of the exposure until the development of severe
symptoms. Until recently it was not known that a relatively short dialysis
related exposure time to Al could be fatal. 
Myocardial dysfunction may arise from Al loading, but this is not
substantiated as yet. Al levels have been found markedly increased in the
heart in patients with chronic dialysis encephalopathy.15 It is presumed that
sudden cardiac death may practically be due to Al cardiotoxicity.27,106 At
pathology evaluation patients Nos. 7-9 showed signs of pulmonary edema. 
Al is also present in the synovial fluid and arthritis-like symptoms have
been reported in patients with Al bone disease, possibly due to an
inflammatory effect on the synovial cells.107,108 We did not see signs of
arthritis shortly after the intoxication, but after several months of
treatment with desferrioxamine, three patients developed a possible
transient synovitis with hydrops in the knee joints. 
Although Al bone disease can occur in any patient intoxicated by Al, the risk
is greater in diabetics. This may be related to a lower than normal bone formation
rate, an abnormality that has be demonstrated in type 1 diabetics prior to the onset
of clinical renal disease.109,110 The risk for developing acute Al encephalopathy also
seems to be increased in diabetic patients; this might be related to a decreased stora-
ge capacity of the bones.17
3.4. Diagnostic Parameters
3.4.1. S-Al levels
It should be stressed that testing of Al in body fluids can be easily
disturbed by contamination, due to the ubiquity of Al. Especially talcum
in medical gloves, and glass tubes are known to be responsible for falsely
elevated values. Protocols have been developed to avoid Al contamination
and Al-free polypropylene and polystyrene tubes prerinsed with 1 N HNO3
are used for this purpose.111 In patients with Al exposure through Al
containing biomaterial in otosurgery, s-Al levels can be below 300
µg/L.112-116 In all other intoxications resulting in acute Al encephalopathy
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s-Al levels are invariably well above 300-500 µg/L. 
3.4.2. Other serum determinants
Especially in Al bone disease hypercalcemia, suppressed PTH levels,
and normal or slightly elevated alkaline phosphates have been reported.
Hypercalcemia may develop in some hemodialysis patients with acute Al
encephalopathy when they are simultaneously exposed to oral calcium and
vitamin D preparations in combination with the available calcium from the
dialysate.17 It is not known whether PTH levels and serum alkaline levels
change during acute Al encephalopathy. 
3.4.3. Liquor 
Al levels in the cerebrospinal fluid are not always helpful for the diagnosis
because even at very low levels (below 10 µg/L) neurotoxic effects can be present.23,80,99
3.4.4. Microcytic anemia
Among dialysis patients, a microcytic anemia most commonly arises due
to iron deficiency but Al toxicity should be suspected in all cases where iron
deficiency is unlikely. Probably most patients with acute and chronic Al
intoxication develop microcytic anemia.93,95-98,105
3.4.5. EEG
Almost all patients with acute or chronic Al encephalopathy showed
EEG alterations. These were characterized by multifocal bursts of slow (delta)
and spike activity. Background rhythms between bursts were relatively normal
in patients with chronic Al encephalopathy, in contrast to uremia and other
metabolic encephalopathies were there is general slowing of the rhythmic
cycle.33,99-102,105,118
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4.  Sources of Al Exposure Leading to Acute and Chronic Al
Intoxication
4.1. Contamination of the Dialysate 
4.1.1. Al Contamination at Drinking Water Plants
4.1.1.1. Al Use in the Drinking Water Industry
Since at least the Roman times, alums and the related Al2(SO4)3 have
been added to drinking water to improve the appearance and it is still the most
widely used coagulant for turbid water to precipitate organic matter, because the
process is cheap and practical in its use. The coagulants commonly used by
water system plants are alum, poly-Al chloride, ferric salt and polymer.119,120 In
the process residual Al levels are generally low. The Environmental Protection
Agency encourages utilities to meet a level of 50 µg/L Al where possible, but
believes that "varying water quality and treatment situations" necessitate a
flexible approach.121 Therefore, and also because no health- based guideline
value for Al was recommended by the World Health Organization (WHO),122-124
large variations in Al concentrations in drinking water can be found due to
variations in source water and water Al levels as high as 1600-2700 µg/L have
been reported.119 Features of Al toxicity can affect a high percentage of dialysis
patients using such water for dialysate preparation because of inadequate water
purification procedures,10,16,17,19,23-26,37,38,46 or when water purification procedures
insufficiently protect the patients.28,30,39,44 Table 6 gives a review of the literature
on dialysate contaminations with Al, the reported serum levels (when available)
and the outcome of the patients. These data clearly demonstrate that there is an
exceptional variation of the severity of symptoms, which hardly seem to
correlate with neurotoxicity or serum levels. This is in part due to the fact that
reported Al levels in municipal drinking water were evaluated retrospectively
and that these levels can vary substantially from month to month.
4.1.1.2. Relatively Low Al Levels (50-75 mg/L) in Water Used for Preparation
of Dialysate
A large discrepancy between dialysate and s-Al levels are found at the
lower end of the spectrum, as there is no linear relationship between Al
concentrations in water used to prepare the dialysate and s-Al concentrations.
104
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Al is transferred against the concentration gradient, because it binds a non-
dialyzable plasma constituent, mainly transferrin. With Al dialysate-water levels of
50-75 µg/L, the plasma Al level can rise by 50% to 70% during a single
hemodialysis procedure. The body load of Al may thus progressively be increased
in a rate of at least 20.5 µg/min, or about 6 mg/dialysis.32 The transport in the
opposite direction can presumably occur when the plasma protein binding sites are
saturated with Al, but the amounts transferred are rather small.42 Such observations
have urged dialysis facilities to keep the dialysate Al level below 5 to 10 µg/L. 
4.1.1.3. High Levels of Al (> 75-200 mg/L) in Water Used for Preparation of
Dialysate
Davison et al. found that the cumulative risk of death due to dialysis
dementia in patients whose water supply had a mean Al concentration > 200
µg/L was significantly greater (27.9% deaths in the first 40 months) than the
risk in patients whose mean water Al content was < 200 µg/L (2.1% deaths in
the fist 490 months). The relation between the mean Al concentration in the
dialysate and time to death was given in the formula:24 The time in months from
the first symptoms of dialysis dementia to death = 65 – 0.081 x [mean Al
concentration (µg/L) in dialysis water]. 
It may be postulated that the severity of exposure to Al determines the
pattern of morbidity. Normally, Al in plasma is bound and transported by
transferrin. However, when plasma Al levels are > 500 to 600 µg/L, transferrrin’s
capacity for binding Al is exceeded, and Al probably exists in plasma in
combination with citrate or as a hydroxide in association with phosphate. Thus,
acute severe exposure may be more likely to produce the neurological disorder
and increased sensitivity to flicker, whereas chronic moderate exposure may
manifest primarily as bone disease and the other less dramatic symptoms.27,125-128
In any case, considering the fact that there have been only two reports of
outbreaks of acute Al encephalopathy in dialysis centers,17,43-45 and s-Al levels of
1200 µg/L44 to 1700 µg/L (Table 1) have been reported (Table 6), acute Al
encephalopathy due to water contamination probably only develops when Al
level in the tap water is well above 1000 µg/L.   
There are several possible reasons why some patients remain relatively
symptom-free while others develop serious neurological symptoms in cases with
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Table 6.  Dialysis water contaminations in dialysis centers. Comparison of serum and dialysate aluminum
                levels in patients without reported symptomsa and patients with classicalb and acute aluminum
                encephalopathy
Location
Reported Al
level in
dialysis
water (µg/L)*
Serum AL
level ( µg/L)
Time between
intoxication and
death or
Encephalopathy
Death
Chronic
Al
encepha
-lopathy
N=
Belgium44     62 154 ± 70a none none NR
Egypt44     85 119 ± 99a none none NR
Paraguay44     98  83  ± 43a none none NR
Denver, USA16 150-350 4-6 year
Cork, Ireland34 70-450 147-423b 22-93 months 5 14 NR
Newcastle, UK35
300-1200 NRb < 2 year 10 NR
NR
Manchester, UK12,127
Manchester, UK37,198
6-109
200-1000
84a
NRb 3-40 months
none
NR
NR
8
NR
34
United Kingdom13,14 < 702
< 80
20-60
< 756b
< 300b
< 165b
NR none
none
none
NR
NR
NR
NR
NR
NR
Minniapolis, UK19 160-1630 NRb NR 20/22 NR
Trent region, UK36,198 < 480 NRb 4 years NR 11 202
Scotland26,27 400 ± 33.3
>1000
NRb
NRb
NR
3 months on home
dialysis
NR
1
none
NR
NR
NR
Eindhoven, The
Netherlands28,29
800-1000 NRb Years NR 8 NR
Portugal23,30,44,45,80 2200 104-1257c Weeks 25 None 71
USA39 up to 262 (in
dialysate
81-8400)*
N=64,b
100-642b
2 years 1 8 64
Curaçao17 [table 1] 690 118- 1700c Weeks 9 or
10
None 27
*calculated retrospectively.
N= total exposed patients
Table 6. Due to insufficient data and retrospective studies, it is impossible to have a proper evaluation of the aluminum levels
in the water used for dialysis, the serum levels in patients and their outcome, from the available literature. Water aluminum
values can vary substantially over a short period, and some water companies may either be reluctant to release their data, or
did not test aluminum on a frequent basis. There have been only two outbreaks of acute encephalopathy: one in Portugal, and
one described in this article, on Curaçao, with similar symtomatology and a mortality rate above 30%. Al levels in the water
used for dialysis was > 650 µg/L in both studies.17,23,30,44,45,80 In several other studies Al levels in the water used to prepare the
dialysate were > 1000 µg/L, and retrospectively calculated concentrations up to 8400 µg/l were reported, but remarkably the
patients no clinical symptoms were reported in theses cases. Because acute aluminum encephalopathy has been extremely rare
and patients seem to tolerate extremely high serum levels (above 1000 µg/l) before acute aluminum encephalopathy develops,
it seems likely that levels of the water used for dialysis probably need to be at least > 1000-1500 µg/l before acute aluminum
encephalopathy will develop.
apparent similar exposure. 
With concomitant use of Al-containing drugs a parenteral exposure is
superimposed on chronic exposure.
The hours of dialysis treatment with subsequent Al loading can vary
substantially, as well as the "effectvity" of dialysis due to flow differences,
artificial kidney characteristics, etc. 
Large individual differences may protect patients from neurotoxicity. Large 
a. 
b. 
c. 
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body stores for Al  (bone, spleen, liver) and volumes of distribution differ 
among patients. Reduced storage capacity in liver failure or osteoporosis
might account for large differences. High PTH levels,29-132 high iron stores79
and high silicon58,59 levels may also protect patients partly due to influences on
the bodily distribution of Al. Some reports have demonstrated large
differences in silicon levels between patients and silicon levels can differ
100-fold in both cerebrospinal fluid and serum compared to subjects with 
normal renal function.20,23,58 The protective effect of silicon against Al
toxicity may be either by affecting the bioavailibility of Al20,23,59 or reversing 
the Al-induced conformational changes of neurofibrillary tangles.51,55,60,61 A 
residual diuresis protects against Al toxicity, as it will be excreted in these
patients67 (Fig. 2, see page 136). 
4.1.1.4. Al Contamination During Drinking Water Distribution
Only one case reported an increase of Al during drinking water distribution
(also discussed in this article), because Al leached from the cement lining of a
water distribution pipe.17,18
4.1.1.5. Al Contamination by Hemodialysis Equipment
In one case, fatal Al toxicity occurred in a dialysis unit in Eindhoven, the
Netherlands, due to the release of Al into water from an electrical anode
used to protect a boiler form corrosion.28 
Several reports have related the use of Redy cartridges in hemodialysis with
Al exposure. Al oxide is present in the Redy cartridge and due to the
increased solubility of Al in alkaline solution, Al can be released from the
Redy cartridge and cross a dialyser membrane.76,132-135 The risk for Al
intoxication is even higher when citrate anticoagulation is used in
combination with Redy dialysis. Infusion of citrate into the arterial line,
followed by infusion of calcium into the venous line, has been used for
regional anticoagulation during hemodialysis of patients with bleeding
diatheses or heparin-induced antiplatelet antibodies. These patients are
often hospitalised in intensive care units where the use of a sorbent
regeneration dialysis system is convenient.134,135
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An outbreak of Al intoxication in hemodialysis patients due to an Al pump
was reported in 1991. In a dialysis centre in Pennsylvania bicarbonate- based
dialysate passed through one of two electric pumps. The electric pumps
used to deliver acid concentrate used in bicarbonate dialysis had an Al
casing, casing cover, and impeller. Elevated levels of Al were found in acid 
concentrate after passing through a pump.39
Eight patients undergoing acetate-free biofiltration suffered aluminum
intoxication. The source of this outbreak was parenteral exposition to high 
concentrations of aluminum in sodium bicarbonate solutions. At the peak
of intoxication serum aluminum determination revealed an average value
of 147.3 ± 21 µg/l. Aluminum levels in bicarbonate solutions were 400 µg/L.96
These outbreaks demonstrates why it is essential to ensure that all
fluid pathways, storage tanks, central delivery systems, and pumps are
compatible with low pH fluids before converting from acetate to bicarbonate
dialysis.
4.2. Desferrioxamine (DFO) Administration
Patients with a substantial Al burden can be detoxified with
desferrioxamine. In some cases where high dosages were used patients may
suffer seizures and myoclonia a few hours after administering the chelator. It
is argued by Ackrill et al. that the rise in plasma Al levels cannot explain the
rapid neurological deterioration since it begins within hours of administering
DFO, whereas peak al levels only occur 24-48 hours following DFO
infusion.11 It has been suggested that desferrioxamine has a direct neurotoxic
effect on the brain. Another hypothesis suggests that after Al alters the
permeability of the blood brain, and allows the aluminoxamine complex
with a relatively low molecular weight of 583 Daltons to cross the blood
brain barrier more readily than naturally circulating Al, that is largely bound
to serum transferrin and albumin, especially because the DFO-Al complex is
lipophilic.136 A recent study however, makes it more likely that unchelated
desferrioxamine passes the blood-brain barrier and chelates the Al present in
the brain to convert it to aluminoxamine causing acute neurological
symptoms in the already damaged brain.80
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4.3. Gastrointestinal Exposure
4.3.1. Oral phosphate binders
Because of poor phosphate removal with dialysis, the use of Al or calcium
phosphate binders has been required for lowering serum phosphate levels in
uremic patients. A prospective, controlled study of pediatric patients
demonstrated that a presumed "safe" dose of Al gels leads to Al accumulation
and the current opinion is that there is no safe dose of Al in chronic renal
failure that is also large enough to control the plasma phosphate concentration.
The dietary intake of phosphate is higher in North America than in many
European and Asian countries, and the amount of Al hydroxide prescribed in
dialysis patients had been high in these countries, resulting in a considerable
number of patients suffering form Al-related bone disease.137-143 Close
correlations have been observed between s-Al levels and the amount of Al-
containing gels ingested in both children and adults undergoing dialysis. In
children with renal failure, the ingestion of doses of Al hydroxide containing
more Al than 75 mg/kg per day was associated with plasma levels of Al above
100 µg/L, and features of Al bone toxicity were common.78,137,143-145 In uremic
patients life- threatening Al encephalopathy has been observed when Al
hydroxide has been administered with sodium citrate146 or calcium citrate.28
Non-dialyzed uremic patients showing Al encephalopathy had received the
combination of oral Al with citrate compounds.146 Citrate is known to enhance
the passage of Al over the intestinal wall and the blood-brain barrier and to
contribute to the development of toxicity.3,147 Uremic patients prescribed
medications containing citrate (calcium citrate, Shohl’s solution) or Alka-Seltzer,
along with those medications containing Al (Basaljel, Amphogel, Carafate) are
particularly prone to Al accumulation.148
4.4. Bladder Irrigation With Al Sulfate
Al toxicity also has been reported from intravesical bladder irrigation
with Al sulfate (alum). Alum is an astringent and controls bladder hemorrhage.
In the past it was regarded to have a non-significant systemic absorption, but
probably a breach of endothelial integrity secondary to hemorrhagic cystitis
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allows Al to leach across the vesical mucosa, contributing to significant tissue
loading. As the intact renal function is essential for a rapid disposal of a
parenteral Al load, most reported instances of encephalopathy after alum
irrigation have occurred in patients with compromised renal function.
Manifestations of encephalopathy appeared after continuous irrigation with 1%
alum for at least 2 days and are associated with elevated s-Al concentrations.
Patients are treated with alum with up to 30 liters of irrigant over a 24 h
period.149 Probably most cases involve acute Al encephalopathy with serum
levels of 135 to 436 µg/L and a high mortality.149-155 The symptoms are similar
to that of acute Al encephalopathy in dialysis patients with convulsions and
coma but interestingly, the lag phase of 2 to 8 days,150 is much shorter than
reported in hemodialysis outbreaks of acute Al encephalopathy. This is possibly
related to both the rapidity and magnitude of Al loading, causing large body
stores for Al (bone, spleen, liver) to be partially bypassed.
Some authors claim to have had patients with Al neurotoxicity
symptoms when the highest s-Al concentration was 17 to 22 µg/L.156,157 It seems
very unlikely that these patients indeed suffered from Al encephalopathy
because the patients did not had typical symptoms and s-Al levels below 100 µg/L
are generally considered unlikely to cause encephalopathy in hemodialysis
patients.20 In these cases several other complicated metabolic abnormalities, in
retrospect, were probably responsible for the neurological symptoms.150
Nevertheless, alum should not be employed as a bladder irrigant, especially not
in patients with acute or chronic renal failure.                                                 
4.5. Al Containing Biomaterial (Cement) in Otosurgery
Ionomeric cements are used routinely in otosurgery, especially in
maxillofacial or skull bone-cementoplasty by an Al-containing biomaterial and
canal reconstructions where the proximity to the facial nerve is evident.
Cement, however, is not inert, and Al is an important constituent of
cement. The literature contains reports of diffusion of Al ions, which can reach
toxic levels in tissue fluid and adjacent bone as the cement hardens. During
setting and hardening, the hybrid bone substitute ionomeric cement achieves a
stable and durable bond with the apatite of the adjacent bone without
interpository soft tissue. A close contact between an Al-containing cement and
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the cerebrospinal fluid results in the release of Al ions, which may reach critical
levels as high as 3000 µg/L.23,128 This has resulted in a fatal (sub)acute Al
encephalopathy in some patients without renal failure. After a latent phase up
to six weeks, patients suffered loss of consciousness, myoclonic jerks, and
persistent grand mal seizures.158-160 A direct toxic effect on peripheral nerve
transmission has been reported when ionomeric cements were introduced into
near-nerve anatomic locations, mainly the facial nerve, following surgical
reconstruction of the posterior ear canal with ionomeric cement. Paralysis
developed in some cases postoperatively within two to three weeks.115 Except in
cases where individual peripheral nerves adjacent to the biomaterial showed
signs of dysfunction, symptoms of post-otosurgery Al encephalopathy are quite
similar to acute Al encephalopathy with other exposure routes. They include
convulsions and myoclonus of the extremities but also stupor, and mutism. In
some patients there was no clinical improvement after the biomaterial was
removed.  Because of these cases the use of one of these cement compounds
(Ionocem) was stopped in France by order of the Direction Généerale de la
Santé in 1994. It was suggested that all patients operated on with these products
should have serum and cerebral fluid Al analysis and electroencephalograms
and the biomaterial should be removed when abnormal values were noted.112
4.6. Peritoneal Dialysis and Acute Al Gastroenteropathy
Acute Al gastroenteropathy with symptoms of nausea, vomiting,
cramp-like abdominal pain and general malaise can follow after accidental Al
contamination of the peritoneal dialysis fluid.81,161 It seems as if Al has a direct
toxic effect on the outer epithelium of the gastrointestinal tract.
4.7. Other Sources of Al Exposure not Related to Acute Al Intoxications 
4.7.1. Parenteral Nutrition and Oral Milk Based Formula in Children
Pediatric patients are particularly at risk for Al neurotoxicity. The
development of the brain occurs in the first year of life. High permeability of
the immature blood-brain barrier to Al, the increased uptake of Al via a
relatively poorly developed gastrointestinal tract, immature formation and
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function of the kidneys and high Al to body ratios probably all contribute to the
Al toxicity.144,145,162-165 Children not on dialysis were intoxicated by Al-containing
phosphate binders and developed encephalopathy.78,162,164,166,167
A study of newborn and premature infants found that the intake from milk
and formulas for preterm infants is about 0.03 mg Al/day.168,169 Several cases were
reported to develop neurological symptoms with elevated Al tissue levels receiving
no dialysis and no Al-containing phosphate binders, but Al-containing milk based
formula.165,170 The Al content of breast milk is very small (about 20 µg/L), and
formulas based on cow’s milk contain about ten times as much Al. The highest
amount of Al has been reported from soya-based formulas for lactose intolerance
(200 µg/L to 1000 µg/L), but its toxicity risk is unknown.171,172
In preterm infants, prolonged intravenous feeding with solutions
containing Al is associated with impaired neurological development. These
studies have methodological problems that may influence the results, but
nevertheless acute Al encephalopathy with seizures and myoclonia has not been
reported. Low dose of Al, present in parenteral nutrition formula, can produce
marked portal inflammation correlating with the duration of exposure and the
amount of Al accumulated in the liver.173 As a result of the concern about Al in
total parenteral nutrition solutions, the United States Food and Drug
Administration now requires that Al concentrations be less than 25 µg/L in
large volume parenteral drug products.174 
4.7.2. Drinking water 
In recent study the relative bioavailibility of Al naturally present in food
and in alum-treated drinking water (ATW) were determined using 29 healthy
volunteers, who drank, during two-day periods, ATW or pure water, with and
without citrate, while on a controlled diet. Only 1-2 percent of the daily intake
of Al came from ATW and only 0.3 to 0.4 percent of the Al in ATW was
absorbed by the body, which was the same percentage that absorbed from food.
It was estimated that drinking 1.6 L/d of ATW containing 140 µg/L Al would
contribute only 0.4-1.1 percent of the lifetime body burden of Al.2 However,
although Al is very poorly absorbed in the gastrointestinal tract, and the
possibility that some Al fractions present in drinking water may be particularly
bioavailable cannot be dismissed at present, especially when exposure starts
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from childhood.61 In addition, oral administration of 26Al to rats resulted in
higher brain 26Al concentrations.176 Nevertheless, recent reports on the risk of Al
levels below 100-200 µg/L in drinking water do not indicate an important risk
for the normal population.122-124,175
4.7.3. Inhalatory Exposure
Most of the Al absorbed from the respiratory tract accumulates in the
lungs. Pulmonary lesions have been described in employees of Al processing or
manufacturing industries and encephalopathy after Al inhalation have been reported.
Al is widely distributed and has many industrial uses, and toxicity from occupational
exposure is assumed to be extremely rare.2,177 Nevertheless, a recent study investigating
adverse effects on the central nervous system of Al welders found an Al-
exposure-related increase in blood an urine Al concentrations, deficits in
neuropsychological test performance and mild diffuse EEG abnormalities.
Therefore the potential for Al-induced neurotoxicity in those occupationally
exposed to Al-fumes may be greater than previously suspected.177
Aerosol antiperspirants can be absorbed systematically via the lungs and
airways and through the nasal-olfactory route. There is as yet insufficient
information available to determine the possibility of Al accumulation in the brain.178
4.7.4. Dermal Exposure
Blepharopigmentation with Al-silicate has been introduced during the last
decade as a technique for creating a permanent line along the eyelid margin, thus
simulating a cosmetic eyeliner. Patients can have a delayed hypersensitivity
granulomatous reaction.179
Dermal perspersants. In a preliminary study the dermal absorption of Al
from antiperspirants have been estimated to be 0.03-4 µg/L, or 0.012% in one
study. The clinical significance is unknown.180
Vaccines adjuvants: the purpose of a vaccine adjuvant is to enhance the
immune response of the vaccine. An adjuvant vaccine will tend to have a
higher, earlier, and longer-lasting immune response than a non-adjuvant
vaccine. Until recently, the only vaccine adjuvants approved for human use were
Al salts generally referred to as alum. Commonly used Al-adjuvant vaccines
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include: diphtheria, tetanus, hepatitis, lyme, rabies and anthrax.181 Known side
effects from Al adjuvants include short-term effects such as swelling, inflammation
and granulomas182 but recently there has been a controversial finding that
macrophagic myofasciitis is associated with Al-containing adjuvants.168,182
Although the dissolution of the Al adjuvants can take 4 to 18 months, according to
animal studies, probably very little Al is incorporated into the brains.168
4.7.5.  Intranasal Absorption
There are no data that could be used to estimate Al bioavailibility
following intranasal exposure to indicate whether this represents a significant
route of exposure,4 but toxicity through this route has not been reported. 
4.7.6. Low, or Absent Toxicity of Other Sources of Al Exposure in Humans in
Normal Circumstances 
Commercially, Al salts are added to foods, such as frozen strawberries,
maraschino cherries, and pickles, to improve their appearance. Al3+ salts are
often added to processed, grain products, salt, cheeses and beer.183 Plants can
accumulate Al3+ especially in acidic soils, and evidently detoxify the Al3+ by
possessing basic fluids or organic chelators. Especially tea is known to store
Al3+ in cell vacuoles in older leaves separate from metabolically active parts of
the plant. As much as 3% of Al3+ can be found in older tealeaves, while only
0.01% in younger ones, a 300-fold difference. Commercial teas yield up to
100 ppm Al3+ in a drink, but much higher Al concentrations can be found in
certain species of leaves.184,185 Adding milk to form the insoluble phosphate
can reduce gastrointestinal absorption of Al from tea but by addition of
lemon substantial amounts of an Al citrate complex will be absorbed.
Numerous other food substances were described as a possible –most likely
harmless- sources of Al, like small amounts of dissolved Al from cookware,
fruit juices, coffee and baking powder.186,187 Some foods contain large amounts
of Al as a result of processing. Levels of up to 4 mg have been reported to be
present in one serving of food.186 Although the major source of Al in drugs
remains the use of Al hydroxide phosphate binders in renal patients, some
common oral pharmaceutical products can contain high amounts of Al, such
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as calcium supplements (12 mg/day), buffered aspirin (10-20 mg/tablet),
and Al-containing antacids (50 mg/tablet).140,188 Much effort is being taken to
reduce the Al content of the above products or to switch to alternative
products, which contain less Al.20
5. Pathogenetic Mechanisms of Aluminum Intoxications
5.1. Speciation, Biokinetics and Metabolism
5.1.1. Al speciation
Despite several decades of clinical experience and animal study, the
pathofysiology of brain encephalopathy is far from understood. One of the
main reasons for the complexity of the research on Al is the difficult interaction
with molecules found in biological systems.  In most natural systems, a small
fraction of Al is found as the simple Al3+ aqua ion. Thus Al absorption,
excretion, tissue retention, and deposition will all depend on the properties of
the Al3+ complexes formed with biological ligands. Unfortunately, the search for
an accurate description of Al complexation equilibria and kinetics has been
consistently frustrated by the tendency of both free Al3+ ion and simple Al
complexes to hydrolyze at or below neutral pH. 
An important issue in the toxicity of Al is the solubility and speciation
of inorganic Al, which are strongly pH dependent, whereas the solubility of
organically complexed Al is correlated with the level of dissolved organic
matter. In aqueous circumstances with low concentrations of dissolved organic
compounds, the dependence of dissolved Al on pH resembles on a logarithmic
scale a parabola with a sharp solubility minimum at around pH 6.5. In water
more acid than pH 5, Al3+ exists as an octahedral hexahydrate, Al(H2O)63+,
usually abbreviated as Al3+ and referred to as free Al. As a solution becomes less
acidic, Al(H2O)63+ undergoes successive deprotonations to yield Al(OH)2+,
Al(OH)2+ and soluble Al(OH)3, with a decreasing and variable number of water
molecules. At pH > 6.2 tetrahedral aluminate, Al(OH)4-, is the primary soluble
Al3+ species. The Al levels in the water will be related to the pH conditions with
Al hydroxide solubility equilibria but in addition to the hydroxide ion, the Al
ion will also form complexes with inorganic ligands such as fluoride (F-),
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sulphate (SO42-) and silicate (HSiO43-). Therefore, the actual chemical species of
Al is strongly predisposing for the availability of Al for intestinal uptake as well
as its metabolic behavior and toxicity.189-193 The mixed Al(ligand) - hydroxide
complexes are the rule, rather than the exception, - and hydroxo-bridged
polynuclear complexes are common.193 Metal hydrophilic species show different
neuritogenic properties indicating the ability of Al3+, when diversely coordinated,
to produce different biological effects.129 Two main Al3+ species are recognized in
aqueous solutions: the hexahydrate Al3+ at pH < 5.5 and the tetrahedral
aluminate at pH > 6.2. In blood plasma, citrate is the main small molecule
carrier and transferrin the main protein carrier of Al3+. In fluids where the
concentrations of these two ligands are low, nucleoside di- and triphosphates
become Al3+ binders. Under these conditions Al3+ easily displaces Mg2+ from
nucleotides. When all three classes of ligands are at low concentrations,
catecholamines become likely Al3+ binders. In biological systems Al3+ will
associate with oxygen donor ligands, at least some of which should be anionic
to counter the 3+ charge of the cation. Carboxylate and phosphate groups,
nucleotides, and polynucleotides meet this description. Double-helical DNA
binds Al3+ weakly.  Al3+ forms weak complexes with amines and sulhydryl
ligands. With multidentate amino-carboxylate ligands such as EDTA, Al3+
forms strong complexes. Al3+ in the cell nucleus probably binds to nucleotides
or phosphorylated proteins.190
5.1.2. Biokinetics
5.1.2.1. Absorbtion and Excretion
In man, without excessive exposure to Al and a normal renal function,
the total body burden of Al is 30 to 35 mg, and the intake of Al in foods is 2 to
3 mg/day, with only a small percentage absorbed.15,129 The lungs contain the
largest amount of Al because dust is trapped in pulmonary macrophages and its
concentration increases slowly with age. After the lungs the highest concentration
of Al is found in the liver, bone, spleen, myocardium and parathyroid cells and
their concentration is 1 to 4 mg/kg dry weight. In these subjects bone and
muscle account for about 40% of total body Al and the lungs for 12%.129,194
Because trace metals are indestructible, chronic accumulation of the element
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will occur in patients with end-stage renal failure, because the major elimination
route, i.e., the kidney is absent. This results in a much higher Al burden, ranging
between 220 and 1600 mg. In these patients also a different distribution is
observed with bone and liver as the major storage sites with comparable Al
concentrations.129 Most ingested Al is eliminated in the stool within several days
and the Al bioavailibility from food is ~ 0.1%. The remaining Al, which enters
the blood via the intestinal system, is then eliminated in urine. Daily urinary Al
excretion has been estimated to be 4-12 µg.4 About 85% of the intravenously
injected Al and gallium citrates is normally removed in two weeks. The amount
of Al that is not eliminated in the urine is then retained in the body by deposition
in tissue and removed very slowly. An estimated terminal t1/2 in one human
being who received intravenous 26Al was 7 years.194,195
For many years, there has been some controversy about the quantitation
of intestinal absorption of Al. Because of the lack of a suitable isotope and a
sensitive technique of analysis, in the past Al have been studied indirectly using
analogs such as 67Ga (t1/2 = 78 h). Recently, with the development of accelerator
mass spectrometry (AMS), it has become possible to use the artificially
produced radionuclide of Al, Al 26 (26Al), (t1/2 = 7.16 x 105 years).84 With this
technique, literature data on fractional gastrointestinal absorption still varied
between 0.04 and 1%.59,87 The fractional intestinal absorption of trace oral doses
of Al hydroxide is at least 0.1% (compared with the previous estimate of  0.01%
using large 27Al oral loads). Absorption of Al citrate given alone is significantly
greater (0.7%) and is further increased to 5% by the accompanying sodium
citrate, consistent with an enhancing effect of added citrate upon mucosal Al
permeability. Al maltolate absorption approximates that of Al hydroxide
(0.1%).129,194 Although no single explanation of the exact mechanism of
gastrointestinal absorption has emerged, it is believed that intestinal absorption
of Al includes both paracellular pathways along enterocytes and through tight
junctions by passive processes as well as transcellular pathways through the
enterocytes involving both active and passive processes.1 In normal subjects
there is little or no increase of tissue Al content  (except in the lungs) with aging;
this suggest that the body is in neutral balance. The factors that affect the
absorption of Al include uremia, dietary factors such as citrate, a low gastric pH,
fasting, and also a lesser effect on absorption has been reported from lactate,
parathyroid hormone and vitamin D. When Al enters the body, the kidney is
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the major organ for excretion and in renal failure there will be a widespread
deposition in extracerebral organ systems of patients with Al overload and the
bone and liver serve as the major storage organs.194 Sequestration of Al in bone
and liver protects the brain from Al toxicity.195,196 This is supported by the fact
that conditions associated with a negative calcium balance, such as immobilization,
surgery, cortocosteroid therapy, and hypophosphatemia, may precipitate the
onset of the disease.197 In the presence of high PTH levels there will be an
increased bone uptake of Al.198,199 On the other hand, Al also influences the
parathyroid negatively and lowers the parat hormone secretion, which reduces
bone turnover.200 An open compartmental model for describing Al biokinetics
after p.o. administration of 26Al has been presented in one study, with a central
compartment consisting of transferrin- and citrate-bound Al in blood plasma
and interstitial fluid, and three peripheral compartments for organs, muscles
and bones and the gastrointestinal tract. The rate constants describing the
transport of Al are normalized to an estimated plasma volume and do not
depend on the size of the individual.201 Other routes of absorption (inhalatory,
dermal and intranasal) are discussed above.
5.1.2.2 Distribution
5.1.2.2.1. Metabolism
Citrate: Since it occurs to the extent of about 0.1 nM in the blood
plasma, citrate becomes the pre-eminent small molecule plasma binder of a
metal ion like Al3+ that prefers oxygen donor ligands. Citrate complexion of Al3+
in the upper gastrointestinal tract with a pH of 2 - 5, may form a zero-charged
complex  that may pass through membranes. Sodium citrate as well as calcium
citrate may cause a 100-fold enhancement of gastrointestinal Al absorption. The
adsorption of Al from Al(OH)3-based antacid rises substantially upon intake of
citrate, and therefore these antacids should not be taken with citrus fruit or
juices.190
Protein binding: Although transferrin is generally acknowledged to be
the serum protein binder of Al, also other proteins such as albumin, albindin205
and de novo synthesized proteins72 have been suggested as potential s-Al
binders. The common albumin and globulin proteins of the plasma bind metal
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ions such as Al3+ only weakly and non-specifically. With a pair of sites that avid-
ly binds Fe2+, transferrin stands as the leading plasma protein for Al3+ binding
and carrier in the plasma.190 The cerebrospinal fluid lacks any transferrin and
contains only about 2 µM citrate. The transport of Al by transferrin favors the
delivery of Al to cells with numerous transferrin receptors, such as hepatocytes
and red blood cells precursors.23
Catecholamines: By binding to the catechol of cathecholamines, trace
amounts of Al3+ may possibly disrupt many neurochemical processes.190
5.1.2.3. Nucleotides and Organic Phosphates
Al behaves as an extremely potent genotoxic agent and specific genetic
sub-compartments are selectively targeted. Numerous molecular genetic
mechanisms have been described, involving Al neurotoxicity towards neuronal
and glial cell nuclei and brain specific gene transcription. In spite of a
considerable body of scientific evidence the precise pathofysiology remains
unclear. One emerging hypothesis is that Al is strongly attracted to the
phosphates of nucleic acids (and nucleotide triphosphates) especially rich in
adenine (A) and thymine (T) residues, so brain RNA and DNA sequences
containing a high molar percentage of A + T nucleotides may be particularly at
risk for the deleterious effects of Al. In particular, the high content of
intranuclear phosphate (approaching 60 mM), the normally decondensed or
extensive euchromatization characteristic of neocortical neuronal nuclei,
their intrinsically high rate of transcriptional output and their generation of
complex RNA message populations required for normal brain cell function
may specifically target neutral cells for many of Al’s genotoxic effects.66 In
experimental Al neurotoxicity studies, especially when acute high dose of Al
were applied, Al targets numerous cytoplasmic and nuclear structures. For
example, a single stereotactic injection of 100 µg/L of a 1 per cent Al lactate
solution into rabbit cerebral ventricles results within 3 hours, in decreased
levels of RNA messages encoding the key cytoskeletal components alpha-tubulin,
beta-actin and the light chain of the neuron-specific neurofilament protein.66,204
This observation would be in accordance with, though not explain, the
development of neurofibrillary pathology as observed in experimental Al
intoxications and in Alzheimer's disease.
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Another interesting speculation is that Al is able to exchange other
key cations like iron, magnesium and zinc from binding sites necessary for
normal molecular genetic function of transcription factor proteins and thereby
play an ancillary role for further disrupting gene transcription mechanisms.66
After calcium and iron, zinc is the third most abundant trace element in the
mammalian brain, and has been receiving a lot of attention lately because of
its potential role in the development of human neuropathology.188,206,207
Excessive synaptic zinc release and postsynaptic zinc accumulation may
contribute to neuronal loss associated with certain acute brain injury
conditions including transient global ischemia and epilepsy. In the normal
brain, zinc is thought to provide highly specialized neuromodulatory,
neuroprotective and neurosecretory functions and is intimately involved
with structural, regulatory and enzymatic proteins that provide these
functions.188 Bioinformatics analysis of newly sequenced human DNA from
the human genome project suggests that up to 1 percent of total human
coding DNA, or up to 1000 genes, encoding zinc-requiring transcription
factors207,208 and therefore Al has the potential to interact with many
important zinc-containing elements of the brain’s gene expression system.66
5.2. Neuropathological Mechanisms
The published descriptions of the neuropathologic changes of chronic
Al encephalopathy in the past have been remarkably brief, absent or non-specific,
and no data at all are available from the neuropathologic changes in acute Al
encephalopathy in humans. In the brain significant Al content was observed in
the hippocampus, the occipito-parietal cortex, the cerebellum, and the striatum.
This topographic distribution correlated with the clinical defects in higher
cortical functions, including aphasia. Spongy changes consisting of vacuoles in
the neuropil and inside nerve cell bodies were found and the vacuoles were
located mainly in dendrites and astrocytic processes. Thus, Al encephalopathy
is a disease of neurons and astrocytes of the cerebral cortex.103,209-211 None of these
abnormalities found post-mortem were sufficient to account for the patients’
neurological conditions.25,211 In animal studies most pronounced changes in the
brain were observed in the hippocampus.212
The development of a new silver-staining technique by Reusche allowed
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the visualization of characteristic patterns and distinct morphological changes of
chronic Al encephalopathy in humans. Central nervous tissue (CNS) and
peripheral organs of 50 autopsy cases with chronic renal failure (CRF) and
dialysis treatment were evaluated for Al-containing argyrophilic inclusions using
the Howell and Black method modified by Reusche.51,195,213 Al encephalopathy
morphology is characterized by lysosome-derived intracytoplasmic, Al-
containing, pathognomonic, argyrophilic inclusions in choroid plexus epithelia,
cortical glia and neurons. The most sensitive structure for CNS deposits is
choroid epithelia, followed by glial cells and neurons. Autonomic ganglia, heart,
ovary/testis, parathyroid, adrenal, and pituitary demonstrated reliably peripheral
deposits.213,214 Glial cells presented massive silver-stained deposits, which were
restricted to the gray matter. Finally, neurons revealed numerous fine-granular
black inclusions, scattered throughout the cytoplasm. Brainstem nuclei were
primarily affected, but neurons within cortex, subcortical gray matter and spinal
cord were also involved to various degrees; inclusions were not evident in the
nucleus dentatus and the oliva inferior. Vessel-related deposits were found
frequently. By electron microscopy the cytoplasm of neurons was filled either
with large amounts of small electron-dense granules, or with lipofuscin granules,
containing numerous irregular, non-membrane-bound inclusions. Massive
electron-dense depositions were seen in the cytoplasm of choroidal epithelia
and in proximity to nuclei of cortical astro- and oligodendroglia. These
deposits remain for many years and even after renal transplantation, with
termination of drug-related Al intake and normalized renal Al excretion, the
Al-induced argyrophilic degradation products remained in the cellular
cytoplasm in unchanged fashion up to ten years.92
Many investigators have also observed neurofibrillary degeneration
changes that were regarded to be similar to neurofibrillary tangles in
Alzheimer's disease and the hallmark of the experimental encephalopathy
induced by Al in rabbits, cats and ferrets is neurofibrillary tangle.50,60,70,215 Al-
induced tangles are due to the accumulation of 10 nm neurofilaments in the
body and processes (axon and dendrites) of neurons.48-50 Neurofilaments
begin to accumulate a few hours after intracisternal injection of Al.21 The
diffuse distribution of neurofibrillary pathology suggests that nearly all nerve
cell populations are prone to the toxic action of Al, the most vulnerable being
neurons of the anterior horns of the spinal cord, of the reticular formation
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and of the basal forebrain, the Purkinje cell system and the pyramidal
neurons of the cerebral cortex. These studies have supported the theory
concerning Al as an etiological agent for cerebral changes in Alzheimer's
disease.70 Recently, however, skepticism has developed about the similarity of
these neurofibrillary tangles in Al encephalopathy and Alzheimer’s
disease. In a study using a new silver staining technique, the described
neuronal changes and, in particular, alterations of choroidal epithelium and
glia were demonstrated to be completely different from characteristic plaques
and tangles in senile dementia of Alzheimer type.51,92 This assumption is also
supported by the fact that neurofibrillary deposits are detected in the
proximal end of the axon only one day after experimental administration of
Al, while it takes several weeks before neurofibrillary degeneration is seen
near the nucleus. During this latency period the neurons show progressive
loss of excitability. Therefore cell damage is conceivably not caused by the
presence of fibrillary deposits, per se, but by the loss of the normal functions
of neurotubules and neurofilaments.31
5.3. Theories of Pathophysiology of Aluminum Encephalopathy
5.3.1. Blood-Brain Barrier (BBB)
The brain is defended by a continuous layer of cell membranes,
the blood-brain barrier (BBB), which not only hinders the entry of large
molecular mass substances into the central nerve system, but additionally
regulates all the exchanges of nutrients, hormones, toxins and therapeutic
agents that enter the CNS from the blood (to see a diagram visit
http://www.sfn.org/briefings/blood-brain.html).216-218 When Al enters the
systemic circulation it binds to transferrin, the predominant Al species in
plasma, and results in a rapid entering of the brain. It has been suggested
that Al can alter the BBB permeability and alter the flux of molecules and
ions into and out of the brain,217 but others state that Al uptake into the
brain is not dependant upon alterations to BBB permeability.218-220 This
brain Al entry could be mediated by transferrin-receptor-mediated
endocytosis and is enhanced when Al binds to citrate (TfR-ME)
(Fig. 3).4,221,222 Al can penetrate into the extracellular space of the brain frontal
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Fig 3. The dynamic partitioning of aluminum in the brain results in three (extracellular, sur-
face associated and intracellular) signifiant sources of biologically available aluminum. Im the
blood, aluminum is bound by proteins, such as transferrin, and a number of lower molecular
weight ligands which could include smallpeptides, nucleotides, nucleic acids, citrate, phosp-
hate and silicic acid. In BIF, aluminum is bound by some of the lower molecular weight
ligands found in blood as well as neurotransmitters such as glutamate and GABA. Aluminum
ia associated the phosphate headgroups of lipids which act as sites for the nucleation and
aggregation of aluminum. Intracellular aluminum may be found bound to ATP or in endo-
plasmic reticulum and Golgi in close proximity to the nucleus. Aluminum may also be found
in nuclear chormatin. There is continuous exchange of aluminum between intracellular and
extracellular compartments and the predominant exchange pathway will change in tandem
with changes in brain physiology.
With permission, from: Exley C. A molecular mechanism of aluminum-induced Alzheimer’s
disease? J Inorg Biochem 1999; 76: 133-40. Elsevier Science.220
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cortex and ventral hippocampus within 20 minutes.217 Although some Al
that enters the brain is rapidly refluxed, it is suggested that a fraction enters
brain compartments within 24 h from which it is only very slowly
eliminated.223 The t1/2 of 26Al in rat brain was > 100 days following
intravenous 26Al transferrin dosing.222-224 Although neurotoxicity may be
the most striking form of Al-related toxicity, the brain (and also blood) in
fact contains the lowest levels of Al overload.31,38,151,225-227 Transferrin
receptors are expressed on blood vessels, large neurons in the cortex,
striatum and hippocampus as well as oligodentrocytes and astrocytes228 but
in the cerebrospinal fluid Al will preferentially bind to citrate due to the
fact that the molar concentration of citrate in cerebrospinal fluid is up to
900-fold higher than that of transferrin.23,218
5.3.2. Brain Al Homeostasis and Cellular Mechanisms
Al has been found in glia (mainly astrocytes, oligodendrocytes and
microglia)229 and in the perinuclear endoplasmatic reticulum of neurons.230,231
Disruption of glial cell function by Al results in the accumulation of
unwanted, probably cytotoxic debris and modulation of synaptic transmission
and neurone-glial signaling.232 Al3+ binds almost 107 more strongly to ATP4-
than does Mg2+ 189 and forms a stable complex, which is more stable than a
complex with Mg.233 Mg2+ is associated with phosphate groups and Al3+ can
compete with Mg2+ for the phosphate sites. In the brain ATP acts upon
extracellular inotropic (P2X) and metabotropic (P2Y) receptors to optimize
the activities of neurotransmitters including glutamate, gamma-aminobutyric
acid (GABA) and acetylcholine.234-236 It was also suggested that a disturbance
of neurotransmitter metabolism in the brain as a result of Al inhibition of
dihydropteridine reductase is responsible for the neurotoxicity.220 To date, 14
different P2 receptors have been identified in the brain. Some of them might
be released as a complex with Mg, and in these cases Al will be intracellular
in competition to form Al-ATP instead of Mg-ATP. Al-ATP might act upon
muscarinic receptors to potentiate the negative feedback controlling the
release of acetylcholine into the synaptic cleft, causing deficits in
neurotransmitter stimulation.237,238 Another mechanism, which might explain
the neurotoxic and other actions of Al, is the interaction with calmodulin.
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One of the most abundant and versatile Ca2+-binding proteins, calmodulin
regulates a large number of cellular processes and target proteins in response
to Ca2+ signaling.  Calmodulin is found in all eukaryotic cells. It couples the
intracellular Ca2+ signal to many essential cellular events by binding and
regulating activities of more than 40 different proteins and enzymes in a
Ca2+-dependent manner.207 The calmodulin-calcium complex modulates a
number of different enzymes and cellular processes.239,240 The N-methyl-D-
aspartate (NMDA) receptor mediates synaptic transmission and plasticity in
the central nervous system (CNS) and is regulated by tyrosine phosphorylation.
Al inhibits Ca-dependent inactivation of NMDA receptor channels.241 It was
suggested that the inhibition of the Ca-dependent inactivation of NMDA
channels by Al could occur through the stabilization of the post-synaptic regula-
tory protein that might be possibly a sub-unit of a P2 receptor238 (Fig. 3). Block
of the channel of N-methyl-D-aspartate (NMDA) receptors by external Mg2+
has broad implications for the many physiological and pathological proces-
ses that depend on NMDA receptor activation241 and it seems likely that
these effects are even more severe with external Al3+. Lipid peroxidation and
the production of superoxide radicals have also been reported as a possible
mechanism of Al toxicity.242
5.3.3. Al and Neurotransmission
Cognitive impairments due to Al may in part be the result of the
alteration of the function of GABA receptors due to cognitive impairment
through disruption of inhibitory circuits.243 Al lowers the excitability of the
nerve cells of hippocampus, which can result in convulsions. Synaptic currents
were normal in animal studies, but the possibility to activate the spike
discharge was less effective. The abnormal excitability of such neurons in vitro
is probably related to abnormal lengthening of the depolarizing after-potential,
with reduced post-discharge depolarization,47 and to reduce electronic length of
the cell as well.244 Another typical feature of Al encephalopathy is the
progression of the disease with an increasing number of clinical epileptogenic
features until coma and death ensues. This might be related to a increasing loss
of neurons. Neuropathological studies show a decreased number of
tangle-bearing neurons and severe nerve cell loss, especially in anterior horns
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and hippocampus, and behavior studies reminiscent of temporal lobe epilepsy,
may be due to the atrophy of the hippocampus.21,22
5.3.4. Delayed Neurotoxicity
Cellular and molecular mechanisms of neurotoxicity are also influenced
by the fact that neurons are postmitotic and do not divide. Thus, the capacity
for replacement of damaged cells does not exist in the nervous system, whereas
most other organ systems have a well-established capacity for regeneration.
Many neurotoxins can cause encephalopathy and an important concept in
neurotoxicology is the delayed manifestation of symptoms sometimes up to
years after the exposure started. Several agents show a lag time between
exposure and neurotoxicity. Examples are organophosphate chemical warfare
agents,245 bismuth intoxications246 and methylmercury intoxication247 with a lag
phase of weeks to months. One of the longest delays in time between exposure
and neurotoxicity however, seems to be in the case of Al encephalopathy, where
it can take several years to develop. In one case report a 14-year old boy was
described who sustained a skull wound as a result of a hand-grenade explosion.
This resulted in implementation of a fragment of metallic Al into the left
occipital brain. Fifteen years later, at age 29, he developed seizures, mental
disturbances and language difficulty. After a gradual deterioration he died
at age 34 in status epilepticus.248 Similar observations on delayed neurotoxicity
in acute Al encephalopathy have been made in animal studies. Mice and rats
seem to be very resistant to the effects of Al, but rabbits are particularly sensitive to
Al neurotoxicity and develop severe neurological changes, especially if the metal
is administered directly into the central nervous system. Rabbits injected
intracerebrally or into the cisterna magna with Al chloride developed
quadriparesis and generalized epileptic seizures within seven to 20 days after an
incubation period during which they seemed completely normal except for the
EEG. Most animals died after a few days of seizures by the 15th day of
injection.52,53 It seems very obvious that several steps are necessary in the process
leading to Al encephalopathy and that each step causes a delay in time before
symptoms can occur. It could be postulated that, in the final analysis, no one of
these mechanisms will emerge as the mechanism but that Al neurotoxicity is
due to many, if not all, of them acting synergistically.249
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5.4. Pathological Mechanisms of Bone Disease
Much clinical and experimental experience has been obtained about the
manifestation of bone diseases, especially in renal patients. Many patients with
Al-induced bone disease remain asymptomatic. There are two distinct forms of
Al done disease. The most severe form is osteomalacia, with recurrent fractures
and resistance to vitamin D therapy. This disease is characterized by an
increase of osteoid due to a mineralization defect induced by Al that is localized
at a critical site in the bone, i.e., the osteoid calcification front.250 The adynamic
bone disease is another form of Al-related bone disease, characterized by a
reduced bone turnover.97 Al can have a direct negative effect on the bone by
deposition at the mineralization front, causing a defective calcification. This is
due to the influence of Al on calcium-phosphorus precipitation, crystal
formation and crystal growth.251 There might also be a toxic effect on the
proliferation of osteoblasts and on mature osteoblasts with a time- and
dose- dependent effect on osteoblast growth and function.143
Al also suppresses PTH secretion and maybe as well as the PTH synthesis,
which results in reduced bone formation and increases Al accumulation in the
bone.252 Other studies have found that:
(1)  human parathyroid gland/parathyroid cells exhibit transferrin receptors;
(2)  Al- transferrin complex is taken up by the parathyroid gland in a dose
dependent manner; and 
(3)  uptake of Al by transferrin receptor-mediated endocytosis reduces the 
secretion of PTH but not its synthesis. 
These in vitro findings allow us to suggest that transferrin receptor-mediated
uptake of Al might, besides other factors such as vitamin D, high calcium
dialysate or CaCO3 intake, play a role in the development of hypoparathyroidism
associated with Al bone disease. The exact mechanism by which Al-transferrin
suppresses iPTH secretion remains to be elucidated.253 Hyperparathyroidism
may afford the bone some protection against the toxic effects of Al.17
5.5. Microcytic anemia
Most patients with Al intoxication develop an erythropoietin-resistant
microcytic anemia in the absence of iron deficiency, and this may be a useful
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early indication of Al toxicity.41,93,254,255 The chemical similarity between Fe3+ and
Al3+ suggest that both elements will have similar metabolic effects, suggesting
that iron and Al compete during erythropoiesis, resulting from a reversible
block in heme synthesis due either to a defect in porphyrin synthesis or to
impaired iron utilization. It was also suggested that the main mechanisms for Al
toxicity in the erythropoietic system are the interference of Al in the uptake and
utilization of iron and an interaction of Al with cellular membrane components,
affecting not only their structures but also their functions.256
6. Treatment of AL Intoxications
6.1. Prevention and Management Al  Intoxication
Because Al toxicity is a serious iatrogen complication, any preventive
measures to avoid exposure to Al are incumbent. Unfortunately, with the
current treatment practices, there continues to be a risk that patients receive
excessive amounts of Al orally or parenterally. If Al compounds cannot be
avoided in patients with renal failure, routine Al tests performed every 3-4
months in serum will identify persons at greatest risk (s-Al levels > 100 to
150 µg/L) for chronic Al intoxication. Ideally, any patient with s-Al higher
than 40 to 50 mg/L should discontinue Al gels and use other substitutes.
These patients should also be warned not to ingest these compounds with
liquids containing citrate, for example, fruit juices. 
Hemodialysis patients in dialysis centers or on home hemodialysis
generally will be protected from Al intoxications by the combination of
deionization and RO devices. Nevertheless, one should realize that the
composition of the dialysate is a combination of "normal" drinking water
according to WHO guidelines and extended water purification. Drinking
water conditions can change unexpectedly and erratically at the water plant
as well as in the water distribution system, making it absolutely unsuitable
for preparation of dialysate upon its arrival in the dialysis unit without
optimal further water treatment. Especially Al concentrations in the water
supply in regions that use Al salts for purification can vary from day to day
and it is impossible to monitor the water Al levels frequently enough to
detect periodic but dangerous increments in Al levels. 
128
C H A P T E R  V
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:02  Pagina 104
Physicians in charge of dialysis centres should be aware of the fact that
they are solely responsible for the water quality of the dialysate63 and that the
conditions of the water treatment system can change, especially due to Al
compounds in the water supply. Membrane fouling in reverse osmosis (RO)
systems is inevitable in many systems and effectively anticipating, compensating
for and counteracting the fouling phenomena is necessary. While overall flux
performances will decline for all membrane systems, the actual time between
cleanings will vary, depending upon membrane type, system design and feed
water quality. Reverse osmosis is an effective means of removing a wide
spectrum of contaminants, including particles, inorganic substances, organic
chemicals with molecular weight greater than 300, bacteria and endotoxins. An
important exception to this general rule relates to Al, which, because of its
amphoteric nature, may be present as a non-ionized species. In such
circumstances, deionisation with mixed bed units may be ineffective for Al
removal and reverse osmosis may be superior to deionisation. Other factors,
especially scalants, can also reduce the quality of the RO membranes. The two
most common scalants are calcium carbonate and calcium sulfate. Sharply
pointed scale crystals may come into contact and cut the membrane, causing
irreversible damage. Well-known fouling particles besides bacteria are Al, iron
and silica.259 Although in a review in the 1980s 92% of reported dialysis dementia
cases were dialyzed with either unprocessed or softened water, still 6% of dialysis
dementia patients were treated with water prepared by either deionisation or reverse
osmosis until the 1990s.46 Even dialysis centres with sophisticated water treatment
devices may be faced with episodes of serous Al intoxication, due to the use of Al
salt coagulants in potable water treatment. The scarce rainfall in the South of
Portugal in 1992 resulted in a subsequent decrease in the level of water sources,
resulting in high concentrations of suspended particles, which, in turn, necessitated
the addition of huge amounts of alum. This action was not reported to the
municipal authorities. In a dialysis centre in Portugal using a RO, the passage
of this severely contaminated water through the water purification installation of
a hemodialysis centre resulted in the obstruction of the RO membranes.30,43-45 The
efficiency of the RO membranes relies on two rejection mechanisms: a mechanical
sieving filter with 200 Dalton pores and an electrostatic repulsive mechanism. The
ionized Al fraction is rejected very efficiently (up to 99%) by the RO membranes.
However, for the bulk Al, present as a colloid, the RO membranes get fouled.
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Membrane fouling does enhance the accumulation of concentration at the
membrane level and masks the electrostatic repulsion mechanism. This is matched
with an increased Al breakthrough. In these circumstances, it has been found that
the ability of the RO to reject Al may become as low as 30% to 50%.
Consequently, RO membranes and cartridge filters had to be replaced frequently.
During these interventions, which took place over a period of several days, insuffi-
ciently treated water was sent directly to the dialysis machines and to the patients
involved. In this case both ways of exposure probably contributed to acute Al
intoxication and all together 18 of 71 (25.3%) patients died of severe
encephalopathy.30,43,44 Al levels up to 2,200 µg/L were measured in water used for
preparation of the dialysate.45 Most RO units, however, make use of continuous
conductivity monitoring of the purified water. A low conductivity represents a low
amount of dissolved ions, which means that the membranes are functioning well.
Nevertheless, in some cases one series of RO membranes may be insufficient which
makes two RO membranes in line necessary.260
It should be stressed that regular monitoring of the Al levels in serum and
dialysate at the normal frequency of one to three times a year,62 might give a false
sense of reassurance when the results are normal, as serious exposure might be
unnoticed between these testing intervals and serious irreversible neurological
damage can develop within weeks. Additional safety precautions can result from a
good cooperation between drinking water companies and dialysis centres. Water
utilities should notify dialysis centres when situations with important changes in
water quality are expected. In particular, dialysis centres should be warned when
the Al concentration in drinking water can exceed 30 µg/L. This implies that the
dialysis centres should be informed when water utilities change the practice of
flocculation to the use of Al flocculants. The centres should also be informed if the
concentration of Al exceeds the relatively high level of 200 µg/L, above the WHO
standards. In addition, when cemented drinking water distribution pipes are put
into service, Al levels should be tested in the tap water and dialysis centres should
be warned when Al levels are above 30 µg/L.18
6.2. Treatment
At the start of therapy one should identify and eliminate the source
or sources of the Al. Up to date, desferrioxamine is the hallmark of therapy
130
C H A P T E R  V
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:02  Pagina 106
for Al intoxication.260-273
6.3. Desferrioxamine (DFO)
Desferrioxamine (DFO) is a trihydroaminic acid obtained from
isolates of Streptomyces pilosus. Since 1963 it has been clinically used as an
iron-chelating agent in patients with iron overload.261 DFO effectively
chelates trivalent ions such as iron and Al, producing respectively
ferrioxamine and aluminoxamine.12,30,260-269 DFO displays rather complicated
physicochemical characteristics. Unchelated DFO is a straight-chained
lipophilic molecule that can penetrate plasma membranes and undergo
metabolic breakdown. In contact with Al, it twines itself around the metal to
form stable hydrophilic complexes.260,261 Since 1980 it is also used in the
diagnosis and treatment of Al overload in dialysis patients.11 DFO treatment
has a number of side effects such as digestive dysfunction, skin rashes,
neutropenia, hypotension, auditory impairment, cataract, visual
impairment, retinal changes similar to those seen in retinitis pigmentosa and
life-threatening infections with non-siderophore-producing germs, especially
mucormycosis with a fatality rate of 86%. This increased susceptibility to
mucormucosis, especially the Rhizopus species, is due to the by-product of
DFO therapy, ferroxamine. Ferroxamine can promote the growth and
pathogenicity of specific Rhizopus species with receptors for ferroxamine.262
In addition, exacerbation of Al encephalopathy is an important side effect,
which limits high doses of this chelating agent in Al intoxications. The
exacerbation of the Al encephalopathy might also be the result of
redistribution of Al mobilized by DFO into the brain when very high plasma
Al levels in excess of 500 µg/L occur.74 It has also been speculated that the Al
chelated compound, that is, aluminoxamine, by its ability to cross the blood-
brain barrier might precipitate or exacerbate Al-related encephalopathy.80,219
On the other hand, DFO itself might be a possible causative agent of these
neurotoxic effects as the neurotoxicity is dose-dependent and it is also obser-
ved in patients with normal renal function.266,267 Chelation of Al with DFO
has been very useful in the treatment of Al encephalopathy, but the best
mode of administration, optimum dose, and duration of treatment are not
clearly established. The current practice is to administer DFO once per
131
Acute  Aluminum Intoxicat ion
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:02  Pagina 107
week; it can be given intramuscularly the evening prior to dialysis, or several hours
before dialysis so that sustained ferroxamine levels are present in the plasma for
the shortest possible time before being removed. Removal of Al from Al
intoxicated patients is difficult due to its large volume of distribution, high protein
binding, and poor dialyzability.268 The Al chelation by DFO is less dose-dependent
compared to iron chelation. Apparently there exists a readily available pool of Al,
which can be chelated by relatively low doses of DFO, while a deeper pool is more
difficult to reach even with higher doses of the chelating agent.269
6.4. Treatment with DFO in Hemodialysis Patients
The optimal dose of DFO for long-term chelation is uncertain,
although toxicity appears to be reduced at lower doses. In the search for an
optimal dose one should consider the following aspects.
Side effects of treatment with DFO 
The potential side effects are, at least in part, dose- and duration-related.
With the high doses used in the past, varying between 30 and 80 mg/kg,
serious side effects have been reported even after a single dose of the
chelator. These include hypotension, exacerbation of Al-related
encephalopathy, retinal and auditory neurotoxicity, rash and fatal
bacterial and fungal infections. Of 89 patients receiving nightly
subcutaneous DFO for transfusion-dependent thalassemia major, 13
presented with visual loss or deafness of acute onset or both. Detailed
ophthalmologic, audiologic, and evoked-potential studies uncovered
abnormalities caused by neurotoxicity in 27 more. Four patients with visual
loss had optic neuropathy, with a marked decrease in acuity, loss of color
vision, and delayed visual evoked potentials. Five asymptomatic patients had
changes in the pigment of the retinal epithelium. The hearing loss was
characterized by a high-frequency sensorineural deficit, which necessitated
hearing aids in six patients. When desferroxamine was stopped, recovery of
vision was complete in two patients and partial in two, and in 22 patients
with abnormal audiograms, reversal of the hearing deficit was complete in
four and partial in one.264
High DFO treatment dosage requires the need of regular follow–up
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(at least every three months). Thus; patients treated with DFO should
be referred to ophthalmology and otorhinolaryngology for baseline and 
follow-up examinations.264
The dosage and interval of DFO treatment should be adjusted to keep
peak s-Al levels below 400-500 mg/L, to avoid exacerbation of neurological
symptoms.265
Low dose DFO (5 mg/kg) has been recommended at the Consensus
Conference on diagnosis and treatment of Al overload in end stage renal
failure in 1992 in Paris.30
DFO infusion can cause hypotension. This can be reduced by slowing
the infusion rate to one hour, and treated by temporarily stopping the
infusion, and administration of a volume expander if required.30
A dosage of 5 mg/kg DFO can differentiate between patients with Al-
related bone disease; increased risk for Al toxicity and Al overload. A
serum increment after DFO of more 50 mg/L or more had a sensitivity
of 91% and a specificity of 95% in the detection of Al overload, thus
suitable to detect patients at an increased risk.30
Techniques of treatment with DFO: 
The removal of aluminoxamine using conventional dialyzers is modest.
However, it can be increased substantially when used in combination
with a charcoal hemoperfusion column (ALUCART) or by replacing
the conventional dialyzers by high flux polysulphone dialyzers. With
the latter devices up to 80% of both the total aluminoxamine and
ferrioxamine can be extracted from the body during a single dialysis
session The presence of DFO and the use of a charcoal column (ALU-
CART) in combination with a conventional dialyzer may markedly
increase the extraction of Al during dialysis.273
Treatment of Al overload using a cartridge with immobilized DFO is
efficient and safe and eliminates the potential toxicity of DFO
treatment. Although this seems to be the treatment of choice in severely
intoxicated patients, this device is not readily available and may be
expensive.273
The high polysulfone F-80 dialyzer effects a much greater removal of the
DFO- chelated complexes, than conventional dialyzers.272
Timing of DFO treatment and monitoring of Al levels: Administering a 
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test dose of DFO and measuring the increment of serum or plasma Al
may estimate the body burden of Al. Patients with Al levels above 300
µg/L at any time are at increased risk for neurotoxicity during the
treatment. The treatment schedule should be adjusted in these patients. 
High-risk patients (peak s-Al levels 300-500 µg/L). Peak alumi-
noxamine levels occur several hours after administration of DFO
and there is no decline of serum aluminoxamine levels during the
inter dialytic period. Unchelated DFO is no longer detectable 6 h
(i.e., 3 half lives) after administration.274 Especially patients with
high Al levels (> 300-500 µg/L) are at risk for developing neuro-
toxicity symptoms during these first 6 hours. Therefore dialysis
should cover these hours in these patients and DFO should be
administered i.m. 5 hours prior to a dialysis session with a high
flux dialyzer and side effects of DFO infusion will then be
minimal.30
Low risk patients (s-Al level < 300 µg/L). Patients with s-Al levels 
below 300 µg/L are at lower risk of neurotoxicity and the chelator
can be given safely during the last hour of a dialysis session at the
start of which a serum sample is taken for Al determination. A
second serum sample is taken at the start of the next dialysis session. 
Practical considerations concerning DFO treatment in hemodialysis
patients: the treatment schedules not only should avoid complications,
but they also should accommodate the patients and dialysis staff as
much as possible and therefore fit into the regular dialysis sessions.
Considering this, as an example dialysis should not be necessary
during the weekends, high Al levels should be avoided during the
weekends, and i.m. injections the day before dialysis should be given
only when strictly necessary.
Duration of treatment:
The optimal duration of treatment is not clearly established. In any case
one should want to reduce the s-Al levels below normal values (60 µg/L)
in dialysis patients, without increment of Al levels above 50 µg/L at two 
successive occasions after low dose DFO treatment. This will lead to
treatment schedules for over a year in some patients, especially those
134
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without residual diuresis. On the other hand, Al intoxication is an
iatrogenic disorder and maybe therefore one should consider treating
patients until their Al burdens have reached the levels before the
intoxication (approximately below 20 µg/L) especially when the Al
intoxication is due to accidental poisoning (see Table 4).
Considering all the above-mentioned facts, a treatment schedule was developed by
W.H. Boer (University of Utrecht, The Netherlands), K. Berend (Diatel Curaçao)
after consultation of M.E. de Broe (University of Antwerpen, Belgium). In our
experience and that of Barata et al.30, the dose of 5 mg/kg once or twice a week
seems safe enough for long-term treatment and further decrease of this dosage
seems unnecessary, although half this dosage may have similar efficacy.265
7. Conclusions
Al is a very potent neurotoxicant, with a wide variety of pathological,
neurochemical, and behavioral consequences of Al exposure. There is no single
unifying mechanism that can explain the wide ranges of toxic effects of Al and
hundreds of cellular processes both in man and animals have been demonstrated
in plants and aquatic animals in nature, experimental animals by several routes of
exposure, and under different clinical conditions in humans.
Acute Al toxicity is an iatrogenic pathology that has an asymptomatic phase,
whereafter severe epileptic manifestations like myoclonus and seizures result in coma
and a high mortality. Especially hemodialysis patients are at risk when the dialysate is
contaminated with high Al. The use of Al in bladder irrigation can lead to acute Al
encephalopathy in patients with reduced kidney function. Not only kidney patients
are at risk for acute Al encephalopathy, also the use of cement in otosurgery has been
related to acute Al encephalopathy. Therefore, every effort should be undertaken to
limit the use of compounds containing Al in patients. Unfortunately, despite
widespread agreement on this point, the abolishment of Al in medicine has only
partially been put in practice. Understanding the trends and basics of materials science
should help the clinician to avoid unnecessary exposure. However, while Al has no
biological function in mankind, it is the most abundant metal in the earth's crust and
the widespread occurrence of Al, both in the environment, foodstuffs and medicine,
makes it virtually impossible for man to avoid exposure. Up to date, despite an
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abundance of literature and almost forty years of research, many questions remain
unresolved and several aspects of the Al metabolism, as well as the mechanisms of
toxicity at the bone and brain level remain to be elucidated. 
8. Recommendations for Further Study 
Adopt a multidisciplinary perspective in Al research, involving collabora-
tive research efforts among scientists from many different specialties.
Provide a full overview of the different drugs, clinical materials containing Al.
Determine Al concentrations in parenteral fluids that are safe for infants 
and children and enforce these standards.
Provide a better characterization of the brain pathology in dialysis
patients, encompassing the entire spectrum from acute and chronic Al
encephalopathy in patients with and without clinical signs of neurotoxi-
city, with emphasis on variations in neuropathology from acute, extreme-
ly high- level exposure to long-term, low- level exposure. All existing
pathology material should be reevaluated for this purpose.
Cement linings of drinking water distribution pipes should be reevalu-
ated for their possible toxicological properties.
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Fig 2. Mean duration of desferrioxamine treatment (weeks) and residual diuresis in 
seventeen patients with aluminum intoxication
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Figure 2. The treatment duration with desferrioxamine was related to the residual diuresis as all patients with a residual diuresis of a liter/day or 
more could be treated less than two months, while the patients with a residual diuresis less than 200 cc/24 h had to be treated up to 91 weeks 
(table 1). Even minimally functioning kidneys can protect patient from aluminum toxicity.
see page 107
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Abstract
Background. Criminal prosecution of physicians for the death of patients
has been extraordinarily rare, but there seems to be a rising trend. This case report
describes the medical and judicial implications of criminal prosecution of two doctors of
a hemodialysis clinic in the Netherlands Antilles that had to stand trial over the death
of ten dialysis patients. The patients died of subacute aluminum intoxication when
aluminum leached from the cement lining of a newly installed water distribution pipe
into the water supply of the dialysis center that did not make use of a water treatment
system (WTS). 
Material and methods. Data of the case history of the dialysis patients, the
criminal prosecution, preliminary judicial inquiry, the defense arguments and verdicts
were reviewed.
Results. The prosecutor first decided to dismiss the case, but after an appeal
by the families, the Court of Appeal decided to pursue prosecution for gross negligence.
It held that the dialysis center should have used a WTS and also held that the dialysis
staff insufficiently reacted on extra alarms on the dialysis machines the two days after
the new water distribution pipe was put in use. From June 6, 1998 until January 1999
a preliminary judicial inquiry was performed in The Netherlands and on Curaçao.
After a cross-examination of thirteen court-appointed experts by the prosecutor and the
investigative judge, the prosecutor charged the two physicians of gross negligence and
manslaughter for not testing the composition of the water after the construction at the
water distribution network. A prison sentence with probation of six months was
demanded. The District Court disagreed on all issues with the prosecutor, but
nevertheless held the medical director of Diatel guilty for performing hemodialysis
without a WTS. In May 2000, the Court of Appeal held that it was not allowed to rule
on the omission to install a WTS because this issue was not included in the charge and
overturned the conviction. 
Conclusions. Medical personnel in charge of potentially dangerous
procedures should be prepared for unexpected changes in the quality of their treatment.
Because court-appointed experts might have an extraordinary role in the decision
making process, guidelines should be prepared to assure the quality of their testimony. 
Key words: Aluminum intoxication hemodialysis prosecution expert witness
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Introduction
Criminal prosecution of physicians for the deaths of patients are
extraordinarily rare,1 but its occurrence continues to rise.2-5 The vast majority of
doctors will not deliberately expose patients to serious risks, but when it
appears as if a physician’s medical acts, or negligence, result in the death of a
patient, the public expects that some action will be taken against the physician.
Some people believe that prosecution is essentially necessary due to the
ineffectiveness of the current disciplinary mechanisms within the health care
profession.3 For the medical practitioner, prosecution will be one of the most
distressing experiences in his medical career, not only because the judicial
process may last several years, but primarily because it touches upon the
foundation of medical ethics. In most cases, expert evidence information is
decisively important in a rapidly growing percentage of decisions throughout
civil and criminal law. This is also because expert witnesses are in a very privileged
position as they may give their opinion as evidence, unlike other witnesses who
can only give evidence of facts.6-9 This report describes the prosecution of the
two physicians of a the hemodialysis center Diatel in the Netherlands Antilles,
after an outbreak of acute aluminum (Al) intoxication when Al leached from the
cement lining of a newly installed drinking water distribution pipe.10,11
Materials and Methods
The dialysis center 
Patients on maintenance hemodialysis are parenterally exposed to
20-30,000 liters of water annually. To ensure the water quality, water treatment
systems WTS with reverse osmosis (RO) filters are used in most countries since
the early 1980’s, but some dialysis centers continued using untreated tap water
long after.12 In Curaçao, an island of the Netherlands Antilles, public city water
is produced by distillation of seawater. This tapwater had been used for
hemodialysis since 1971 in the local hospital. In 1993 the hospital installed a
WTS in the dialysis unit but remained using tapwater for hemodialysis in the
intensive care unit. In 1992, a non-profit dialysis center Diatel was opened with
the financial and technical support of the Dutch Kidney Foundation. Initially
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it was decided not to install a WTS, but because of water pressure problems a
WTS with a booster pump and storage tank was scheduled to be installed in
August 1996. Table 1 shows the water analysis of 1994 and 1996, compared
with several dialysis standards,13-15 toxicity levels14 and the WHO drinking water
guidelines.16 Four of the tested chemicals were above American standards in
1994,13 but below toxic levels14 and below the European Union (EU) guideline for
Al (see table 1).15 To prepare dialysis fluid, water is mixed by the dialysis machine
with a bicarbonate concentrate and an "acid" component, containing calcium,
magnesium and other compounds. The first 3.5 years with 9600 dialysis
treatments were uneventful and the mortality low (one local patient and one
tourist had died). In May 1996, the water distribution company tried to assist
Diatel with the low water pressure and connected the water supply of the dialysis
center to an earlier installed new water distribution pipe after flushing of the entire
pipe. The interruption of the water supply lasted a few hours and dialysis
was performed without incident that afternoon. During the following two days
however, six of the eight dialysis machines produced repeatedly intermittent
conductivity alarms for seconds to minutes. This is an indication of technical
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Table 1. Waterb analysis in 1994 and 1996, compared with several dialysis13-15 and drinking water
standards16.
Tapwaterb
analysis
January,
1994
Tapwaterb
analysis
September,
1994
Tapwaterb
analysis
July,
1996
A.A.M.I.
hemodialysis
waterb
standards13
Water;b
lowest
toxicity
level14
EC
Directive,
waterb 15
WHO
drinking
water
guideline16
Sodium, mg/L 22.98 14.48 70 300
Aluminum, µg/L 16 650 10 60 30 200
Calcium, mg/L 10.79 8.4 18.1 2 88 a
Copper, mg/L 0.003 < 0.005 0.1 0.49
Magnesium, mg/L 4.618 5.1 1.665 4 88 a
Zinc, mg/L 0.184 0.062 0.1 0.2
Fluoride, mg/L 0.18 0.5 0.2 1
Nitrate(N), mg/L <0.2 < 0.2 2 21
Sulfate, mg/L 5.1 4.1 100 200
aThe sum of the Calcium and Magnesium levels should be below 88 mg/l.14
b To prepare dialysis fluid, (purified) tap water is mixed by the dialysis machine with a bicarbonate concentrate and an
  "acid" component, containing calcium, magnesium and other compounds.
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problems or a change of electrical conductivity that reflects the total concentration
of the dissolved ions of the dialysis solution.13,17,18 Because an external conductivity
meter demonstrated normal values of the dialysate the technician focused on
technical defects and changed water tubes because of suspected air leakage and
thereafter the frequency of the alarms reduced to normal proportions. 
The patients
Dialysis continued for several weeks but at the end of June 1996, the
dialysis center had to be closed when some patients suffered from symptomatic post
dialysis hypercalcemia resulting from calcium that leached from the cement layer into
the water supply. The patients recovered temporarily after transfer to the dialysis unit
of the hospital but days to weeks later 10 of the 27 patients developed sepsis,
convulsions, coma and myoclonic jerks of the extremities and died. The court
requested post-mortem toxicological analysis of four patients. Aluminum
concentrations in serum, liver, bone, and cerebral cortex were significantly increased
as compared with background levels. The serum aluminum level of the non-survivors
was 359-1275 µg/l (mean 808 µg/l) and that of the survivors 113-490 µg/l (mean
255 µg/l) [<60 µg/l normally seen in dialysis patients without symptoms]. Aluminum
intoxication was, therefore, considered to be the most likely cause of death in these
patients.19,20 The 17 survivors were transferred to The Netherlands and were
successfully detoxified, by using the chelator desferrioxamine.20
The water distribution pipe
Subsequent evaluation demonstrated that a very high Al content of the
cement coating of the newly installed water distribution pipe in combination
with aggressive water in a low flow situation was responsible for the prolonged
high Al levels that intoxicated the patients during dialysis treatment.10
Results
The prosecution.
Curaçao is part of The Kingdom of The Netherlands and most judges
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and prosecutors work on a short time contract from The Netherlands. The
penal system is quite similar to that in The Netherlands. On April 9, 1997,
after an extensive investigation with the aid of The Netherlands Health
Inspectorate, Water Authorities from The Netherlands and the Pan American
Health Organization, the prosecutor decided to dismiss the case. He concluded
that it was not criminally negligent to dialyze without a WTS because: a) the
water quality was generally considered to be good; b) consultants considered a
WTS to be superfluous; c) there had been extensive consultation with experts
from The Netherlands and the USA; d) several nephrologists had visited
Diatel without advising the purchase of a WTS; e) since 1993 the purchase
of a WTS was considered and eventually ordered in November 1995; f ) the
installation of the WTS was delayed for constructional reasons; g) there was
no legislation concerning dialysis treatments; h) there was no control by the
Health Inspectorate; i) the dialysis unit in the hospital acquired a WTS in
1993, not because of problems with the water quality, but to introduce a
special (high flux dialysis) treatment  for which a WTS is necessary and; j)
the intensive care unit in the hospital still performed dialysis without a WTS
in 1996. 
On January 27, 1998, after an appeal of the family, the Court of
Appeal decided to pursue prosecution. It held that it was a severe omission
a) to dialyze without a WTS because A.A.M.I. standards13 were not met
before (table 1); b) that no water tests were performed after the interruption
of the water supply and c) that no water quality guarantees were obtained
from the Water Company after the new water distribution pipe was installed.
Some patients also requested the prosecution of board members of the water
utilities but neither the water utilities, nor the board members of Diatel
could be prosecuted, because at that time no legal provision was in force to
allow this. 
Expert witness testimony during the preliminary judicial inquiry 
From June 6, 1998, until January 1999, a preliminary judicial inquiry
was performed in The Netherlands and Curaçao. Expert assistance was appointed
by the investigative judge and consisted of two water experts, two dialysis
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technicians and nine medical and nursing experts from four universities and
three dialysis clinics. During the questioning of the experts, the prosecutor,
the investigating judge and the defense attorney were present. Table 3 shows
some important expert witness statements that were regarded as erroneous by
the defense.
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To dialyze without a
WTSb is a severe
omission because
certain dialysis
standards for water13
were not met before in
1994.
The WTSb was not an
element of the charge,
as the prosecutor did
not find it criminally
negligent that dialysis
was performed on
tapwater.
1. At the opening of the dialysis center dialysis
had been performed on tap water for 26 years
on the island and the staff was advised by
consultants not to install a WTSb.
2. The contaminations of 1994 were within safe
limits.
3. A WTS is not always capable to prevent Al
intoxications.21-25
Contamination could occur at
any time since a chemical
contamination already had
occurred in 1994 (table 2).
Water tests should have
been performed after the
interruption of the water
supply, when extra
alarms were noted on
the dialysis machines.
The dialysis staff did
not react properly on
the extra alarms and
should have tested the
water as it may have
been a sign of
improper water
quality.
1. It is impossible to neglect or overrule these
“conductivity” alarms because dialysis
machines automatically interrupt dialysis
treatment until the conductivity problem has
been solved.17,18
2. Aluminum could not have caused the
conductivity alarms because these levels were
very low compared with the concentration of the
other standard ions in the dialysate (Table 1).
3. The extra conductivity alarms were probably
due to air bubbles that deregulated the internal
conductivity cells of the dialysis machines.
4. There was no reason to test the chemical
composition of the water when the external
conductivity meter demonstrates normal values.
5. Aluminum is not a normal component of
distilled water, but even if it were tested,
certainly no higher levels would have been
found early after the water interruption because
the entire pipe had been flushed after
installation.
Agreed with the defense.
Water quality
guarantees should have
been obtained from the
Water Company after
the new water
distribution pipe was
installed.
Idem. 1. The water utility was notified that dialysis was
performed without extended water purification.
2. It was unknown by the water utilities that a
substantial change of water quality could occur
during distribution.
Agreed with the defense.
Prison sentence on
probation of 6 months
was demanded.
Prison sentence on probation of
6 months demanded and
(maximum) penalty of 10,000
NAF (6,500 US $).
a On April 9, 1997 the prosecutor decided to dismiss the case.  On January 27, 1998, after an appeal of the family, the Court of Appeal
  decided to pursue prosecution.
bWTS water treatment system.
Table 2. Points of contention. Verdict summaries of the Court of Appeal after it decided to pursue prosecution, the
charge and allegations of wrongdoing of the prosecutor after the preliminary judicial inquiry (June 6, 1998 - January
1999), the defense arguments and the summary of the verdict report of the District Court.
Ruling of the Court of
Appeal, before the
preliminary judicial
inquiry.
Charge and
allegations of
wrongdoeing  by
the prosecutor
Arguments of the defense Ruling of the District Court
(November 1999)
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The charge 
In October 1999, the prosecutor charged both physicians for
manslaughter of at least eight patients and held it gross negligence that the
water was not tested after the water interruption or in the two days of the
extra alarms on the dialysis machines. It was not regarded criminally negligent
to dialyze without a WTS. A prison sentence on probation of 6 months was
demanded. 
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Table 3. Important expert witness statements that were regarded as erroneous by the defense
1 Testimony: “You ask me if I am aware that the European Community (EC) directive requires that a water
treatment system (WTS) is installed and that aluminum levels should be below 10 µg/l; my answer is yes. “If I had
seen the water analysis of 1994, I would definitely have advised to install a WTS”; “the EC Directive norm for
aluminum in the water used for dialysis is since the eighties 10 µg/l”.*
Defense: The EU does not require a WTS and the EC Directive aluminum norm is 30 µg/l.15
2 Testimony: “A Reverse Osmosisa (RO) excludes a Al intoxication”; “The calamity in Portugal was due to bypass
of the RO”. ‡
Defense: A RO does not exclude a Al intoxication.21-25 If the Al present is weakly ionized, reverse osmosis
rejection rates may be decreased to as low as 30-50%21,23 and double RO systems in line may be necessary.22
Possibly it was not the bypass of the RO, but membrane fouling that was the major contributing factor of the
intoxication in Portugal.23
3 Testimony: “If alarms are pushed away, that is a mistake. You can overrule almost every alarm on a dialysis
machine”; “ It is possible to push away alarms and continue to dialyze”. “ It is possible to turn off the alarm
without solving the problem”. “If the alarm is pushed away, the pump continues to roll and there will be an
exchange between blood and dialysate”.  “To push away alarms can be life threatening”. ‡
Defense: It is impossible to “push away” or to “overrule” a conductivity alarm. Dialysate conductivity monitoring
is especially developed to guarantee safety in case of mix-up of concentrates.13,17,18 Audible and visible alarms
interrupt delivery of dialysate to the hemodialyzer and prevent blood in the hemodialyzer from reaching the
patient.13,17,18
4 Testimony: “You can change the sensitivity of a conductivity alarm. If you go too far you create a time bomb”. ‡
Defense: Upper and lower conductivity alarm limits are set at + 5% of the expected conductivity. Limits cannot be
set beyond a certain level fixed at the factory.17,18
5 Testimony: “Symptoms of an acute Al intoxication are especially speech problems”; “Every nephrologist should
know the symptoms of an acute Al intoxication”; “The symptoms of an acute Al intoxication and hypercalcemia
are quite similar but after a few days the difference should become obvious”. ‡
Defense: Speech problems are not a sign of acute Al intoxication.11,25 The symptoms of hypercalcemia are not
similar and Al intoxication has a symptom free interval of several days to weeks.11,25
RO = Reverse Osmosis (RO filters are nowadays part of in a WTS in dialysis centers)
* Testimony acquired by police officers.
‡ Testimony acquired by the prosecutor and the investigative judge.
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The defense
The defense disagreed with the allegations of the charge and some
statements of the expert witnesses (table 3) and provided publications to the court
on water quality issues,13-16 alarms on dialysis machines,17,18 water treatment
systems21-24 and symptoms of aluminum intoxication (table 1-3).12,25
Court rulings
After a court hearing and a deliberation of 10 h on 18 and 25 October
1999, the District Court disagreed with the prosecutor on all issues, but
nevertheless held the medical director guilty for performing dialysis without a
WTS, although the use of a WTS was not an element of the charge. The Court
held that contamination could occur at any time since a chemical
contamination already had occurred in 1994 (see table 1). The medical director
was sentenced to the maximum financial penalty of 10,000 Antillean guilders
(approximately 6,500 US dollars). The other physician was acquitted because he
was not involved in the purchase of the WTS.
In May 2000, the Court of Appeal gave a final decision. Since the
indictment of the prosecutor did not include the omission to install a WTS the
court held that it was unable to address this element. As it sustained the other
issues of the first ruling, both defendants were acquitted.
Discussion 
The intoxication
Trust is a dangerous companion in medicine. More than two decades
tap water was relied upon to be sufficiently pure for dialysis because its quality
is one of the best in the world.26 After a seemingly unimportant interruption of
the water supply, the Al level increased unexpectedly more than 40 times (table 1)
which resulted in the death of ten dialysis patients, a flood of media coverage in
Curaçao and The Netherlands, the resignation of the Minister of Health and
prosecution of two physicians. The tragedy is that the good initial water
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quality in fact was indirectly responsible for the fatal outcome. Pure, low
calcium water is corrosive for iron water pipes and therefore other pipes with a
"protective" cement coating were installed. At that time however, it was not
known that the Al content of the cement layer was four times higher than
common and that the purity of the water enhanced the leaching of Ca and Al.
Clearly, no one had been aware of the possibility of an Al contamination dur-
ing distribution, as this had never happened before in dialysis history.10,11,20
Nevertheless, hemodialysis is a potentially dangerous therapy and according to
the law, everyone who is under control of anything whatever, which, in the
absence of precaution or care, may endanger human life, has the duty to take
reasonable precautions against and to use reasonable care to avoid such danger.27
The failure to take precautions had been the result from the lack of awareness
on the part of the physicians and external consultants that any precautions were
required because it was believed that the Water Authorities would take all
relevant measures involved in the water supply. This is in fact an excuse of
ignorance or negligence but when several patients die, the public opinion and
that of the Court can easily rise to the level of gross negligence, which then
justifies prosecution. 
This case shows that although the quality of the water delivered by the
factory may be constant, it can change suddenly during distribution and the
physician in charge of dialysis treatments will be held responsible for the
consequences. The intoxication was caused by a unique and complex set of
circumstances that not only involved the physicians, but also external consultants,
the board of Diatel, the local Water Authorities, the cement industry and the
water distribution industry but the local law28 -which was amended the following
year-,29 did not permit the prosecution of board members of legal entities like
foundations.
Expert witness testimony
In the criminal process that lasted almost 4 years, police officers,
the prosecutor and the investigating judge questioned 18 different
court-appointed experts in The Netherlands and on Curaçao. Although the
defense had proposed most experts in the preliminary judicial inquiry, they did
170
C H A P T E R  V I
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:02  Pagina 146
not testify on behalf of the defendants. Neither the defendants nor an expert on
behalf of the defendants were invited to attend these cross-examinations; that
does not comply with article 6 Section 1 and 3 of the European Convention on
Human Rights.30 Therefore, several errors in expert witness testimony could not
be corrected before these statements were produced as evidence (table 3). The
case mainly focused on three technical issues discussed during the preliminary
judicial inquiry with the expert witnesses
Firstly, the question if the water quality had been good enough to dialyze
without a WTS. In 1994 the aluminum level in the water supply had been
below the below the European Community (EC) standard,15 but one of the
experts erroneously testified to police officers that the dialysis clinic breached
this standard (tables 1 and 3). This error in testimony was an important
reason for the Court of Appeal to pursue prosecution after family members
appealed the decision not to prosecute. 
Secondly, the question of whether the dialysis staff had reacted sufficiently
on the numerous "conductivity" alarms of the dialysis machines the 2 days
following the water interruption. Hemodialysis machines monitor continuously
the total concentration of ions in the solution by a built-in conductivity
meter and visual and audible alarms alert the dialysis staff if the conductivity
is beyond certain levels. This serves as a "watchdog" to protect the patients
as dialysis machines automatically go into 'bypass' so that the blood stream
will not be exposed to the dialysate.13,17,18 The extra alarms were, in retrospect,
probably due to air bubbles from the water mains that deregulated the conductivity
meters repeatedly for seconds to minutes. It seems unlikely that high
concentrations of solutes like Al or Ca can activate the conductivity meters
intermittently for such a short time period.  The prosecutor, however,
regarded these conductivity alarms as a sign of improper water and implicated
that dialysis should have been stopped until the water quality was ensured.
The prosecutor probably based his opinion on some expert’s statements,
implicating that bypassing the audible alarm may be hazardous (table 3). Even
after the Magistrate of the District Court held that it is impossible to neglect
conductivity alarms and continue dialysis, the prosecutor sustained this theory
before the Court of Appeal. 
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And thirdly, the question whether a WTS would have prevented the Al
intoxication. Some medical experts testified that a WTS is always sufficient to
prevent Al intoxications (table 3) and because the judge at the District Court
neglected evidence that proved the contrary21-25 he ruled that a WTS sufficiently
protects patients and convicted the physician involved in the purchase of the
WTS for this matter, as he did not install this WTS.
In an attempt to counterbalance the errors in testimony, counter expert
reports had been presented at trial. These documents however, were found to be
inadmissible by the District Court, because if  it is to be used, the defense has
to disclose expert opinion reports to the prosecutor, before trial. Although the
Court of Appeal accepted the validity of the counter expertise reports, it
remained difficult to convince the judges and the prosecutor at trial of the errors
in the testimonies. No experts were called to trial because the defense was
unable to find experts that could cover all issues sufficiently. This meant a
heavy burden of proof to the defendants who made no use of their right to
remain silent and had to discuss the errors in expert witness testimony in
court. 
Unlike a charge of malpractice, a criminal charge must be proved
beyond a reasonable doubt.1,8 Because the judge at the District Court disagreed
on all issues of the charge with the prosecutor, "reasonable doubt" was established
and therefore the defendants should have been acquitted.  The Court of Appeal
indeed held that it was not allowed to rule on the installation of a WTS because
this was not included in the charge. 
Worldwide, legal institutions in civil and criminal trials have difficulty in
differentiating adequately between reliable and unreliable expert evidence.6-9,31-33 In
this case, the expert witness testimony was obtained in the absence of the
defendants or an expert on behalf of the defendants. In such cross-examinations it
is not easy to avoid errors. Oral statements require quick judgments, which may
obscure a more complex truth especially when only possible culpable evidence
is presented and opinions are not required to be supported by peer-reviewed
publications. Experts, who are not trained in giving evidence, can easily
underperform because of the unusual and stressful circumstances. Because few
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qualified experts were available on Curaçao, highly specialized knowledge had
to be attained in The Netherlands and Belgium. Such experts may lack the
necessary perspective of community clinical reality and introduce the risk that
opinions are not based on the common local practice and technical possibilities.
As an example, dialysis centers in Europe have a higher need for a WTS, because
the drinking water quality in Europe is far worse34 than that of Curaçao.26
The process of criminal investigations in The Netherlands and United States
compared
The Dutch criminal procedure differs much from the common law systems
employed in Anglo-American law, and cases like this would follow a different
path in each system of law. The Netherlands has professional judges and no jury
or other form of lay participation in the decision-making exists in contrast with
American trial judges that possess little power over the course of the
litigation.8,31-33,35,36 The Dutch code on criminal proceedings regulates the criminal
procedure as a whole: starting with preliminary inquiries and investigation and
concluding with rules about the execution of court decisions. In the Dutch
criminal justice system, experts are to be appointed by the (investigative) judge.
If this is not contrary to the interest of the investigation, the investigating judge
will select the experts from the persons recommended by the defendant. This is
meant to ensure that the expert remains an impartial actor, with no interests in
advance but the general interest of the pursuit of justice. In the Dutch criminal
justice system records of police officers (including expert statements obtained by
them) constitute admissible evidence, and may even constitute the sole means
in proving guilt.8,32,36
The United States has the most complex and restrictive set of
exclusionary rules of evidence in the world: American courts can routinely bar
evidence which would be admitted as a matter of course by tribunals in other
countries.8,31,32,35-37 Experts’ reports are generally not admissible in criminal
proceedings. To be admissible, they must comport with certain conditions
outlined in Federal Rule of Evidence 803 or state equivalents to that rule.38,39
These rules provide an expert evidentiary barrier to conviction. If American
prosecutors want to introduce expert evidence, they have to call the expert to
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give testimony at trial, thus allowing the opposing party to cross-examine the
expert with regards to his knowledge and reasoning process. This difference is
due to the fact that in the United States the parties often retain experts and
therefore more assurances of trustworthiness may be considered necessary.40
Under Dutch and United States law, the prosecutor is entitled to decide
whether to prosecute or to drop a case. In contrast to with the United States,
however, the Dutch law allows involving parties to appeal the prosecutor's
decision not to file criminal charges,8 as happened in this case.
The right of the defendant to participate in the discourse of the expert
witnesses testimony is similar in Continental and American systems of law.
According to the European Convention on Human Rights and Fundamental
Freedom, the Treaty of Rome 1950, the defendant has the right "to examine or
have examined the witness against him and to obtain the attendance and
examination of witnesses on his behalf under the same conditions as witnesses
against him".29,41 Under circumstances this provision of the European
Convention can also be applied to expert witnesses testimony. In the United
States the Sixth Amendment to the American Constitution states that criminal
defendants have the right "to be confronted with the witnesses against him;
[and] to have compulsory process for obtaining witnesses in his favor".41
According to the European Court all evidence must be produced in the
presence of the accused at a public hearing and the prosecution must, therefore
ensure the presence of these witnesses.8,42 Nevertheless, in contrast with the
United States, in The Netherlands, experts are still infrequently called to testify
in open court and more often than not, courts limit themselves to documented
expert evidence contained in the case file.8
The use of expert evidence in the Dutch criminal justice system has
not escaped criticism. In the last 10 years there have been calls for reform of
the law affecting expert evidence. Proposals include the adoption of standard
questionnaires for experts; of criteria whether the person testifying can be
considered as an "expert"; of standards for deciding whether the expert’s oral
or written statements are sufficiently reliable to be used by the trial courts;
and broader proposals for revision of the procedural and evidentiary rules
affecting this type of evidence.8,32,36 
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Doctors charged for manslaughter may face years of uncertainty, the
treat of imprisonment or revoking of license and negative publicity. The only
thing an accused can do is to try and understand the litigation process in order
to reduce the anxiety that comes from the sometimes seemingly random course
of the prosecution and ruling by the judges. Moreover, the accused should
become an active participant in the preparation of the case, critical to ensuring
that his interests are properly protected. At trial he should have more knowledge
and valid opinions about the case than the experts. It has an added benefit of
reducing the psychological burden of standing helplessly by, while the verdict
unfolds.
To conclude, in the United States the erroneous expert witness evidence
in this case would probably not have been admissible due to the better protection
by the federal rules of evidence. 
As expert witness testimony is both unavoidable and decisive in medical
cases, it obligates experts to be very aware of the legal and ethical impact of their
testimony as their evidence may form the central core of a case that may lead to
life imprisonment. It is important to audit expert medical evidence but courts
are not the appropriate place for this.43 Courts and legislators should realize that
expert testimony can be erroneous even if the expert is unpaid, neutral and
court-appointed and therefore medicolegal work should be similarly peer-
reviewed and subject to quality assurance even if the expert appears to be neu-
tral.43,44
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In chapter I, an introduction was given with general information on
aluminum toxicity and an outbreak of subacute aluminum intoxication in a
hemodialysis clinic, with related aspects such as drinking water management
and forensic and legal consequences. 
Water quality and cement linings
In chapter II, the impact of the use of water distribution pipes with
an inner cement lining on aluminum levels in tap water, is described. In
Curaçao, drinking water is prepared by distillation of seawater, after which
calcium carbonate (CaCO3) is added at the water plant for corrosion prevention
of iron water mains. In the beginning of the nineties, this calcium carbonate
level was low (25-40 mg/L1; preferred value > 50 mg/L2) and one of the main
reasons of corrosion of the water mains.1,3-11 The water distribution avoided
this problem by using other pipes with an interior cement lining and these pipes
(with a total length of 2.2 km) were installed at Diatel in May, 1996, in order
to assist Diatel with low water pressure problems. Cement layers, however, are
not inert and will always react with water, especially as a protective calcium layer
will not be formed on the cement lining with low calcium carbonate ("soft")
water.1,3-11 In this case, calcium and aluminum leached for a long period of time
from the cement layer into the tap water of Diatel. The aluminum concentration
increased from less than 5 µg/L at the water plant to the highest level on the
island (550 µg/L to 690 µg/L) at the dialysis center, 2 months after the pipe was
put in use. Factors which might have contributed to these excessively high
levels, were a) the newly installed pipe, b) the aggressiveness of the water, c) the
low pH and d) high temperature of the water, e) the cement composition with
a four times higher aluminum content than usual,5 f ) a long residence time and
g) the use of the corrosion inhibitor polyphosphate.1,6
In 1996, after the tragedy in Diatel Curaçao, KIWA investigated the
leaching of aluminum from cement-mortar water pipelines in The Netherlands.
Samples were taken on twenty locations with cemented pipes and asbestosos
cement-pipes. Locations with ‘worst case scenarios" favoring the leaching of
aluminum were chosen, defined as low flow, soft water, new pipes and small
diameter. The aluminum levels in the tap water never reached levels above
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11 µg/L at any location.5 As the cement types in the study in The Netherlands
were probably different from the ones used in the present situation,
manufacturers have to prove the appropriateness of the cement linings when
other cement types than those recommended, are applied.12
Aluminum
In chapter III, the outbreak of subacute aluminumencephalopathy in a
dialysis center is described. In 1996, 27 hemodialysis patients of Diatel Curaçao
were exposed to contaminated dialysate with calcium and aluminum. Initially
7 patients showed symptoms of a 'hard water syndrome' with nausea, vomiting, and
postdialysis hypercalcemia. The hypercalcemia disappeared with low-calcium dia-
lysate and the withdrawal of calcium and vitamin D supplements, but microcytic ane-
mia and neurological symptoms developed. Of the 27 patients who had a simi-
lar exposure (approximately 60 hours) to the contaminated dialysate, 10 died
from subacute aluminum encephalopathy, whereas 17 patients had minor
symptoms and survived. Serum aluminum concentrations, available in seven
non-survivors were significantly higher than in the survivors (808 +/- 127 vs.
255 +/- 25 microg/L, P < 0.01). We found that comparable aluminum loads
appear to induce a more severe intoxication in malnourished, older patients
with a low lean body mass and low residual diuresis. The hypercalcaemia was
probably partly due to the aluminum intoxication.13,14 As there will always be a
latent phase of days to weeks before encephalopathy can develop, we found that
"acute" encephalopathy -implicating neurotoxic symptoms to occur within
hours- as such does not exist.14
In chapter IV, the post-mortem toxicological findings in subacute
aluminumencephalopathy are presented. In an outbreak of aluminum intoxication
in 27 hemodialysis patients, 10 patients died of subacute aluminum encephalopathy
with convulsions, sepsis, and coma. The court requested post-mortem toxicological
analysis of four patients. Aluminum concentrations in liver, bone, and cerebral
cortex were significantly increased as compared with background levels.
Aluminum intoxication was therefore considered to be the most likely cause of
death in these patients. The high levels of aluminum that were found in liver
and bone may implicate that these organs serve as a storage pool for aluminum
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in order to protect the brain. Nevertheless, a significant amount of aluminum
was observed in the brain, in the hippocampus and the occipito-parietal cortex,
implicating that liver and bone storage was relatively oversaturated.14,15
In chapter V, the literature on symptomatology, the sources of aluminum
exposure and pathogenic mechanisms of aluminum intoxications is reviewed. Also
a treatment schedule to treat hemodialysis patients with aluminum intoxication
was developed.14
There are wide variations in the clinical manifestations and degrees of
expression of aluminum toxicity. The most obvious clinical problems are toxic
effects on the brain, bone and hemopoietic tissue.13-17 Despite a rapidly growing
amount of literature on aluminum toxicity, few data are available on (sub)acute
aluminum encephalopathy. For practical purposes aluminum encephalopathy
can be divided in two types: "chronic" aluminum encephalopathy and "acute"
(or subacute) aluminum encephalopathy indicating the time span between the
onset of the intoxication and the development of symptoms. When the exposure
level is relatively low, aluminum toxicity symptoms develop after months to
years ("chronic"), whereas with extremely high exposure, symptoms develop
within weeks ("acute" or "subacute"). In both subacute and chronic aluminum
intoxications microcytic anemia13-17 and EEG changes13,14 are noted and
sometimes precede clinical symptoms.17,18 The most severe symptoms in both
forms of aluminum encephalopathy are convulsions, coma and myoclonic jerks
of the extremities. Some of the clinical manifestations of chronic aluminum
encephalopathy, however, seem to be "bypassed" in subacute aluminum
encephalopathy, probably due to the overpowering of the storage capacity of
liver, spleen and bones. While absent in subacute aluminum encephalopathy,
speech disorders are an important clinical sign of chronic aluminum intoxication,
besides bone fractures.14,20,21 The severe neurotoxic symptoms in subacute
aluminum encephalopathy can even develop days to weeks after the exposure is
terminated. It seems as if brain pathology ultimately reaches a point of no return
where frequent epileptic insults will inevitably lead to coma and death.13-15
Treatment of aluminum intoxication. As aluminum intoxications are
preventable, every effort should be undertaken to limit exposure to this
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neurotoxicant. To date, desferrioxamine (DFO) is the single most used drug for
the treatment of aluminum intoxication. It has been clinically used since 1963
as an iron-chelating agent in patients with iron overload22 and since 1980 it has
also been used in the diagnosis and treatment of aluminum overload in dialysis
patients.23 Especially in the latter case a number of serious side effects such as
the exacerbation of encephalopathy have been reported22 and the optimal dose
of DFO for long-term chelation in dialysis patients is uncertain. We developed
a practical treatment schedule for severely intoxicated hemodialysis patients to
avoid unnecessary treatments in the weekends or dangerously high aluminum
levels induced by DFO, for a prolonged time. We found that in severe
intoxications with serum aluminum levels of 300-500 µg/L, DFO can be
safely administrated two times a week, five hours before high flux dialysis, in a
dose of 5 mg/kg and a dialysis schedule of four times a week. If serum aluminum
levels are below 300 µg/L, DFO can be administered in the same dose during
the last hour of dialysis session with a dialysis schedule of three times a week.
The treatment duration was significantly related to the residual diuresis as all
patients with a residual diuresis of a liter/day or more required treatment of less
than two months while other patients with anuria had to be treated for up to
91 weeks.14
Forensic aspects 
In chapter VI, the judicial implications of the outbreak of subacute
aluminum intoxication are set out. When Diatel was opened in 1992, it was
common to use tap water for hemodialysis on Curaçao. In the nineties most
dialysis centers in other countries made use of a water treatment system (WTS)
with reverse osmosis membranes. Usually such a device is capable of rejecting
99% of the aluminum in the water supply, but in some cases, especially when
the water contains large amounts of aluminum over a prolonged time, these
devices may be insufficiently able to reject aluminum.24,25 After the interruption
of the water supply in Diatel –to establish the connection to a newly installed
water pipe-, the dialysis machines functioned normally the same day. The next
two days extra alarms were noted intermittently for seconds to minutes on
several machines. In retrospect this was probably due to technical problems,
which may have been the result of air bubbles in the water supply.26
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A criminal investigation, started in September 1996, evaluated the
possibility of a criminal liability of the water authorities or the board and medical
staff of the dialysis center. After an extensive investigation with the aid of The
Netherlands Health Inspectorate, Water Authorities from The Netherlands and
the Pan American Health Organization, the prosecutor decided to dismiss the
case. The relatives of the deceased however, appealed the decision not to prosecute
and the Court of Appeal then ordered the prosecutor to reopen the investigation
of the case. Some patients also requested the prosecution of board members of
the water utilities but neither the water utilities, nor the board members of
Diatel could be prosecuted, because the local law -which was amended the
following year-,27 did not permit the prosecution of board members of legal
entities like foundations.28 After a preliminary judicial inquiry, the prosecutor
did not consider it criminally negligent performing dialysis treatments without
a WTS, but charged both physicians guilty with the death of at least eight
patients for not testing the water after the water interruption, or after the extra
alarms on the dialysis machines. A prison sentence on probation of 6 months
was demanded. The District Court however, disagreed with the prosecutor on
all issues but still found the medical director guilty of performing dialysis
without a WTS, even though the absence of a WTS was not an element of the
charge. The medical director was sentenced to the maximum penalty of 10,000
Antillean guilders (approximately 6,500 US dollars). The other physician was
acquitted because he was not involved in the purchase of the WTS. The Court
of Appeal held that since the indictment of the prosecutor did not include the
omission to install a WTS, it was not allowed to address this element. As the
Court of Appeal sustained the other issues of the first ruling, both defendants
were acquitted.26
Expert witnesses played an important role both in the initial conviction and the
reopening of the prosecution due to errors in their testimony. The preliminary
judicial inquiry process particularly introduced a series of risks for errors in
testimony. Firstly, the expert witness testimony was obtained behind closed
doors in the absence of the defendants or an expert on behalf of the defendants.
During such cross-examinations it is difficult to avoid subjective interpretations,
mainly since opinions were not required to be supported by peer-reviewed
publications. Secondly, experts who are not trained in giving evidence can
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easily underperform on account of the unusual and stressful circumstances.
Thirdly, because highly specialized knowledge had to be obtained from other
countries, these foreign experts lacked the necessary perspective of local facts.
Accordingly, some of their opinions were not based on common local practice
and technical possibilities. And finally, the expertise that was required, served
the exclusive purpose of the criminal proceedings and were not particularly
directed towards data that scientists are normally interested in or necessarily
knowledgeable of.26 Therefore, guidelines should be enacted not only to ensure
the independence of expert witnesses, but also to assure the scientific quality of
their testimony. 
Closing remarks
The intoxication
After a seemingly unimportant interruption of the water supply, the aluminum
level in the water supply of the dialysis center Diatel unexpectedly increased
more than 40 times. This resulted in the death of ten dialysis patients, a flood
of media coverage in Curaçao and The Netherlands, the resignation of the
Minister of Health and the criminal prosecution of two physicians. Calamities
generally only occur when more parts of a safety chain are disrupted simultaneously
as was the case in this incident. People in charge of dialysis facilities and water
utilities in Curaçao encounter several specific problems related to limitations
confronted on a small island pertaining to lack of legislation, standards or
regulations that would have prevented these incidents. Although hemodialysis
had been performed using tap water in many countries in the past, this is the
first event of intoxication during dialysis caused by a water distribution pipe.6
Many countries make use of cement coatings in water distribution pipes to protect
the pipe from corrosion, but it is very unusual that these cement coatings
release aluminum, one of the main constituents. The release of aluminum and
the subsequent intoxication of the patients in this case can be attributed to
several coinciding unfortunate factors:
A water distribution industry, which at that time manufactured water
distribution pipes with a cement lining that can leach aluminum to very
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high levels under certain conditions.6 A cement composition that appeared
to be different from those recommended in the United States8-11,29 or in The
Netherlands, where the applicator has to prove the appropriateness of the
pipe, when other types than those recommended, are applied.12 A local
water distribution company that used this pipe in an area with a low water
flow enhancing the built-up of aluminum.6
A local water company producing water with an unusually low calcium
carbonate content (25-40 mg/L), favoring the deterioration of cement-
lined water pipes.1 In comparison, in a number of European countries (for
example The Netherlands,30 Germany, Denmark, and some parts of
France) the authorities require that drinking water should be high in calcium
carbonate (above 60-80 mg/L)3 to reduce corrosion or deterioration of
cement linings especially with regard to metal release.30
Absence of legislation requiring standardized drinking water quality. The
WHO has no health-based guideline value for aluminum but recommends
a level below 200 µg/L,31 which is much lower that the highest value of
690 mg/L reported in this case.6 The European Union applies a resolution
that defines a maximum aluminum level of 30 µg/L for water, used for
hemodialysis and emphasizes that the drinking water companies should
warn the health authorities if the aluminum level in drinking water exceeds
this level. In addition, the resolution states that "The authorities responsible
for water distribution and hemodialysis shall inform all dialysis units, if
possible in advance, of any important change in the treatment of water
which might increase the aluminum level in the water distributed, and also
of any accidental pollution of the water distributed".32 These regulations,
however, are intended for cases where aluminum salts are used to prepare
drinking water and are not intended as a risk warning of the use of cement
linings in drinking water distribution. 
Diatel did not make use of a water purification system, which would
probably have reduced the mortality rate. 
The physicians in charge of Diatel nor the water utility companies realized
that the water quality could change dramatically after a change in water
distribution.  As a consequence the physicians did not see the need for a
sophisticated water treatment device. In addition to this, routine water
quality tests had been performed infrequently. However, because Diatel
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was closed soon after the patients became symptomatic and because it takes 6-
8 weeks before these test results are available. And finally, because the water dis-
tribution pipe was flushed after installation, the aluminum concentration would
have been low at that time. It remains therefore unlikely that more frequent
water tests would have prevented serious intoxication of the patients.
From these events it is clear that although the quality of the water
delivered by a factory may be constant, it can inadvertently change and in the
case of a hemodialysis unit, the physician in charge will be held responsible for
the consequences. 
The patients
New observations on aluminum intoxication and new therapeutic
insights were obtained in relation to this tragic incident. The early stages of the
aluminum intoxication passed by unnoticed for weeks since the patients had
minimal (or no) symptoms, because it takes time and a certain cumulative
amount of toxicant to produce symptoms. In spite of the fact that patients were
transferred to the dialysis facility of the hospital, some patients that had been
symptom-free developed severe neurological symptoms such as convulsions and
coma. Medical textbooks lacked specific information for use in elucidating the
source of the complaints. In addition, no information could be obtained from
the water utilities, as they were also unaware of the toxicological properties of
the water distribution system. The lack of laboratories on Curaçao that could
determine aluminum levels further delayed adequate diagnosis and therapy. 
Due to logistic limitations, detoxification treatment could not be initiated
in Curaçao and the survivors had to be transferred to The Netherlands. A new
treatment protocol had to be developed because data on these severe intoxications
were very limited. Fortunately, the seventeen patients could be treated successfully
and all these patients returned to Diatel for dialysis treatment. 
The judicial system
The court system in general is particularly dependent on specific expertise
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in science and medicine.33-35 The preliminary judicial inquiry as part of the
prosecution was also influenced by the limitations confronted on a small island.
Court appointed expert witnesses had to be attained from other countries
whereas these experts lacked the necessary perspective of community clinical
reality. It is unjustified however, that courts assume that medical professionals
always disclose reliable knowledge when the expert is court-appointed and not
at the request of the defense. Some expert witnesses make statements that would
not hold firm in a scientific forum, especially when they lack the necessary
knowledge of certain facts, the practical applications of which solely confined to
the purposes of jurisprudence, and are therefore entirely overlooked in the usual
routine of medical study.35 Therefore, the increasing presence of scientific and
technical matters in civil and criminal litigation implicates that the legal system
should find ways to assure the best science available in order to make rational
decisions. Guidelines should be enacted to ensure the quality of expert witness
testimony, which should include analysis of common local practice and technical
possibilities.
The defendant
For the medical practitioner, prosecution for the death of patients is one
of the most distressing experiences in his medical career, not only because the
judicial process may last several years, but primarily because it touches upon the
foundation of medical ethics. 
Most physicians are unacquainted with the intricacies of judicial inquiry
and few physicians involve themselves in the preparation of their cases.35 Even in
areas where the law is difficult to comprehend, a proper understanding of the
litigation process can make the stressful experience more bearable. Health care
practitioners should therefore understand how trials are conducted and be
acquainted with the basic standards for the admission of evidence. The only
thing an accused can do is to try and understand this process, in order to reduce
the anxiety that comes from the sometimes seemingly random course of the
prosecution and ruling by the judges. Moreover, the defendant should become
an active participant in the preparation of the case, ensuring that his interests
are properly protected. At a trial he should have more knowledge about the case
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than the experts. It has the added benefit of reducing the psychological burden
of standing by helplessly, while the verdict unfolds.
In conclusion, it should be evident that although sophisticated medical
treatment like hemodialysis is technically feasible and qualified physicians
available, introduction of innovative medical techniques in small communities
should only take place after a thorough analysis and implementation of
necessary legislation and protocols for all parties involved. People in charge of
medical facilities on small islands or similar communities should also be aware
that for quality assurance they have to be knowledgeable of many more factors
than is the case in many large developed countries where one can rely on
regulations and laws that protect patients. The water distribution industry
should be aware that cemented water distribution pipes may have toxic properties.
Guidelines should be enacted to ensure the quality of expert witness testimony,
which should include analysis of common local practice and technical
possibilities.
191
Summar y and conc luding remarks
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:02  Pagina 167
192
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:02  Pagina 168
Samenvatting en slotwoord
C H A P T E R  V I I I
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:02  Pagina 169
Hoofdstuk 1 biedt een introductie met algemene informatie over
aluminiumtoxiciteit en over een epidemie van subacute aluminiumintoxicatie
in een dialysekliniek met daaraan gerelateerde waterleidingkundige aspecten
alsmede forensische en juridische consequenties.  
Waterkwaliteit en de cementlaag in de drinkwaterleiding
Hoofdstuk II beschrijft de gevolgen van het gebruik van drinkwater-
buizen met een binnenlaag van cement, op de aluminiumconcentratie in het
kraanwater. Op Curaçao wordt drinkwater bereid door distillatie van zeewater,
waarna in de waterfabriek o.a. calciumcarbonaat (CaCO3) wordt toegevoegd,
om metalen drinkwaterbuizen tegen interne corrosie te beschermen. Aan het
begin van de jaren 90 was de calciumcarbonaat concentratie laag (25-40 mg/L1;
streefwaarde > 50 mg/L2), hetgeen een van de belangrijkste oorzaken van
corrosie van metalen drinkwaterbuizen was.1,3-11 Het drinkwaterdistributiebedrijf
omzeilde dit probleem door andere buizen met een binnenlaag van cement
aan te schaffen en deze buizen (met een totale lengte van 2,2 km) zijn bij
Diatel geïnstalleerd om Diatel te helpen met problemen van lage waterdruk.1
Cement is echter niet inert en bestanddelen (waaronder calcium en aluminium)
kunnen in contact met water in oplossing gaan en vooral als het calcium-
carbonaat gehalte van het water laag is ("zacht water"), omdat er dan geen
beschermend kalklaagje op de cementbekleding gevormd kan worden.1,3-11
Aluminium is langdurig uit deze laag blijven uitlogen en heeft het water
wat in het dialysecentrum Diatel voor dialyse werd gebruikt vervuild.1,5-9 De
aluminiumconcentratie steeg daarbij van minder dan 5 µg/L (ter plaatse van de
waterfabriek) tot tenminste 550 µg/L à 690 µg/L (bij Diatel, ten tijde dat
de drinkwaterbuis ruim twee maanden in gebruik was). Deze waarden
waren de hoogste aluminiumconcentratie die op het eiland gemeten zijn.1
Factoren die vermoedelijk hebben bijgedragen tot deze uitzonderlijk hoge
waarden zijn a) het in gebruik nemen van een nieuwe drinkwaterbuis, b)
de agressiviteit van het drinkwater, c) de lage zuurgraad en d) de hoge
temperatuur van het water, e) de cementsamenstelling met een viermaal
hoger aluminiumgehalte dan gebruikelijk,1,5 f ) de trage doorstroomsnelheid
van het water en g) mogelijk ook het gebruik van de corrosieremmer
polyfosfaat die cementlagen kan aantasten.1,6
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In 1996 heeft het Keuringsinstituut voor Waterleiding Artikelen
(KIWA) na de tragedie in Diatel onderzocht of het uitlogen van aluminium uit
cementlagen van drinkwaterbuizen ook in Nederland een probleem was.
Monsters werden genomen op 20 locaties waar buizen met een binnenbekleding
van cement of asbestcement werden gebruikt. De locaties die werden onder-
zocht waren die, welke risicovol zijn voor het uitlogen van aluminium, t.w. die
met "zacht" water, een lage doorstroomsnelheid van het water en het gebruik
van drinkwaterbuizen met een kleine diameter die slechts kort in gebruik waren.
De aluminiumwaarden in het kraanwater stegen in deze situaties tot maximaal
11 µg/L.5 In Nederland worden vermoedelijk andere cementbuizen toegepast
dan in het onderhavige geval. Geconcludeerd kan worden dat niet alle cement-
samenstellingen geschikt zijn voor gebruik in de drinkwaterindustrie.
Fabrikanten moeten daarom de toepasbaarheid in verschillende situaties aantonen
indien afgeweken wordt van de gebruikelijke cementsoorten.12
Aluminium
In hoofdstuk III wordt een epidemie van subacute aluminiu-
mencephalopathie beschreven bij patiënten van het dialysecentrum Diatel
Curaçao. In 1996 werden 27 hemodialyse patiënten blootgesteld aan een
contaminatie van het dialysaat met calcium en aluminium. In eerste instantie
vertoonden 7 patiënten na enkele weken symptomen van het 'hard water
syndroom' met misselijkheid, braken en hypercalciaemie na dialyse. De
hypercalciaemie verdween na behandeling met calciumarm dialysaat en het
onthouden van de onderhoudsmedicatie van calcium en vitamine D sup-
plementen. Desondanks ontwikkelden een aantal patiënten  microcytaire
anemie, sepsis, epileptische insulten en coma. Van de 27 patiënten die evenredig
waren blootgesteld (ongeveer 60 uur) aan het gecontamineerde dialysaat,
overleden er 10 aan subacute aluminiumencephalopathie, terwijl 17 patiënten
geringe symptomen hadden en het hebben overleefd. Serumconcentraties van
aluminium werden bepaald bij zeven overleden patiënten. Deze waren
significant hoger dan bij de overlevenden (808 + 127 vs. 255 + 25 µg/L, P < 0.01).
We constateerden dat vergelijkbare parenterale blootstelling aan aluminium
vooral een ernstiger intoxicatie veroorzaakt bij oudere patiënten met een slechte
voedingstoestand, een relatief laag lichaamsgewicht en/of een geringe restdiurese.
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De vastgestelde hypercalciaemie werd in geringe mate medeveroorzaakt door de
aluminiumintoxicatie.13,14 Aangezien er altijd een latente fase van dagen tot
weken zal zijn voordat de encephalopathie kan optreden, kunnen we stellen dat
"acute" aluminium encepahlopathie –te weten het optreden van neurotoxische
symptomen binnen enkele uren- als zodanig niet bestaat.14
In hoofdstuk IV worden post-mortem toxicologische bevindingen van
subacute aluminiumencephalopathie beschreven bij vier patiënten in het kader
van een strafrechtelijk onderzoek. Aluminiumgehalte in lever, bot en hersen-
schors waren significant verhoogd in vergelijking tot normale waarden. De hoge
concentraties van aluminium die in deze studie werden gevonden in lever en
botten impliceert dat deze organen als opslagplaats kunnen fungeren om de
hersenen te beschermen. De significant hoge concentratie van aluminium die
werd gevonden in hippocampus en occipito-parietale cortex van de hersenen,
maakt duidelijk dat de opslagcapaciteit van lever en botten werd over-
schreden.14,15 Aluminiumintoxicatie was derhalve de meest waarschijnlijke
doodsoorzaak bij deze patiënten. 
Hoofdstuk V geeft een overzicht van de literatuur aangaande symptomen,
bronnen van aluminiumintoxicatie en pathogenetische mechanismen van
aluminiumintoxicatie. Tevens wordt een therapieschema voor de behandeling
van hemodialysepatiënten met aluminiumintoxicatie beschreven.14
Er is een grote variatie in klinische manifestatie en mate van expressie
bij aluminiumintoxicatie. De meest markante verschijnselen zijn de effecten op
hersenen, botten en rode bloedcellen.13-17 Er zijn tal van publicaties betreffende
aluminiumintoxicaties in het algemeen, maar er is weinig bekend over de
(sub)acute aluminiumencephalopathie. Uit praktische overwegingen
wordt meestal onderscheid gemaakt tussen twee vormen, t.w. "chronische"
aluminiumencephalopathie en "acute" (of subacute) aluminiumencephalopathie.
Dit onderscheid heeft betrekking op de duur van de incubatietijd alvorens
symptomen optreden. Indien de (parenterale) blootstelling relatief laag is,
treden symptomen van aluminiumencephalopathie op zijn vroegst op na
maanden tot jaren ("chronisch"), terwijl bij extreem hoge blootstelling
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deze symptomen na weken ("subacuut") kunnen optreden. Aangezien er
altijd een latente fase van dagen tot weken is voordat de symptomen van
encephalopathie manifest worden, kunnen we stellen dat "acute" encephalopathie
–oftewel het optreden van neurotoxische symptomen binnen enkele uren-, als
zodanig niet bestaat. Bij zowel subacute als chronische aluminiumintoxicatie
worden microcytaire anemie13-17 en EEG veranderingen13,14 gezien, die soms
voorafgaan aan de klachten.17,18 De meest ernstige symptomen bij beide vormen
van aluminiumencephalopathie zijn epileptische insulten, coma en myoclonieën
van de extremiteiten. Het lijkt aannemelijk dat sommige manifestaties van
chronische aluminiumencephalopathie "gebypassed" worden bij acute
aluminiumencephalopathie, mogelijk doordat de opslagcapaciteit van lever,
milt en botten wordt overschreden. Daardoor worden spraakstoornissen niet
gezien bij subacute aluminiumencephalopathie, terwijl deze (samen met bot-
breuken) juist een belangrijke symptoom zijn bij de chronische vorm.14,20,21 Het
blijkt dat bij subacute aluminiumencephalopathie de neurologische symptomen
zelfs dagen tot weken na beëindiging van de blootstelling kunnen optreden.
Vermoedelijk bereikt de hersenpathologie op een gegeven moment een punt
waarbij er geen weg terug is en o.a. frequente epileptische insulten zullen leiden
tot coma en het overlijden van de patiënt.13-15
Therapie van aluminiumintoxicatie. Aangezien aluminiumintoxicaties
te voorkomen zijn, moet er alles aan gedaan worden om de iatrogene blootstelling
te minimaliseren. Tot op heden is desferrioxamine (DFO) het enige middel voor
de behandeling van aluminiumintoxicaties. Sinds 1963 wordt DFO toegepast
bij de ijzer chelatie therapie bij patiënten met hemosiderose22 en vanaf 1980
wordt het tevens toegepast bij de diagnose en therapie van aluminiumintoxicaties.23
Dit middel heeft echter vooral in dit laatste geval een aantal ernstige bijwerkingen,
zoals bijvoorbeeld een exacerbatie van encephalopathie.22 De optimale dosis
voor de veelal langdurige behandeling met DFO bij dialyse patiënten met
ernstige aluminiumintoxicatie is onbekend, zodat wij een behandelingsschema
hebben moeten ontwikkelen. Bij dit schema worden risico’s zoveel mogelijk
vermeden en het blijkt dat DFO veilig tweemaal per week te weten vijf uur voor
aanvang van de zgn. "high flux" dialysebehandelingen kan worden toegediend
in een dosis van 5 mg/kg bij ernstige aluminiumintoxicaties (aluminiumwaarden
van 300-500 µg/L). Als de serumaluminiumwaarden onder de 300 µg/L zijn
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kan DFO in dezelfde dosis worden toegediend maar dan in het laatste uur van
de dialysesessie, bij voorkeur aan het begin van de week. De behandelingsduur
is vooral gerelateerd aan de urine-uitscheiding aangezien patiënten met een
urineproductie van een liter of meer per dag in circa twee maanden uitbehandeld
zijn, terwijl sommige patiënten met anurie  bijna 2 jaar behandeling nodig
hebben.14
Forensische aspecten
In hoofdstuk VI, worden de juridische implicaties van de subacute
aluminiumintoxicatie beschreven. Bij de opening van Diatel in 1992, was het
gebruikelijk op Curaçao om kraanwater, zonder verdere waterzuivering, te
gebruiken voor hemodialyse. Sinds de jaren negentig maken de meeste
dialysecentra elders gebruik van een waterzuiveringsinstallatie met reverse
osmosis membranen. In normale omstandigheden kunnen deze installaties tot
99% van de hoeveelheid aluminium uit het kraanwater verwijderen, maar
in specifieke omstandigheden kan dit veel minder zijn waardoor patiënten
onvoldoende beschermd worden.24,25 Voor de aansluiting van een nieuwe drink-
waterbuis op het drinkwaternetwerk bij Diatel was er een korte onderbreking
van de drinkwatervoorziening. Aanvankelijk werden er geen bijzonderheden opge-
merkt, terwijl de volgende twee dagen, intermitterend, gedurende enkele secon-
den tot minuten, extra alarmsignalen bij de dialysemachines afgingen.
Retrospectief waren deze alarmen vermoedelijk het gevolg van technische
problemen, zoals bijvoorbeeld de aanwezigheid van luchtbellen in de
drinkwatervoorziening.26
In september 1996 werd een strafrechtelijk onderzoek gestart, om na te
gaan of er strafbare feiten waren gepleegd door het drinkwaterproductie- of dis-
tributiebedrijf, of door de medische staf of het bestuur van het dialysecentrum.
Na een uitgebreid onderzoek met de hulp van het openbaar ministerie in
Nederland, drinkwaterexperts van Nederland en de Pan American Health
Organization besloot de officier van justitie de zaak te seponeren. De nabe-
staanden gingen echter in beroep tegen deze beslissing en in hoger beroep werd
besloten het strafrechtelijk onderzoek te heropenen. De drinkwaterbedrijven en
de bestuursleden van Diatel werden evenwel niet strafrechtelijk vervolgd omdat
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de wet, die het jaar daarop werd gewijzigd,27 geen mogelijkheid bood om
bestuursleden van stichtingen strafrechtelijk te vervolgen.28 Na een gerechtelijk
vooronderzoek heeft de officier van justitie vastgesteld, dat het niet strafrechtelijk
verwijtbaar was om dialysebehandelingen zonder een waterzuiveringsinstallatie
uit te voeren. In de tenlastelegging werden de twee artsen van Diatel schuldig
geacht aan de dood van ten minste acht van de tien patiënten wegens het niet
analyseren van het kraanwater na de onderbreking van de drinkwatervoorziening
of gedurende de twee dagen dat er extra alarmeringen waren bij de dialysemachines.
Er werd een voorwaardelijke gevangenisstraf van zes maanden geëist. Alhoewel
het geen onderdeel van de dagvaarding was, oordeelde de rechter in eerste
aanleg dat het dialyseren zonder een waterzuiveringsinstallatie strafrechtelijk
verwijtbaar was en werd de medische directeur veroordeeld tot de maximale
boete van 10,000 Antilliaanse gulden (ca. 6500 US dollars). De andere arts
werd vrijgesproken omdat hij niet betrokken was bij de aanschaf van de
waterzuiveringsinstallatie. In hoger beroep werden de artsen vrijgesproken
aangezien de waterzuiveringsinstallatie geen element was van de dagvaarding en
de rechters het eens waren met de overige beslissingen van de rechter in eerste
aanleg.26
De getuige-deskundigen speelden een belangrijke rol in het juridische
proces. De wijze waarop het gerechtelijk vooronderzoek plaatsvond verhoogde
het risico van fouten in verklaringen. Ten eerste werden deze verklaringen
afgenomen achter gesloten deuren, zonder dat de verdachten (of een deskundige in
hun naam) waren uitgenodigd. Het is dan moeilijk om bij een verhoor onder
dergelijke omstandigheden subjectieve interpretaties te vermijden; vooral ook
omdat het geen vereiste was om verklaringen te ondersteunen met "peer-reviewed"
publicaties. Ten tweede hadden deze getuige-deskundigen geen ervaring in het
geven van verklaringen in juridische zaken, zodat ze onder stressvolle
omstandigheden eerder geneigd zouden kunnen zijn om minder goed
onderbouwde verklaringen af te leggen. Ten derde bleek het nodig om
deskundigen uit andere landen te horen omdat de vereiste "know-how" lokaal
niet aanwezig was. Deze "superspecialisten" uit andere landen missen echter
kennis over lokale omstandigheden en technische mogelijkheden. Tenslotte
zijn deskundigenverklaringen in dit soort situaties enkel en alleen bedoeld
om strafrechtelijk bewijs te vergaren; dit is een andere insteek dan de gebruike-
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lijke toepassing van hun vakkennis.26 Daarom moeten niet alleen richtlijnen
worden opgesteld die de onafhankelijkheid van de deskundigen zoveel mogelijk
garanderen, maar tevens richtlijnen voor de wetenschappelijke kwaliteit van
hun verklaringen. 
Slotwoord
De intoxicatie
Na een ogenschijnlijk onbelangrijke onderbreking van de watertoevoer
steeg de aluminiumconcentratie in de watertoevoer naar het dialysecentrum
Diatel onverwachts meer dan veertigmaal.  Hierdoor overleden tien nierpatiënten,
trad de minister van Volksgezondheid af en volgde een strafrechtelijk onderzoek
tegen de twee artsen van Diatel. Calamiteiten ontstaan in het algemeen alleen
als meerdere onderdelen van een veiligheidsketen tegelijk deficiënt zijn; dat was
ook hier het geval. Personen die verantwoordelijk zijn voor dialysefaciliteiten
en ook degenen die dat zijn voor drinkwaterbedrijven op Curaçao, worden
geconfronteerd met diverse beperkingen en problemen die gerelateerd zijn aan
een klein eiland; specifieke wetten en regelgeving kunnen dit soort incidenten
voorkomen. Alhoewel hemodialyse met kraanwater in het verleden in veel
landen werd toegepast, is dit het eerste geval waarbij een intoxicatie het gevolg
was van het afgeven van stoffen uit een drinkwaterbuis.6 In veel landen wordt gebruik
gemaakt van cementlagen als binnenbekleding van ijzeren drinkwaterbuizen
om deze te beschermen tegen corrosie, maar het is zeer ongebruikelijk dat deze
cementlagen aluminium tot zeer hoge concentraties kunnen afgeven. Deze
aluminiumintoxicatie was een tragische samenloop van omstandigheden:
De drinkwaterdistributie-industrie, die een drinkwaterbuis produceerde
met een binnenlaag van cement die in staat was de aluminiumconcentratie
in het water tot zeer hoge concentraties te laten stijgen onder bepaalde
omstandigheden.6 Een cementsamenstelling die afweek van de richtlijnen
in bijvoorbeeld de Verenigde Staten8-11,29 en in Nederland. In Nederland
moet de applicator de geschiktheid aantonen als afgeweken wordt van de
standaard cementtypen.12 Een drinkwaterdistributiemaatschappij die zulk
een drinkwaterbuis toepast in een gebied met een lage doorstroomsnelheid
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van het drinkwater, waardoor er ongebruikelijk hoge concentraties van
uitgeloogde stoffen kunnen ontstaan.6
Een lokale waterfabriek die water produceerde met een ongebruikelijk lage
concentratie van calciumcarbonaat (25-40 mg/L) waardoor de cementlaag
van de buis langdurig kon worden aangetast.1 In een aantal Europese landen
(bijvoorbeeld Nederland,30 Duitsland, Denemarken en sommige delen van
Frankrijk) eist de overheid dat drinkwater een hogere concentratie van
calciumcarbonaat (boven de 60-80 mg/L)3 moet hebben om corrosie van
drinkwaterbuizen met de kans op het uitlogen van metalen tegen te gaan.30
Het ontbreken van wetgeving aangaande de drinkwaterkwaliteit, zoals dat
in veel landen wel via de wet geregeld is. De WHO (World Health
Organization) geeft geen richtlijn voor aluminium aan in drinkwater ten
aanzien van de volksgezondheid, maar adviseert wel om de concentratie
beneden de 200 µg/L31 te houden, hetgeen veel lager is dan de hoogst
gemeten waarde van 690 µg/L in het onderhavige geval.6 De Europese
Gemeenschap heeft een resolutie aangenomen die aangeeft dat indien de
maximale aluminiumconcentratie in het drinkwater de grens van 30 µg/L
overschrijdt, de drinkwaterautoriteiten medische instellingen dienen te
waarschuwen. Ook stelt de resolutie dat de autoriteiten die verantwoordelijk
zijn voor de drinkwaterdistributie alle dialyseafdelingen, bij voorkeur van
tevoren, moeten waarschuwen bij elke belangrijke verandering in de drink-
waterproductie die in staat is het aluminium gehalte in het drinkwater te
verhogen en tevens bij elke accidentele vervuiling van het gedistribueerde
water met aluminium.32 Deze bepalingen zijn overigens bedoeld voor die
gevallen waar aluminiumzouten gebruikt worden bij de drinkwaterbereiding
en niet zozeer om te waarschuwen voor risico’s die inherent zijn aan het
uitlogen van aluminium uit cementbekledingen van drinkwaterbuizen. 
Diatel maakte geen gebruik van een waterzuiveringsinstallatie, die op zijn
minst de mortaliteit zou hebben verminderd. 
Noch de artsen, noch de drinkwaterbedrijven hebben zich gerealiseerd
dat de waterkwaliteit in die mate kon verslechteren na de korte
wateronderbreking voor de installatie van de nieuwe drinkwaterbuis.
Dientengevolge hebben de artsen geen noodzaak gezien om een water-
behandelingsinstallatie te plaatsen. Bij Diatel werden er sporadisch routine-
waterkwaliteitstesten gedaan. Het lijkt echter niet waarschijnlijk dat deze
201
Samenvatt ing  en s lo twoord
2. 
3. 
4. 
5.
Hoofdstuk 2-9  vanaf pag 24  10-09-2003  17:02  Pagina 177
testen een ernstige intoxicatie bij de patiënten zou hebben voorkomen,
aangezien Diatel kort nadat de patiënten symptomatisch werden, werd
gesloten en het bovendien minstens 6-8 weken zou duren voordat deze
bepalingen beschikbaar zouden zijn. Tenslotte is de buis na installatie
doorgespoeld  zodat de aluminiumconcentratie bij het testen laag zou zijn.
Dit incident maakt duidelijk dat een constante kwaliteit van het water
als dit de drinkwaterfabriek verlaat, geen garanties geeft voor het distributienetwerk:
de drinkwaterkwaliteit kan in korte tijd veranderen, waarbij in het geval van
dialyseafdelingen, de behandelende artsen verantwoordelijk kunnen worden
gehouden voor de gevolgen. 
De patiënten 
Aangaande aluminiumintoxicaties zijn er nieuwe bevindingen gedaan
en werden met deze studie nieuwe therapeutische inzichten verkregen. De
vroege stadia van een subacute aluminiumintoxicatie kunnen enkele weken
ongemerkt blijven aangezien patiënten dan minimale symptomen vertonen; er
is tijd nodig voordat neurotoxische effecten kunnen manifesteren. Ondanks het
feit dat de patiënten overgeplaatst waren naar de dialysefaciliteit van het
ziekenhuis en zij niet meer blootgesteld werden aan parenteraal aluminium
kregen sommige patiënten die tot op dat moment nagenoeg klachtenvrij waren,
ernstige neurologische symptomen. Uit medische handboeken kon onvoldoende
informatie verkregen worden om de bron van de klachten te achterhalen.
Bovendien kon er geen informatie verkregen worden van de locale drinkwater-
autoriteiten, aangezien deze zich evenmin bewust waren van de toxicologische
aspecten van hun drinkwaterdistributie. Het niet aanwezig zijn van laboratoria
op Curaçao die in staat waren om op adequate wijze aluminiumbepalingen te
verrichten, veroorzaakte een verdere vertraging van de diagnose en de therapie. 
Om logistieke redenen kon de behandeling van de aluminiumintoxicatie
in eerste instantie niet op Curaçao plaatsvinden en moesten de patiënten naar
Nederland worden overgeplaatst. Een nieuw therapieprotocol moest worden
ontwikkeld aangezien de literatuur onvoldoende praktische behandelingsmoge-
lijkheden bood. De zeventien patiënten die de intoxicatie hebben overleefd
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konden succesvol behandeld worden en al deze patiënten keerden terug voor
dialysebehandeling in Diatel. 
Het juridische proces 
Rechtbanken zijn in hoge mate afhankelijk van specifieke expertise
indien medische aspecten moeten worden geëvalueerd.33-35 Zoals dat voor
bovengenoemde aspecten van de intoxicatie gold, werd was het gerechtelijk
vooronderzoek als onderdeel van het strafrechtelijk proces beïnvloed door
de beperkingen van een klein eiland. Voor een grondige evaluatie waren
getuige-deskundigen uit het buitenland nodig. Deze laatsten ontbrak de
kennis met betrekking tot lokale omstandigheden.  Uit deze zaak blijkt dat
rechtbanken er niet zondermeer vanuit kunnen gaan dat hoog gekwalificeerde
deskundigen, die als onafhankelijke deskundigen zijn aangetrokken door
de rechtbank, altijd betrouwbare getuigenverklaringen zullen afgeven.
Aangezien technische aspecten aan de orde kunnen komen die enkel en
alleen van belang zijn voor de jurisprudentie en derhalve niet altijd onder-
bouwd hoeven te zijn met gegevens uit de specifieke medische vakliteratuur,
kunnen deskundigen verklaringen afleggen die geen stand zouden houden
in een wetenschappelijk forum.35 Door een toenemende vertechnisering
van de geneeskunde zullen rechtbanken in toenemende mate afhankelijk
worden van specifieke wetenschappelijke kennis in civiele en strafrechtelijke
zaken. Om een rationeel oordeel te kunnen vormen moet het juridische
systeem oplossingen vinden om betrouwbaar gebruik te kunnen maken
van wetenschappers. Er dienen richtlijnen opgesteld te worden die in
wetenschappelijke zin de kwaliteit van getuige-deskundigen garanderen en
in kleine gemeenschappen moeten deze tevens een analyse omvatten
aangaande de lokale technische mogelijkheden.
De verdachte
Voor een medicus is de strafrechtelijke vervolging voor de dood van patiënten
een van de meest ingrijpende ervaringen in zijn medische carrière. Dit niet
alleen omdat het proces vele jaren duurt, maar vooral ook omdat het ingrijpt in
de fundamenten van de medische ethiek. 
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De meeste artsen en gezondheidswerkers zijn onervaren in juridische
aangelegenheden en bij aanklachten tegen hun persoon blijken zij zich vaak
onvoldoende bezig te houden met de voorbereiding van hun zaak.35 Ook al is
het moeilijk om vanuit een medisch standpunt het juridische proces goed
te begrijpen, het blijft wenselijk dat artsen zich actief opstellen, zich in de
materie verdiepen en op de hoogte te raken van de wijze waarop men in een
gerechtelijk onderzoek met bewijsmateriaal omgaat. Dit kan als bijkomend
voordeel hebben dat de stress die een dergelijke zaak oplevert beter gehanteerd
kan worden.
Concluderend kunnen wij stellen, dat zelfs indien hoogtechnologische
medische behandelingen zoals hemodialyse technisch mogelijk zijn en er
gekwalificeerde medici ter beschikking staan, de introductie van deze
technieken in kleine gemeenschappen pas dient plaats te vinden na een
grondige analyse en implementatie van de relevante wetgeving en protocollen.
Het creëren van kwaliteitsgaranties stelt speciale eisen aan degenen die
verantwoordelijkheid dragen voor de medische zorg in kleinschalige
gemeenschappen. Het feit dat op een eiland met beperkte mogelijkheden
protocollen uit landen met hoog ontwikkelde technologie niet zomaar kunnen
worden overgenomen, impliceert dat het scheppen van nieuwe kaders voor
medisch handelen gepaard moet gaan met een uitvoerige, lokaal relevante
studie. Dit heeft hier een hogere prioriteit dan in de zogenaamde eerste
wereldlanden waar de patiënten veelal beschermd worden door een reeds
bestaand veiligheidsnet van wetten en voorschriften. De drinkwaterindustrie
moet rekening houden met het feit dat drinkwaterbuizen met een bekledende
binnenlaag van cement toxische eigenschappen kunnen hebben. Richtlijnen
moeten worden opgesteld die de kwaliteit van de getuigenverklaringen van
deskundigen zoveel mogelijk garanderen. 
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In dit proefschrift wordt achtereenvolgens beschreven: 
een incident van subacute aluminiumintoxicatie bij nierpatiënten, alsmede
nieuwe medische inzichten in aluminium-toxiciteit, 
de oorzaken van het incident, in relatie met waterleidingkundige aspecten en 
de juridische gevolgen hiervan.
Na de inleiding in deze problematiek (hoofdstuk I) wordt in hoofdstuk II
de aspecten van de drinkwaterdistributie beschreven die de basis vormt van deze
intoxicatie.
Het aantal nierpatiënten op Curaçao is de laatste jaren sterk toegenomen
omdat de incidentie van de belangrijkste oorzaken van nierproblemen, te weten
suikerziekte en hoge bloeddruk sterk is toegenomen. Als de nieren niet meer
functioneren  kan met behulp van "hemodialyse" het zuiveren van het bloed
gedeeltelijk door machines worden overgenomen. Met behulp van de
Nierstichting Nederland en Diatel Amsterdam is in 1992 het dialysecentrum
Diatel Curaçao geopend. Bij hemodialysebehandelingen wordt veel water
gebruikt. Aangezien er problemen waren met lage waterdruk heeft het drink-
waterdistributiebedrijf in mei 1996 een nieuwe drinkwaterbuis geïnstalleerd.
Enkele weken later ontwikkelden 7 van de 27 patiënten klachten van misselijkheid
en braken, waarbij een verhoogd calcium in hun bloed werd vastgesteld.
Aanvankelijk werd verondersteld dat het enige dat de klachten van de
dialysepatiënten had veroorzaakt een hoger calcium van het leidingwater was,
waarna Diatel werd gesloten en de patiënten overgeplaatst. Desondanks werden
na een kortdurend herstel tien patiënten binnen enkele weken ernstig ziek en
overleden zij na epileptische insulten en coma. Uit onderzoek bleek dat er zowel
calcium als aluminium uit de cementen binnenbekleding van de drinkwaterbuis
was vrijgekomen. Deze buizen werden toegepast omdat de oorspronkelijke,
metalen, drinkwaterbuizen snel corrodeerden door het relatief kalkarme
gedestilleerde drinkwater; de cementlaag aan de binnenkant van de buizen zou
deze corrosie moeten voorkómen. De cementlaag bleek evenwel een viermaal
hoger aluminiumgehalte dan gebruikelijk te hebben en was bovendien niet
bestand tegen bovengenoemde eigenschappen van het drinkwater. Achteraf
gezien blijkt aluminium jarenlang uit de cementlaag uit te kunnen logen waarbij
de concentratie in het drinkwater maandenlang boven de streefwaarde van de
World Health Organization kan komen; derhalve dient deze cementsoort niet
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toegepast te worden bij drinkwaterbuizen. 
In hoofdstuk III worden de klinische bevindingen beschreven van
subacute aluminiumintoxicatie bij de onderhavige patiëntengroep. De overleden
patiënten waren gemiddeld ouder, minder goed doorvoed en hadden een lagere
urineproductie dan de zeventien patiënten die het overleefd hebben.
Het postmortem onderzoek van vier patiënten wordt weergegeven in
hoofdstuk IV. Aluminiumgehalte in lever, bot en hersenschors was significant
verhoogd in vergelijking tot normale waarden, wat duidelijk maakt dat de
normale opslagcapaciteit van lever en botten werd overschreden.
Hoofdstuk V geeft een overzicht van de literatuur aangaande symptomen,
bronnen van aluminiumintoxicatie en pathogenetische mechanismen van
aluminiumintoxicaties. Tevens wordt een therapieschema voor de behandeling
van hemodialysepatiënten met aluminiumintoxicatie met het medicament
desferrioxamine beschreven, waarmee zeventien patiënten succesvol werden
behandeld. 
In hoofdstuk VI worden de juridische implicaties van het incident
beschreven. Het openbaar ministerie voerde een strafrechtelijk onderzoek uit en
concludeerde aanvankelijk dat er geen strafbare feiten waren gepleegd en dat de
patiënten waren overleden als gevolg van een uitzonderlijke samenloop van
omstandigheden. De nabestaanden gingen in beroep tegen deze beslissing en na
een gerechtelijk vooronderzoek in Curaçao, Nederland en België werden de
twee artsen van Diatel door het openbaar ministerie gedagvaard.  Enkele patiënten
eisten tevens vervolging van de drinkwaterinstanties, maar hun eis werd niet
ontvankelijk verklaard omdat het volgens de toen geldende wet niet mogelijk
was rechtspersonen strafrechtelijk te vervolgen. In de dagvaarding werden de
artsen verantwoordelijk geacht voor het overlijden van de patiënten, omdat
er na het plaatsen van de drinkwaterbuis onvoldoende op alarmeringen van
dialysemachines zou zijn gereageerd en het water niet was getest in die periode.
Het openbaar ministerie was namelijk van mening dat de toegenomen
frequentie van alarmeringen het gevolg zou zijn van een hoge concentratie
aluminium in het dialysewater. De rechter oordeelde evenwel dat dit niet
mogelijk kon zijn, noch dat het testen van het water het overlijden van de
patiënten met zekerheid had kunnen voorkomen. Alhoewel het geen element van
de dagvaarding was, veroordeelde de rechter de medisch directeur voor het
niet-installeren van een waterzuiveringsinstallatie bij Diatel en legde een
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geldelijke boete en een voorwaardelijke gevangenisstraf op. In hoger beroep
werd de arts vrijgesproken. 
Concluderend kunnen wij stellen dat zelfs indien op kleine eilanden
hoogtechnologische medische behandelingen zoals hemodialyse technisch
mogelijk zijn, de introductie en implementatie van deze technieken alleen plaats
dient te vinden na een grondige analyse en implementatie van de relevante wet-
geving en protocollen. 
Den e disertashon akí ta deskribí supsiguientemente:
un kaso di intoksikashon sup-agudo di aluminio serka algun pashènt di
nir, ademas ideanan médiko nobo riba toksisidat di aluminio,
loke a kousa e intoksikashon, en relashon ku aspektonan di awa di pipa, i
konsekuenshanan hurídiko di un ke otro.
Despues di un introdukshon den e problemátika akí (kapítulo 1) ta deskribí na
kapítulo 2 e aspektonan di distribushon di awa di bebe ku a forma base di e
intoksikashon en kuestion.
Último añanan e kantidat di pashènt di nir a oumentá konsiderablemente na
Kòrsou, komo e prinsipal kousanan di problema di nir, esta malu di suku i
preshon haltu di sanger, a oumentá supstansialmente. Ora e nirnan no ta funshoná
mas, tin aparato ku, hasiendo uso di "hemodiálisis", parsialmente por purifiká
e sanger. Na 1992 a inougurá e sentro di diálisis Diatel Curaçao, ku sosten di
Nierstichting Nederland i Diatel Amsterdam. Na tratamentu ku hemodiálisis ta
usa mashá awa. Ya ku tabata eksistí problema ku preshon di awa ku tabata
muchu abou, e kompania di distribushon di awa a instalá na mei 1996 tuberia
nobo. Algun siman despues a presentá serka 5 di e 27 pashèntnan keho, den
sentido ku nan tabatin walmentu di stoma i gana di arohá. Ademas a konstatá
oumento di kalsio den nan sanger. Na prinsipio a suponé ku oumento di kalki
den e awa di pipa tabata úniko kousa di e kehonan serka e pashèntnan ku tabata
dialisá. E or'ei a sera Diatel i a trasladá e pashèntnan. No opstante, despues di
un rekuperashon ku a dura poko tempu, dies pashènt a bira grave i a fayesé
despues di a presentá síntoma di atake di epilepsia i a bai den koma. Di
investigashon a bin resultá ku tantu kalki komo aluminio di e furu di paden di
e pipanan a bruha den e awa. A introdusí e pipanan ku un furu di semènt parti
paden, komo esunnan original di metal tabata frusa lihé debí na e defisiensia di
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kalki den e awa destilá di bebe; e furu di semènt parti paden di e pipanan
mester a prevení ku e pipanan lo a frusa parti paden. A resultá, sin embargo, ku
e nivel di aluminio di e furu di semènt tabata kuater biaha mas haltu ku normal
i ademas e no tabata resistente kontra e karakterístikanan ariba menshoná di e
awa di bebe. Di e investigashon a resultá tambe ku pa añanan largu aluminio di
e furu di semènt por a lòs drenta e awa di bebe, pa motibu di lokual pa lunanan
largu e konsentrashon di aluminio den e awa di bebe tabata mas haltu ku e
nivel ku Organisashon Mundial di Salú (WHO) ta konsiderá rekomendabel;
konsekuentemente no mester usa e tipo di semènt akí den pipa di awa di bebe. 
Na kapítulo 3 ta deskribí e resultadonan klíniko di intoksikashon
sup-agudo di aluminio serka e grupo di pashènt en kuestion. E pashèntnan ku
a fayesé tabatin un promedio di edat avansá, nan tabata ménos bon nutrí i nan
tabatin produkshon di orina mas abou ku e diesshete pashèntnan ku a sobreviví.
E eksamen despues di morto di kuater pashènt ta deskribí na kapítulo 4.
Nivel di aluminio den higra, wesu i "hersenschors" tabata signifikantemente
haltu kompará ku e nivelnan normal, loke ta mustra klaramente ku a surpasá e
kapasidat normal di higra i wesu pa akumulá aluminio.
Kapítulo 5 ta duna un bista di loke tin den literatura tokante síntomanan,
fuentenan di intoksikashon di aluminio i mekanismonan ku a kousa e
intoksikashon di aluminio. Ta deskribí ademas un skema di terapia pa tratamentu
di pashèntnan di hemodiálisis ku intoksikashon di aluminio ku e remedi
desferrioxamine, ku kua a trata diesshete pashènt ku éksito.
Kapítulo 6 ta deskribí e implikashonnan hurídiko di e kaso. Ministerio
Públiko a efektuá un investigashon penal i a konkluí na promé instansia ku no
a kometé aktonan kastigabel i ku e pashèntnan a fayesé debí na un koinsidensia
i sirkunstansha ekstraordinario. Famianan di e difuntunan a apelá e desishon di
Ministerio Públiko i, despues di un investigashon hudisial preliminar na
Kòrsou, Hulanda i Bélgika, Ministerio Públiko a dagfar e dos dòkternan di
Diatel. Algun pashènt a eksigí ademas pa pèrsiguí e instanshanan di awa di bebe,
pero Korte a disidí ku no por a atmití nan demanda, pasobra segun lei vigente
e tempu ei no tabata posibel pèrsiguí penalmente un persona hurídiko. Den e
dagvaarding a konsiderá ku e dòkternan ta responsabel pa morto di e pashèntnan,
komo, despues ku a instalá e pipanan di awa di bebe, e dòkternan en kuestion a
reakshoná insufisientemente riba señalnan di alarma di e aparatonan di diálisis i
komo no a tèst e awa den e periodo ei. Ministerio Públiko tabata di opinion ku
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oumento di frekuensha di e señalnan di alarma tabata komo konsekuensha di e
konsentrashon haltu di aluminio den e awa di diálisis. Pero hues a opiná ku esei
no por tabata posibel, ni ku tèstmentu di e awa lo por a prevení ku siguridat
morto di e pashèntnan. Ounke no tabata parti di e dagvaarding, hues a kondená
e direktor médiko pa e echo ku no a manda instalá un instalashon di purifikashon
di awa na Diatel i a dun'é un but i konden'é na un kastigu di prizòn kondishonal.
Den un siguiente huisio di apelashon e dòkter a sali liber.
Konkluyendo por bisa ku hasta ora na islanan chikí tratamentu di
teknologia haltu riba tereno médiko, manera hemodiálisis, ta téknikamente
posibel, introdukshon i aplikashon di e téknikanan en kuestion únikamente
mester tuma lugá despues di un análisis profundo i implementashon di leinan i
protokòlnan relevante.  
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Mijn medeleven gaat uit naar de nabestaanden. Moge de patiënten
die zijn overleden in vrede rusten in de hoop dat hun overlijden ertoe kan
bijdragen andere patiënten te helpen.
Dit proefschrift is tot stand gekomen met de hulp en medewerking van
velen. Hiervoor mijn oprechte dank. Enkele personen wil ik met name
noemen. Op de eerste plaats wil ik de geïntoxiceerde patiënten bedanken
voor hun blijk van vertrouwen; zonder hun steun was ik nimmer aan dit
proefschrift begonnen. De medewerkers van het Laboratorium voor
Toxicologie in het Leids Universitair Medisch Centrum ben ik dankbaar
voor het vele extra werk dat zij hebben verzet en het feit dat zij altijd
behulpzaam wilden zijn bij het verschaffen van literatuur. Collega Hilton
Hewitt was mijn kompaan in donkere tijden en wist me altijd te motiveren
om door te gaan. Achter de schermen waren Ashley Duits en Rob Rojer
onmisbaar als coeditors en klankbord voor ideeën, vooral wanneer ik
diverse aspecten te eenzijdig had belicht. Speciale dank gaat ook uit naar de
directe collega’s waaronder Rauf Engels, Nouaf Ajubi en Cay Winkel die
altijd klaar stonden om voor me waar te nemen als ik weer voor onderzoek
het land uit moest of me moest terugtrekken om stukken te schrijven. Cay,
bedank ik ook voor het beschikbaar stellen van de prent van Curaçao.
Yvonne en Peter Baauw bedankt voor het anders leren denken en het
leren reduceren van te veel informatie tot precies genoeg. Leo Spigt was een
rots in de branding en ik kijk met genoegen terug naar de discussies en de
wijze lessen. Mijn hartelijke dank gaat ook uit naar Ella Rijnschot, mijn
secretaresse, die altijd klaar stond voor het verzetten van bergen typwerk,
het maken van tabellen, of het doen van extra klusjes. Elisabeth Statius
Muller, Els dank ik hartelijk voor de hand- en spandiensten. Christa Weijer
ben ik dankbaar voor het bijstellen van Nederlandse en Engelse teksten en
ook Ingrid Schuringa heeft geholpen om het Engels leesbaarder te maken.
Michael en Julie, jullie waren mijn inspiratiebron om me op te laden als ik
weer ergens voor moest gaan zitten. Jullie hebben je vader vele uren moe-
ten afstaan aan de voorbereiding voor dit proefschrift. Gerardine, het
schrijven van een proefschrift is voor de wederhelft een minstens zo inspan-
nende aangelegenheid. Jou wil ik bedanken voor je steun, het geduld en de
support die je me de afgelopen jaren hebt gegeven en het feit dat je je hebt
kunnen bedwingen de PC het raam uit te gooien. 
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De schrijver van dit proefschrift is geboren op 21 maart 1955 te
Willemstad, Curaçao. Hij heeft zijn middelbare school gevolgd in Amersfoort,
Paramaribo, Maastricht en Heerlen en behaalde in 1976 het VWO diploma
(Atheneum B) aan het Grotius College te Heerlen. In datzelfde jaar werd
begonnen met de studie Geneeskunde aan de Universiteit van Utrecht, waarna
in september 1983 het artsexamen werd behaald. 
Het eerste deel van de opleiding Inwendige Geneeskunde werd gedaan
van oktober 1983 tot maart 1986 in het St. Elisabeth Hospitaal te Curaçao
(opleider: Prof. Dr. A.E.C. Saleh). Aansluitend werd de specialisatie voltooid in
het Academisch Ziekenhuis Utrecht (opleider: Prof. Dr. A. Struyvenberg). 
Na zijn registratie in maart 1989 als internist werkt hij sindsdien in het St.
Elisabeth Hospitaal te Curaçao. Van 1992 tot aan de fusie met het St. Elisabeth
Hospitaal in 1999 was hij tevens medisch directeur van Diatel Curaçao.
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